WO2020149716A1 - Compound and organic light emitting diode comprising same - Google Patents

Compound and organic light emitting diode comprising same Download PDF

Info

Publication number
WO2020149716A1
WO2020149716A1 PCT/KR2020/000947 KR2020000947W WO2020149716A1 WO 2020149716 A1 WO2020149716 A1 WO 2020149716A1 KR 2020000947 W KR2020000947 W KR 2020000947W WO 2020149716 A1 WO2020149716 A1 WO 2020149716A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
substituted
unsubstituted
present specification
light emitting
Prior art date
Application number
PCT/KR2020/000947
Other languages
French (fr)
Korean (ko)
Inventor
강경준
홍완표
금수정
김경희
Original Assignee
주식회사 엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지화학 filed Critical 주식회사 엘지화학
Priority to CN202080005797.8A priority Critical patent/CN112888695B/en
Publication of WO2020149716A1 publication Critical patent/WO2020149716A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02Boron compounds
    • C07F5/027Organoboranes and organoborohydrides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02Boron compounds
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/16Electron transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • H10K50/171Electron injection layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/18Carrier blocking layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/321Metal complexes comprising a group IIIA element, e.g. Tris (8-hydroxyquinoline) gallium [Gaq3]
    • H10K85/322Metal complexes comprising a group IIIA element, e.g. Tris (8-hydroxyquinoline) gallium [Gaq3] comprising boron
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K99/00Subject matter not provided for in other groups of this subclass

Definitions

  • the present specification relates to a compound and an organic light emitting device including the same.
  • the organic light emitting phenomenon refers to a phenomenon that converts electrical energy into light energy using an organic material.
  • An organic light emitting device using an organic light emitting phenomenon usually has a structure including an anode and a cathode and an organic material layer therebetween.
  • the organic material layer is often composed of a multi-layered structure composed of different materials, for example, may be formed of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, and the like.
  • Patent Document WO2017-018326 A1
  • This specification is intended to provide a compound and an organic light emitting device comprising the same.
  • A1 to A3 are the same as or different from each other, and each independently an substituted or unsubstituted aromatic hydrocarbon ring; Or a substituted or unsubstituted aromatic heterocycle,
  • X is B or N
  • Y is N(R11), Z is O; S; Or N(R12),
  • Y is O; S; Or N(R11), Z is N(R12),
  • R1 is a substituted or unsubstituted aryl group
  • R2 is a substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group,
  • R11 is -(L11)n11-Ar1
  • R12 is -(L12)n12-Ar2
  • L11 and L12 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted divalent heterocyclic group,
  • Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Halogen group; Nitrile group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted haloalkyl group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
  • n11 and n12 are the same as or different from each other, and each independently 1 or 2,
  • L11 is the same as or different from each other
  • L12 is the same as or different from each other.
  • the present specification is a first electrode; A second electrode provided to face the first electrode; And an organic light emitting device including at least one layer of an organic material provided between the first electrode and the second electrode, wherein at least one layer of the organic material layer includes a compound represented by Chemical Formula 1 do.
  • the compound according to the exemplary embodiment of the present specification is used in an organic light emitting device, so that a driving voltage of the organic light emitting device can be lowered and light efficiency can be improved.
  • the lifespan characteristics of the small intestine can be improved by the thermal stability of the compound.
  • 1 to 3 show an example of an organic light emitting device according to an exemplary embodiment of the present specification.
  • Figure 4 shows the luminous efficiency (Example 14) according to the doping concentration of the compound A-2 according to an exemplary embodiment of the present specification.
  • the compound represented by Chemical Formula 1 has a structure in which a polycyclic ring is condensed, and the A1 ring and the A2 ring are connected by carbon (bridge alkyl site). By connecting the two rings, it is possible to lower the overall fluidity of the structure and obtain a narrow half-width light emission wavelength. In addition, by introducing various substituents such as an alkyl group and an aryl group at the bridge alkyl site, the emission wavelength can be adjusted. In addition, the polycyclic structure is excellent in stability, and when used as a dopant in the light emitting layer of the organic light emitting device has long life and high efficiency characteristics.
  • the bulk of the three-dimensional structure of the molecule is bulky compared to the structure in which only the alkyl group is connected (bulky). It is possible to increase, and the interaction between the host and the dopant is reduced, thereby improving the life of the device.
  • Cn refers to n carbon atoms.
  • Cn-Cm refers to n to m carbon atoms.
  • substitution means that the hydrogen atom bonded to the carbon atom of the compound is replaced with another substituent, and the position to be substituted is not limited to a position where the hydrogen atom is substituted, that is, a position where the substituent is substitutable, and when two or more are substituted , 2 or more substituents may be the same or different from each other.
  • substituted or unsubstituted in this specification is deuterium; Halogen group; Nitrile group; Alkyl groups; Alkoxy groups; Cycloalkyl group; Amine group; Silyl group; Aryl group; And one or two or more substituents selected from the group consisting of heterocyclic groups, or substituted with two or more substituents among the above-described substituents, or having no substituents.
  • the term "substituted or unsubstituted” is deuterium; Halogen group; C1-C10 alkyl group; C1-C10alkoxy group; C3-C30 cycloalkyl group; Amine group; Silyl group; C6-C30Aryl group; And N, O, or substituted with one or more substituents selected from the group consisting of C2-C30 heterocyclic group containing S or. It means that two or more groups selected from the above group are substituted with linked substituents or have no substituents.
  • substituted or unsubstituted is deuterium; Halogen group; C1-C10 alkyl group; Amine group; Silyl group; C6-C30Aryl group; And N, O, or substituted with one or more substituents selected from the group consisting of C2-C30 heterocyclic group containing S or. It means that two or more groups selected from the above group are substituted with linked substituents or have no substituents.
  • two or more substituents are connected means that hydrogen of one substituent is connected to another substituent.
  • an isopropyl group and a phenyl group are connected or It can be a substituent of.
  • two phenyl groups and isopropyl groups are connected or It can be a substituent of. The same applies to those above which four or more substituents are connected.
  • examples of the halogen group include fluorine, chlorine, bromine, or iodine.
  • the alkyl group may be straight chain or branched chain, and the number of carbon atoms is not particularly limited, but is preferably 1 to 50, more preferably 1 to 30.
  • Specific examples are methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, sec-butyl, 1-methylbutyl, 1-ethylbutyl, pentyl, n-pentyl, iso Pentyl, neopentyl, tert-pentyl, hexyl, n-hexyl, 2-methylpentyl, 4-methylpentyl, 3,3-dimethylbutyl, 2-ethylbutyl, heptyl, n-heptyl, 1-methylhexyl, cyclopentyl Methyl, cyclohexylmethyl, octyl,
  • the cycloalkyl group is not particularly limited, but is preferably 3 to 60 carbon atoms, and more preferably 3 to 30 carbon atoms.
  • the haloalkyl group may be a straight chain or a branched chain, and the hydrogen of the aforementioned alkyl group is substituted with one or two or more halogen groups.
  • Carbon number is not particularly limited, but is 1 to 30; 1 to 20; 1 to 10; Or it is preferably 1 to 5.
  • the description of the alkyl group described above may be applied to the alkyl group.
  • Specific examples of haloalkyl groups include, but are not limited to, fluoromethyl groups, difluoromethyl groups, trifluoromethyl groups, chloromethyl groups, dichloromethyl groups, trichloromethyl groups, bromomethyl groups, dibromomethyl groups, tribromomethyl groups, and the like. Does not work.
  • the silyl group includes Si and the Si atom is a substituent directly connected as a radical, and is represented by -SiR 201 R 202 R 203 , R 201 to R 203 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; Alkyl groups; Alkenyl group; Alkoxy groups; Cycloalkyl group; Aryl group; And a heterocyclic group.
  • silyl group examples include trimethylsilyl group, triethylsilyl group, t-butyldimethylsilyl group, vinyldimethylsilyl group, propyldimethylsilyl group, triphenylsilyl group, diphenylsilyl group, phenylsilyl group, and the like. It is not limited.
  • the aryl group is a monocyclic aryl group
  • the number of carbon atoms is not particularly limited, but is preferably 6 to 50 carbon atoms, more preferably 6 to 30 carbon atoms.
  • the monocyclic aryl group may be a phenyl group, a biphenyl group, a terphenyl group, a quarterphenyl group, and the like, but is not limited thereto.
  • the aryl group is a polycyclic aryl group
  • the number of carbon atoms is not particularly limited. It is preferable that it is 10-50 carbon atoms, and 10-30 is more preferable.
  • the polycyclic aryl group may be a naphthyl group, anthracenyl group, phenanthryl group, pyrenyl group, perylenyl group, triphenyl group, chrysenyl group, fluorenyl group, but is not limited thereto.
  • the fluorenyl group may be substituted, and adjacent substituents may combine with each other to form a ring.
  • the substituent of carbon 9 may form a ring to form a spiro structure.
  • the heteroaryl group is a heteroatom containing at least one of N, O, S, Si, and Se, and carbon number is not particularly limited, but is preferably 2 to 60 carbon atoms, and more preferably 2 to 30 carbon atoms. Do.
  • heteroaryl group examples include thiophene group, furan group, pyrrol group, imidazole group, thiazole group, oxazole group, oxadiazole group, triazole group, pyridine group, bipyridine group, pyrimidine group, triazine group, and acry Dean group, pyridazine group, pyrazine group, quinoline group, quinazoline group, quinoxaline group, phthalazine group, phthalazine, pteridine group, pyrido pyrimidine group, pyridodo pyrimidine group, pyridodo pyridine group pyrazine), pyrazino pyrazine, isoquinoline, indole, pyrido indole, indo pyrimidine, carbazole, benzoxazole, benzimidazole , Benzothiazole group, benzocarbazole group, benzothioph
  • the amine group may be represented by the formula of -NR 301 R 302 , wherein R 301 and R 302 are each hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted aryl group; Or it may be a substituted or unsubstituted heterocyclic group.
  • the amine group is an alkylamine group; Arylalkylamine groups; Arylamine group; Aryl heteroarylamine group; Alkyl heteroarylamine groups; And a heteroarylamine group, and more specifically, a dimethylamine group; Diphenylamine group; And the like, but is not limited to these.
  • the arylamine group means a group in which the nitrogen atom of the amine is substituted with an aryl group.
  • the arylamine group include a substituted or unsubstituted monoarylamine group; Or a substituted or unsubstituted diarylamine group.
  • the aryl group in the arylamine group may be a monocyclic aryl group or a polycyclic aryl group.
  • An arylamine group including the two or more aryl groups is a monocyclic aryl group; Or it may contain a polycyclic aryl group, or may include a monocyclic aryl group and a polycyclic aryl group at the same time.
  • arylamine group examples include phenylamine, naphthylamine, biphenylamine, anthracenylamine, diphenylamine group, phenylnaphthylamine group, ditolylamine group, phenyltolylamine group, and the like. no.
  • a heteroarylamine group means a group in which the nitrogen atom of the amine is substituted with a heteroaryl group.
  • the heteroarylamine group is, for example, a substituted or unsubstituted monoheteroarylamine group; Or it may be a substituted or unsubstituted diheteroarylamine group.
  • the heteroaryl group in the heteroarylamine group may be a monocyclic heteroaryl group or a polycyclic heteroaryl group.
  • the heteroarylamine group including the two or more heteroaryl groups is a monocyclic heteroaryl group; Or it may include a polycyclic heteroaryl group, or may include a monocyclic heteroaryl group and a polycyclic heteroaryl group at the same time.
  • the aryl heteroarylamine group means an amine group substituted with an aryl group and a heteroaryl group.
  • the aralkylamine group means an amine group substituted with an aryl group or an alkyl group.
  • the description of the aforementioned alkyl group may be applied to the alkyl group in the aralkylamine group and the alkylaryl group.
  • the aryl group in the aryl heteroarylamine group, the aralkylamine group, and the arylamine group may be applied to the aryl group described above.
  • heteroaryl group described above may be applied to the heteroaryl group in the arylheteroarylamine group.
  • the arylene group means that the aryl group has two bonding positions, that is, a divalent group. These may be applied to the description of the aryl group described above, except that each is a divalent group.
  • the heteroarylene group means that the heteroaryl group has two bonding positions, that is, a divalent group. These may be applied to the description of the heteroaryl group described above, except that each is a divalent group.
  • the “adjacent” group refers to a substituent substituted on an atom directly connected to an atom in which the substituent is substituted, a substituent positioned closest to the substituent and the other substituent substituted on the atom in which the substituent is substituted.
  • two substituents substituted in the ortho position on the benzene ring and two substituents substituted on the same carbon in the aliphatic ring may be interpreted as "adjacent" groups to each other.
  • ring is a substituted or unsubstituted hydrocarbon ring; Or substituted or unsubstituted heterocyclic ring.
  • the hydrocarbon ring may be an aromatic, aliphatic or aromatic and aliphatic condensed ring, and may be selected from examples of the cycloalkyl group or aryl group except for the non-monovalent.
  • the aromatic ring may be monocyclic or polycyclic, and may be selected from examples of the aryl group, except that it is not monovalent.
  • the heterocycle is a non-carbon atom, and contains one or more heteroatoms.
  • the hetero atom may include one or more atoms selected from the group consisting of O, N, Se, and S.
  • the heterocycle may be monocyclic or polycyclic, may be aromatic, aliphatic or aromatic and aliphatic condensed ring, and may be selected from examples of the heteroaryl group except for non-monovalent.
  • the adamantyl group (adamantly group) is a type of cycloalkyl group, and the cyclohexane ring is condensed in a bridge form.
  • adamantane (C 10 H 16 ) one hydrogen is connected to the other linker, or It can be displayed as.
  • A1 to A3 are the same as or different from each other, and each independently an substituted or unsubstituted aromatic hydrocarbon ring; Or a substituted or unsubstituted aromatic heterocycle.
  • A1 to A3 are the same as or different from each other, and each independently substituted or unsubstituted C6-C30 aromatic hydrocarbon ring; Or a substituted or unsubstituted C2-C30 aromatic heterocycle.
  • A1 to A3 are the same as or different from each other, and each independently substituted or unsubstituted C6-C20 aromatic hydrocarbon ring; Or a substituted or unsubstituted C2-C20 aromatic heterocycle.
  • A1 to A3 are the same as or different from each other, and each independently a substituted or unsubstituted monocyclic to tricyclic aromatic hydrocarbon ring; Or a substituted or unsubstituted monocyclic to tricyclic aromatic heterocycle.
  • A1 to A3 are the same as or different from each other, and each independently a substituted or unsubstituted monocyclic to bicyclic aromatic hydrocarbon ring; Or a substituted or unsubstituted monocyclic to bicyclic aromatic heterocycle.
  • A1 to A3 are the same as or different from each other, and each independently a substituted or unsubstituted monocyclic aromatic hydrocarbon ring; Or a substituted or unsubstituted monocyclic aromatic heterocycle.
  • A1 to A3 are the same as or different from each other, and each independently a substituted or unsubstituted monocyclic to bicyclic aromatic hydrocarbon ring.
  • A1 to A3 are the same or different from each other, and each independently a substituted or unsubstituted benzene ring.
  • A1 to A3 are benzene rings.
  • A1 to A3 may be substituted or unsubstituted by Q.
  • Q is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted amine group; A substituted or unsubstituted arylamine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
  • Q is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted arylamine group; Or a substituted or unsubstituted aryl group.
  • Q is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted C1-C20 alkyl group; A substituted or unsubstituted C1-C20 alkoxy group; A substituted or unsubstituted C1-C20 amine group; A substituted or unsubstituted C6-C60 arylamine group; A substituted or unsubstituted C6-C30 aryl group; Or a substituted or unsubstituted C2-C30 heterocyclic group.
  • Q is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C1-C10 alkoxy group; A substituted or unsubstituted C1-C20 amine group; A substituted or unsubstituted C6-C40 arylamine group; A substituted or unsubstituted C6-C20 aryl group; Or a substituted or unsubstituted C2-C20 heterocyclic group.
  • Q is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C1-C10 alkoxy group; A substituted or unsubstituted C6-C40 arylamine group; Or a substituted or unsubstituted C6-C20 aryl group.
  • Q when Q is a substituted aryl group, deuterium; C1-C10 alkyl group; C1-C5 alkyl group; Methyl group; Or it may be substituted with a t-butyl group.
  • Q when Q is a substituted alkoxy group, a halogen group; More preferably, it may be substituted with fluorine.
  • Q is hydrogen; heavy hydrogen; Fluorine; Methyl group; t-butyl group; -OCF 3 ; Diphenylamine group; An amine group substituted with a phenyl group unsubstituted or substituted with deuterium or t-butyl group; Or carbazole.
  • X is B or N.
  • X is B.
  • R1 is a substituted or unsubstituted aryl group.
  • R1 is a substituted or unsubstituted C6-C30 aryl group.
  • R1 is a substituted or unsubstituted C6-C20 aryl group.
  • R1 when R1 is a substituted aryl group, deuterium; C1-C10 alkyl group; Or it may be substituted with a C1-C5 alkyl group.
  • R1 is a C6-C20 aryl group unsubstituted or substituted with a deuterium or alkyl group.
  • R1 is a C6-C20 aryl group unsubstituted or substituted with one or more substituents selected from the group consisting of deuterium or C1-C5 alkyl groups or two or more groups selected from the group.
  • R1 is a C6-C20 aryl group unsubstituted or substituted with deuterium or a C1-C5 alkyl group.
  • R1 is a phenyl group unsubstituted or substituted with a deuterium or methyl group.
  • R2 is a substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
  • R2 is a substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted C6-C30 aryl group.
  • R2 is a substituted or unsubstituted C1-C5 alkyl group; Or a substituted or unsubstituted C6-C20 aryl group.
  • R2 when R2 is a substituted alkyl group, it may be substituted with deuterium.
  • R2 when R2 is a substituted aryl group, deuterium; C1-C10 alkyl group; Or it may be substituted with a C1-C5 alkyl group.
  • R2 is a substituted or unsubstituted C1-C5 alkyl group; Or a C6-C20 aryl group which is unsubstituted or substituted with one or more substituents selected from the group consisting of deuterium or C1-C5 alkyl groups or two or more groups selected from the group.
  • R2 is a substituted or unsubstituted C1-C5 alkyl group; Or a C6-C20 aryl group unsubstituted or substituted with deuterium or a C1-C5 alkyl group.
  • R2 is a methyl group; Or a phenyl group unsubstituted or substituted with deuterium or methyl groups.
  • R1 and R2 are the same or different from each other, and are each independently a substituted or unsubstituted C6-C30 aryl group.
  • R1 and R2 are the same as or different from each other, and each independently substituted with one or more substituents selected from the group consisting of deuterium or C1-C5 alkyl groups or two or more groups selected from the group, or It is an unsubstituted C6-C20 aryl group.
  • Y is O; S; Or N(R11).
  • Z is O; S; Or N(R12).
  • Y is N(R11).
  • Y is N(R11), Z is O; S; Or N(R12).
  • Z is N(R12), Y is O; S; Or N(R11).
  • R11 is -(L11)n11-Ar1.
  • R12 is -(L12)n12-Ar2.
  • L11 and L12 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted divalent heterocyclic group.
  • L11 and L12 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted C6-C30 arylene group; Or a substituted or unsubstituted C2-C30 divalent heterocyclic group.
  • L11 and L12 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted C6-C20 arylene group; Or a substituted or unsubstituted C2-C20 divalent heterocyclic group.
  • L11 and L12 are the same as or different from each other, and each independently a direct bond; Or a substituted or unsubstituted C6-C20 arylene group.
  • L11 and L12 are the same as or different from each other, and each independently a direct bond; Or a substituted or unsubstituted phenylene group.
  • L11 or L12 when L11 or L12 is a substituted arylene group, an alkyl group; C1-C10 alkyl group; C1-C5 alkyl group; Heterocyclic group; C6-C30 heterocyclic group; Or it may be substituted with a C6-C20 heterocyclic group.
  • L11 or L12 when L11 or L12 is a substituted arylene group, deuterium; And one or more substituents selected from the group consisting of alkyl groups or two or more groups selected from the group. More preferably, the arylene group of L1 or L2 is deuterium; And it may be substituted with one or more substituents selected from the group consisting of C1-C5 alkyl group or two or more groups selected from the group.
  • L11 or L12 when L11 or L12 is a substituted divalent heterocyclic group, an alkyl group; C1-C10 alkyl group; C1-C5 alkyl group; Aryl group; C6-C30Aryl group; Or it may be substituted with an aryl group of C6-C20.
  • L11 and L12 are the same as or different from each other, and each independently a direct bond; A C6-C20 arylene group unsubstituted or substituted with a C1-C5 alkyl group or a C2-C20 heterocyclic group; Or a C2-C20 divalent heterocyclic group unsubstituted or substituted with a C1-C5 alkyl group or a C6-C20 aryl group.
  • L11 and L12 are the same as or different from each other, and each independently a direct bond; Or a C6-C20 arylene group unsubstituted or substituted with a C1-C5 alkyl group.
  • L11 and L12 are the same as or different from each other, and each independently a direct bond; A phenylene group unsubstituted or substituted with a methyl group or a t-butyl group; Naphthylene group; A fluorenylene group substituted with a methyl group; Terphenylene group; A divalent pyridine group unsubstituted or substituted with a phenyl group; Divalent dibenzofuran group; Or a divalent dibenzothiophene group.
  • L11 and L12 are the same as or different from each other, and each independently a direct bond; Or a phenylene group unsubstituted or substituted with a methyl group or a t-butyl group.
  • n11 is 1 or 2.
  • n12 is 1 or 2.
  • n11 is 1.
  • n12 is 1.
  • L11 when n11 is 2, L11 is the same or different from each other, and when n12 is 2, L12 is the same or different from each other.
  • Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Halogen group; Nitrile group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted haloalkyl group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
  • Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Halogen group; Nitrile group; A substituted or unsubstituted C1-C20 alkyl group; A substituted or unsubstituted C3-C30 cycloalkyl group; A substituted or unsubstituted C1-C20 haloalkyl group; A substituted or unsubstituted C1-C60 silyl group; A substituted or unsubstituted C6-C30 aryl group; Or a substituted or unsubstituted C2-C30 heterocyclic group.
  • Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Halogen group; Nitrile group; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C3-C20 cycloalkyl group; A substituted or unsubstituted C1-C10 haloalkyl group; A substituted or unsubstituted C1-C40 silyl group; A substituted or unsubstituted C6-C20 aryl group; Or a substituted or unsubstituted C2-C20 heterocyclic group.
  • Ar1 and Ar2 are the same as or different from each other, and each independently a substituted or unsubstituted C3-C30 cycloalkyl group; A substituted or unsubstituted C6-C30 aryl group; Or a substituted or unsubstituted C2-C30 heterocyclic group.
  • Ar1 and Ar2 are the same as or different from each other, and each independently a substituted or unsubstituted C3-C20 cycloalkyl group; A substituted or unsubstituted C6-C20 aryl group; Or a substituted or unsubstituted C2-C20 heterocyclic group.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted alkyl group, deuterium; Or it may be substituted with a halogen group.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted silyl group, an alkyl group; C1-C10 alkyl group; C1-C5 alkyl group; Methyl group; Aryl group; C6-C30Aryl group; C6-C20Aryl group; Or it may be substituted with a phenyl group.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted aryl group, deuterium; Halogen group; Alkyl groups; An alkyl group substituted with deuterium; Haloalkyl group; Silyl group; And one or more substituents selected from the group consisting of heterocyclic groups or two or more groups selected from the group.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted aryl group, deuterium; Halogen group; Alkyl groups; An alkyl group substituted with deuterium; Haloalkyl group; A silyl group substituted with an alkyl group; Or it may be substituted with a heterocyclic group.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted aryl group, deuterium; Halogen group; C1-C10 alkyl group; A C1-C10 alkyl group substituted with deuterium; C1-C10 haloalkyl group; A silyl group substituted with a C1-C10 alkyl group; Or it may be substituted with a heterocyclic group of C2-C30.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted aryl group, deuterium; Halogen group; C1-C5 alkyl group; A C1-C5 alkyl group substituted with deuterium; C1-C5 haloalkyl group; A silyl group substituted with an alkyl group of C1-C5; And C2-C20 heterocyclic groups, or one or more substituents selected from the group, or two or more groups selected from the group, may be substituted with linked substituents.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted aryl group, deuterium; Halogen group; C1-C5 alkyl group; A C1-C5 alkyl group substituted with deuterium; C1-C5 haloalkyl group; Or it may be substituted with a C2-C20 heterocyclic group.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted aryl group, deuterium; And C1-C5 alkyl group may be substituted with one or more substituents selected from the group consisting of two or more substituents.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted aryl group, deuterium; C1-C5 alkyl group; Or it may be substituted with a C1-C5 alkyl group substituted with deuterium.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted aryl group, deuterium; Halogen group; Methyl group; Ethyl group; Propyl group; t-butyl group; CD 3 ; CF 3 ; Pyridine group; Pyrimidine group; Dibenzofuran group; Dibenzothiophene group; Or it may be substituted with a carbazole group.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted aryl group, deuterium; A methyl group unsubstituted or substituted with deuterium; It may be substituted with a t-butyl group.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted heterocyclic group, deuterium; Halogen group; Alkyl groups; An alkyl group substituted with deuterium; Haloalkyl group; Or it may be substituted with an aryl group.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted heterocyclic group, deuterium; Halogen group; C1-C10 alkyl group; A C1-C10 alkyl group substituted with deuterium; C1-C10 haloalkyl group; Or it may be substituted with an aryl group of C6-C30.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted heterocyclic group, deuterium; Halogen group; C1-C5 alkyl group; A C1-C5 alkyl group substituted with deuterium; C1-C5 haloalkyl group; And a C6-C20 aryl group, or one or more substituents selected from the group or two or more groups selected from the group may be substituted with linked substituents.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted heterocyclic group, deuterium; Halogen group; C1-C5 alkyl group; A C1-C5 alkyl group substituted with deuterium; C1-C5 haloalkyl group; Or it may be substituted with an aryl group of C6-C20.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted heterocyclic group, deuterium; Halogen group; Methyl group; Ethyl group; Propyl group; t-butyl group; CD 3 ; CF 3 ; Phenyl group; Biphenyl group; Naphthyl group; Terphenyl group; Or it may be substituted with a fluorenyl group.
  • Ar1 or Ar2 when Ar1 or Ar2 is a substituted heterocyclic group, deuterium; A methyl group unsubstituted or substituted with deuterium; It may be substituted with a t-butyl group.
  • Ar1 and Ar2 are the same as or different from each other, and each independently a C3-C20 cycloalkyl group; A substituted or unsubstituted C6-C20 aryl group; Or a substituted or unsubstituted C2-C20 heterocyclic group.
  • Ar1 and Ar2 are the same as or different from each other, and each independently a C3-C30 cycloalkyl group; In the group consisting of deuterium, halogen groups, C1-C5 alkyl groups, C1-C5 alkyl groups substituted with deuterium, C1-C5 haloalkyl groups, C1-C5 alkyl group-substituted silyl groups, and C2-C20 heterocyclic groups.
  • a C6-C20 aryl group which is unsubstituted or substituted with one or more substituents selected or two or more groups selected from the group; Or in the group consisting of deuterium, halogen group, C1-C5 alkyl group, C1-C5 alkyl group substituted with deuterium, C1-C5 haloalkyl group, C1-C5 alkyl group-substituted silyl group, and C6-C20 aryl group. It is a C2-C20 heterocyclic group unsubstituted or substituted with one or more substituents selected or two or more groups selected from the group.
  • Ar1 and Ar2 are the same as or different from each other, and each independently a C3-C30 cycloalkyl group; In the group consisting of deuterium, halogen groups, C1-C5 alkyl groups, C1-C5 alkyl groups substituted with deuterium, C1-C5 haloalkyl groups, C1-C5 alkyl group-substituted silyl groups, and C2-C20 heterocyclic groups.
  • a C6-C20 aryl group which is unsubstituted or substituted with one or more substituents selected or two or more groups selected from the group; Or C2 substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium, an alkyl group of C1-C5, an alkyl group of C1-C5 substituted with deuterium, and an aryl group of C6-C20, or two or more groups selected from the group.
  • -C20 heterocyclic group which is unsubstituted or substituted with one or more substituents selected or two or more groups selected from the group.
  • Ar1 and Ar2 are the same as or different from each other, and each independently substituted or substituted with one or more substituents selected from the group consisting of deuterium and C1-C5 alkyl groups or two or more groups selected from the group.
  • Ar1 and Ar2 are the same as or different from each other, and each independently an adamantyl group; A phenyl group unsubstituted or substituted with deuterium, fluoro, methyl, t-butyl, trifluoromethyl, trimethylsilyl or pyridine groups; A biphenyl group unsubstituted or substituted with deuterium, fluoro, t-butyl or trifluoromethyl; A terphenyl group unsubstituted or substituted with a deuterium or trifluoromethyl group; Naphthyl group; A fluorenyl group unsubstituted or substituted with a methyl group; A methyl group, a methyl group substituted with deuterium, or a pyridine group unsubstituted or substituted with a phenyl group; a dibenzofuran group unsubstituted or substituted with a t-butyl group; Or
  • Ar1 and Ar2 are the same as or different from each other, and each independently a phenyl group unsubstituted or substituted with deuterium, a methyl group, or a t-butyl group; A biphenyl group unsubstituted or substituted with deuterium or t-butyl group; Or dibenzofuran group.
  • Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Halogen group; A C1-C10 alkyl group unsubstituted or substituted with deuterium; C3-C20 cycloalkyl group; CF 3 ; Trimethylsilyl group; C6-C20 aryl group unsubstituted or substituted with deuterium or C1-C10 alkyl group; Or a substituted group of CD 3 or C1-C10 alkyl group or C2-C20 heterocyclic group.
  • Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Fluorine; Methyl group; t-butyl group; CD 3 ; Adamantyl group; CF 3 ; Trimethylsilyl group; A phenyl group unsubstituted or substituted with deuterium, fluorine, methyl group, t-butyl group, CD 3 , CF 3 , or pyridine group; Naphthyl group; A terphenyl group unsubstituted or substituted with deuterium; A fluorenyl group unsubstituted or substituted with a methyl group; a dibenzofuran group unsubstituted or substituted with a t-butyl group; a dibenzothiophene group unsubstituted or substituted with a t-butyl group; A carbazole group unsubstituted or substituted with a phenyl group; Or
  • Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Fluorine; Methyl group; t-butyl group; CD 3 ; Adamantyl group; CF 3 ; Trimethylsilyl group; A phenyl group unsubstituted or substituted with deuterium; Naphthyl group; A fluorenyl group unsubstituted or substituted with a methyl group; Dibenzofuran group; Dibenzothiophene group; A carbazole group unsubstituted or substituted with a phenyl group; Or a pyridine group unsubstituted or substituted with a methyl group, CD 3 , or CF 3 .
  • Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Fluorine; Methyl group; t-butyl group; CD 3 ; Adamantyl group; CF 3 ; Trimethylsilyl group; Phenyl group; Naphthyl group; Fluorenyl group; Dibenzofuran group; Dibenzothiophene group; Carbazole; Or a pyridine group.
  • Chemical Formula 1 is represented by Chemical Formula 2 below.
  • R1, R2 and X to Z are the same as defined in Formula 1,
  • Q1 to Q3 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted amine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
  • q1 to q3 are each an integer of 0 to 3, and when q1 to q3 are each 2 or more, the substituents in parentheses are the same or different from each other.
  • definitions of Q1 to Q3 are the same as those of the Q.
  • Q1 to Q3 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C1-C10 alkoxy group; A substituted or unsubstituted C6-C40 arylamine group; A substituted or unsubstituted C6-C20 aryl group; Or a substituted or unsubstituted C2-C20 heterocyclic group.
  • Q1 and Q2 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted C6-C30 aryl group.
  • Q1 and Q2 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A C1-C10 alkyl group unsubstituted or substituted with deuterium; Or a C6-C30 aryl group unsubstituted or substituted with deuterium or halogen groups.
  • Q1 and Q2 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; C1-C5 alkyl group; Or a C6-C20 aryl group unsubstituted or substituted with a halogen group.
  • Q1 and Q2 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Methyl group; Or a phenyl group unsubstituted or substituted with a fluoro group.
  • Q3 is hydrogen; heavy hydrogen; Halogen group; C1-C10 alkyl group; C1-C10alkoxy group; C1-C30 trialkylsilyl group; C6-C60 arylamine group; C6-C30Aryl group; And a C2-C30 heterocyclic group, or one or more substituents selected from the group, or two or more groups selected from the group.
  • Q3 is hydrogen; heavy hydrogen; Halogen group; C1-C10 alkyl group; C1-C30 trialkylsilyl group; C6-C60 arylamine group; C6-C30Aryl group; And a C2-C30 heterocyclic group, or one or more substituents selected from the group, or two or more groups selected from the group.
  • Q3 is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted arylamine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
  • Q3 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; A substituted or unsubstituted arylamine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
  • Q3 is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C1-C10 alkoxy group; A substituted or unsubstituted C6-C60 arylamine group; A substituted or unsubstituted C6-C30 aryl group; Or a substituted or unsubstituted C2-C30 heterocyclic group.
  • Q3 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C6-C60 arylamine group; A substituted or unsubstituted C6-C30 aryl group; Or a substituted or unsubstituted C2-C30 heterocyclic group.
  • Q3 is hydrogen; heavy hydrogen; Halogen group; A C1-C10 alkyl group unsubstituted or substituted with deuterium; A C1-C10 alkoxy group unsubstituted or substituted with a halogen group; C6-C60 arylamine group unsubstituted or substituted with deuterium or C1-C30 trialkylsilyl group; C6-C30 aryl group unsubstituted or substituted with deuterium, halogen group or C1-10 alkyl group; Or a C2-C30 heterocyclic group unsubstituted or substituted with deuterium or a C1-10 alkyl group.
  • Q3 is hydrogen; heavy hydrogen; Halogen group; A C1-C10 alkyl group unsubstituted or substituted with deuterium; C6-C40 arylamine group unsubstituted or substituted with deuterium or C1-C30 trialkylsilyl group; C6-C20 aryl group unsubstituted or substituted with deuterium, halogen group or C1-10 alkyl group; Or a C2-C20 heterocyclic group unsubstituted or substituted with deuterium or a C1-10 alkyl group.
  • Q3 is hydrogen; heavy hydrogen; Halogen group; A C1-C5 alkyl group unsubstituted or substituted with deuterium; C6-C40 arylamine group unsubstituted or substituted with deuterium or C1-C15 trialkylsilyl group; C6-C20 aryl group unsubstituted or substituted with deuterium, halogen group or C1-C5 alkyl group; Or a C2-C20 heterocyclic group unsubstituted or substituted with deuterium or a C1-C5 alkyl group.
  • Q3 is hydrogen; heavy hydrogen; Fluoro groups; Methyl group; t-butyl group; Trifluoromethoxy group; A diphenylamine group unsubstituted or substituted with deuterium or trimethylsilyl group; A phenyl group unsubstituted or substituted with deuterium, a fluoro group, or a t-butyl group; Or a carbazole group unsubstituted or substituted with a t-butyl group.
  • Q3 is hydrogen; heavy hydrogen; Methyl group; t-butyl group; A diphenylamine group unsubstituted or substituted with deuterium or trimethylsilyl group; A phenyl group unsubstituted or substituted with deuterium, a fluoro group, or a t-butyl group; Or a carbazole group unsubstituted or substituted with a t-butyl group.
  • Q3 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C6-C40 arylamine group; A substituted or unsubstituted C6-C20 aryl group; Or a substituted or unsubstituted C2-C20 heterocyclic group.
  • q1 is an integer from 0 to 3.
  • q2 is an integer from 0 to 3.
  • q3 is an integer from 0 to 3.
  • q1 is 1.
  • q2 is 1.
  • q3 is 1.
  • q1 when q1 is 2 or more, a plurality of Q1s are the same or different from each other. In another exemplary embodiment, when q2 is 2 or more, a plurality of Q2s are the same or different from each other. In another exemplary embodiment, when q3 is 2 or more, a plurality of Q3s are the same or different from each other.
  • Chemical Formula 3 is represented by any one of the following Chemical Formulas 301 to 303.
  • R1, R2, L11, L12, Ar1, Ar2, n11 and n12 are as defined in Formula 1,
  • Y1 is O; Or S,
  • Z1 is O; Or S,
  • Q1 to Q3 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted amine group; A substituted or unsubstituted arylamine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
  • q1 to q3 are each an integer of 0 to 3, and when q1 to q3 are each 2 or more, the substituents in parentheses are the same or different from each other.
  • Y1 is O.
  • Y1 is S.
  • Z1 is O.
  • Z1 is S.
  • Q1 to Q3 in Chemical Formulas 301 to 303 are the same as the definitions of Q1 to Q3 in Chemical Formula 2.
  • q1 to q3 in Chemical Formulas 301 to 303 are the same as the definitions of q1 to q3 in Chemical Formula 2.
  • A1 to A3 are the same as or different from each other, and each independently a substituted or unsubstituted benzene ring,
  • L11 and L12 are the same as or different from each other, and each independently a direct bond; Or a C6-C20 arylene group unsubstituted or substituted with a C1-C5 alkyl group,
  • Ar1 and Ar2 are the same or different from each other, and each independently a deuterium and a C1-C5 aryl group which is unsubstituted or substituted with one or more substituents selected from the group consisting of alkyl groups of C1-C5 or two or more groups selected from the group; Or a C2-C20 heterocyclic group.
  • the compound represented by Chemical Formula 1 is any one selected from the following compounds.
  • the compound according to one embodiment of the present specification may be prepared by a manufacturing method described later. If necessary, a substituent may be added or excluded, and the position of the substituent may be changed. In addition, starting materials, reactants, reaction conditions, etc. can be changed based on techniques known in the art.
  • the compound represented by Formula 1 may have a core structure as shown in Formula 1 below.
  • Substituents can be combined by methods known in the art, and the type, location, or number of substituents can be changed according to techniques known in the art. Substituents may be combined as shown in Formula 1 below, but are not limited thereto.
  • R11, R12, Y and R2 are defined as defined in Formula 1.
  • Intermediate IM-3 can be obtained by coupling reaction using Pd catalyst of intermediate IM-1 and intermediate IM-2 or ring formation or SNAr reaction using acid, and in this process, only when R2 of formula 1 is phenyl group
  • the intermediate IM-3 in which R2 is an aryl group other than a phenyl group can be synthesized using an aryl group other than a phenyl group.
  • a compound having Formula 1 can be synthesized by a Li-X exchange reaction followed by a boron addition reaction.
  • the present specification provides an organic light emitting device comprising the above-described compound.
  • This specification is the first electrode; A second electrode provided to face the first electrode; And an organic light emitting device including at least one layer of an organic material provided between the first electrode and the second electrode, wherein at least one layer of the organic material layer includes a compound represented by Chemical Formula 1 do.
  • the organic material layer includes a light emitting layer
  • the light emitting layer includes a compound represented by the formula (1).
  • the'layer' is a meaning compatible with the'film' mainly used in the technical field, and refers to a coating covering a desired area.
  • the size of the'layer' is not limited, and each'layer' may have the same or different sizes. In an exemplary embodiment, the size of the'layer' may be the same as that of the entire device, may correspond to the size of a specific functional area, or may be as small as a single sub-pixel.
  • the meaning that a specific A material is included in the B layer means i) one or more A materials are included in one B layer, and ii) the B layer is composed of one or more layers, and the A material is a multilayer B. All of the layers included in one or more layers are included.
  • the meaning that a specific A material is included in the C layer or the D layer includes i) one or more of the C layers of one or more layers, ii) one or more of the D layers of one or more layers, or iii ) It means both included in each of the C layer of one or more layers and the D layer of one or more layers.
  • the organic light emitting device may include an additional organic material layer in addition to the light emitting layer.
  • the organic material layer of the organic light emitting device of the present specification may have a single layer structure, but may have a multi-layer structure in which two or more organic material layers are stacked.
  • it may have a structure including a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, an electron blocking layer, a hole blocking layer, and the like.
  • the structure of the organic light emitting device is not limited to this, and may include fewer organic layers.
  • the organic light emitting diode according to the exemplary embodiment of the present specification includes a light emitting layer, and the light emitting layer includes a compound represented by Formula 1 and a compound represented by Formula H below.
  • L21 and L22 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted heteroarylene group,
  • R21 to R28 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted silyl group; A substituted or unsubstituted phosphine oxide group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heteroaryl group,
  • Ar101 and Ar102 are the same as or different from each other, and each independently a substituted or unsubstituted aryl group; Or a substituted or unsubstituted heteroaryl group.
  • L21 and L22 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted heteroarylene group.
  • L21 and L22 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted C6-C30 arylene group; Or a substituted or unsubstituted C2-C30 heteroarylene group containing N, O, or S.
  • L21 and L22 are the same as or different from each other, and each independently a direct bond; C6-C20arylene group; Or a C2-C20 heteroarylene group containing N, O, or S.
  • the arylene group or heteroarylene group is substituted or unsubstituted with a C1-C10 alkyl group, a C6-C20 aryl group, or a C2-C20 heteroaryl group.
  • the'substituted or unsubstituted' refers to a C1-C10 alkyl group, a C6-C20 aryl group, or a C2-C20 heteroaryl group, or no substituent.
  • L21 and L22 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted phenylene group; A substituted or unsubstituted naphthylene group; Or a substituted or unsubstituted thiophenylene group.
  • L21 and L22 are the same as or different from each other, and each independently a direct bond; Phenylene group; Naphthylene group; Or a thiophenylene group.
  • L21 and L22 are the same as or different from each other, and each independently a direct bond; Phenylene group; Or a naphthylene group.
  • L21 and L22 are a direct bond.
  • Ar101 and Ar102 are the same as or different from each other, and each independently a substituted or unsubstituted aryl group; Or a substituted or unsubstituted heteroaryl group.
  • Ar101 and Ar102 are the same as or different from each other, and each independently a substituted or unsubstituted C6-C30 aryl group; Or a C2-C30 heteroaryl group unsubstituted or substituted with Y1.
  • Ar101 and Ar102 are the same as or different from each other, and each independently a substituted or unsubstituted C6-C20 aryl group with Y1; Or a C2-C20 heteroaryl group unsubstituted or substituted with Y1.
  • Ar101 and Ar102 are the same as or different from each other, and each independently a monocyclic to 4 ring aryl group which is unsubstituted or substituted with Y1; Or a monocyclic to 4 ring heteroaryl group unsubstituted or substituted with Y1.
  • Ar101 and Ar102 are the same as or different from each other, and each independently a phenyl group; Biphenyl group; Naphthyl group; Or dibenzofuran group.
  • Y1 is deuterium; Halogen group; Nitrile group; C1-C10 alkyl group; A cycloalkyl group having 3 to 20 carbon atoms; A silyl group substituted with an alkyl group of C1-C10; Or it is a C6-C30 aryl group.
  • Y1 is deuterium; Halogen group; Nitrile group; C1-C5 alkyl group; A cycloalkyl group having 3 to 10 carbon atoms; C1-C5 alkyl group substituted silyl group; Or it is a C6-C20 aryl group.
  • Y1 is deuterium; Halogen group; Nitrile group; Methyl group; Cyclohexyl group; Trimethylsilyl group; Or a phenyl group.
  • Y1 is deuterium; Fluorine; Nitrile group; Methyl group; Cyclohexyl group; Or a trimethylsilyl group.
  • R21 to R28 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted silyl group; A substituted or unsubstituted phosphine oxide group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heteroaryl group.
  • R21 to R28 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted cycloalkyl group having 3 to 20 carbon atoms; A substituted or unsubstituted silyl group; A substituted or unsubstituted phosphine oxide group; A substituted or unsubstituted C6-C30 aryl group; Or a substituted or unsubstituted C2-C30 heteroaryl group.
  • R21 to R28 are each hydrogen; Or deuterium.
  • R21 to R28 are hydrogen.
  • R21 to R28 are deuterium.
  • the compound represented by Chemical Formula H is any one selected from the following compounds.
  • the organic light emitting device includes a light emitting layer, the light emitting layer includes a compound represented by Formula 1 as a dopant in the light emitting layer, and a compound represented by Formula H as a host of the light emitting layer.
  • the content of the compound represented by Formula 1 is 0.01 parts by weight to 30 parts by weight; 0.1 to 20 parts by weight; Or 0.5 to 10 parts by weight.
  • the emission layer may further include a host material in addition to the compound represented by Chemical Formula H.
  • the host material (mixed host compound) further included may be a condensed aromatic ring derivative or a heterocyclic compound.
  • condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, fluoranthene compounds, etc.
  • heterocyclic compounds include dibenzofuran derivatives, ladder-type furan compounds, Pyrimidine derivatives, and the like, but are not limited thereto.
  • the mixing ratio of the compound represented by Formula H and the mixed host compound is 95:5 to 5:95.
  • the light emitting layer including the compound represented by Chemical Formula 1 and the compound represented by Chemical Formula H has a blue color.
  • the organic light emitting diode includes two or more light emitting layers, and at least one of the two or more light emitting layers includes a compound represented by Formula 1 and a compound represented by Formula H.
  • the light emitting layer including the compound represented by Formula 1 and the compound represented by Formula H has a blue color, and the light emitting layer not containing the compound represented by Formula 1 and the compound represented by Formula H is blue known in the art, Red or green light-emitting compounds.
  • the organic material layer includes a hole injection layer or a hole transport layer.
  • the organic material layer includes an electron injection layer or an electron transport layer.
  • the organic material layer includes an electron blocking layer.
  • the organic material layer includes a hole blocking layer.
  • the organic light emitting device is a hole injection layer, a hole transport layer. It further includes at least one layer or two or more layers selected from the group consisting of a light emitting layer, an electron transport layer, an electron injection layer, a hole blocking layer, and an electron blocking layer.
  • the organic light emitting device includes a first electrode; A second electrode provided to face the first electrode; A light emitting layer provided between the first electrode and the second electrode; And two or more organic material layers provided between the light emitting layer and the first electrode, or between the light emitting layer and the second electrode.
  • two or more organic material layers may be selected from the group consisting of a light emitting layer, a hole transport layer, a hole injection layer, a layer simultaneously performing hole transport and hole injection, and an electron blocking layer.
  • the organic light emitting device may be an organic light emitting device having a structure in which an anode, one or more organic material layers, and a cathode are sequentially stacked on a substrate.
  • the organic light emitting device may be an inverted type organic light emitting device in which an anode, one or more organic material layers, and a cathode are sequentially stacked on a substrate.
  • FIGS. 1 to 3. 1 to 3 illustrate an organic light emitting device and are not limited thereto.
  • FIG. 1 a structure of an organic light emitting device in which an anode 102, a light emitting layer 106, and a cathode 110 are sequentially stacked on a substrate 101 is illustrated.
  • the compound represented by Chemical Formula 1 is included in the light emitting layer.
  • the compound represented by the formula (H) may be further included in the light emitting layer.
  • the compound represented by Chemical Formula 1 is included in the light emitting layer.
  • the compound represented by the formula (H) may be further included in the light emitting layer.
  • the compound represented by Chemical Formula 1 is included in a hole injection layer or a hole transport layer.
  • the structure of the organic light emitting device in which the electron injection layer 109 and the cathode 110 are sequentially stacked is illustrated.
  • the compound represented by Chemical Formula 1 is included in the light emitting layer.
  • the compound represented by the formula (H) may be further included in the light emitting layer.
  • the compound represented by Chemical Formula 1 is included in a hole injection layer, a hole transport layer, an electron blocking layer, a hole blocking layer, an electron transport layer, or an electron injection layer.
  • the organic light emitting device of the present specification may be made of materials and methods known in the art, except that the light emitting layer includes the compound, that is, the compound represented by Formula 1 and the compound represented by Formula H.
  • the organic material layers may be formed of the same material or different materials.
  • the organic light emitting device of the present specification can be manufactured by sequentially laminating a first electrode, an organic material layer, and a second electrode on a substrate.
  • a positive electrode is deposited by depositing a metal or conductive metal oxide or an alloy thereof on a substrate using a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation. It can be produced by forming and forming an organic material layer including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer thereon, and then depositing a material that can be used as a cathode thereon.
  • an organic light emitting device may be manufactured by sequentially depositing a cathode material, an organic material layer, and an anode material on a substrate.
  • the compound represented by the formula (1) or the compound represented by the formula (H) may be formed into an organic material layer by a solution coating method as well as a vacuum deposition method when manufacturing an organic light emitting device.
  • the solution application method means spin coating, dip coating, doctor blading, inkjet printing, screen printing, spraying, roll coating, and the like, but is not limited thereto.
  • an organic light emitting device may be made by sequentially depositing an organic material layer and a cathode material from a cathode material on a substrate.
  • the manufacturing method is not limited thereto.
  • the first electrode is an anode
  • the second electrode is a cathode
  • the first electrode is a cathode
  • the second electrode is an anode
  • the positive electrode material is usually a material having a large work function to facilitate hole injection into the organic material layer.
  • Metals such as vanadium, chromium, copper, zinc, gold or alloys thereof;
  • Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO:Al or SnO 2 : combination of metal and oxide such as Sb;
  • Conductive polymers such as poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDOT), polypyrrole, and polyaniline, but are not limited thereto.
  • the cathode material is preferably a material having a small work function to facilitate electron injection into an organic material layer.
  • Metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin and lead or alloys thereof;
  • a multilayer structure material such as LiF/Al or LiO 2 /Al, and the like, but is not limited thereto.
  • the organic light emitting device may include an additional light emitting layer other than the light emitting layer including the compound represented by Chemical Formula 1 or the compound represented by Chemical Formula H.
  • the additional emissive layer can include a host material and a dopant material.
  • the host material may be a condensed aromatic ring derivative or a heterocyclic compound.
  • condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, fluoranthene compounds, etc.
  • heterocyclic compounds include dibenzofuran derivatives, ladder-type furan compounds, Pyrimidine derivatives, and the like, but are not limited thereto.
  • Examples of the dopant material include aromatic amine derivatives, strylamine compounds, boron complexes, fluoranthene compounds, and metal complexes.
  • examples of the aromatic amine derivative include condensed aromatic ring derivatives having substituted or unsubstituted arylamine groups, such as pyrene, anthracene, chrysene, and periplanene having an arylamine group.
  • the styrylamine compound is a compound in which at least one arylvinyl group is substituted with a substituted or unsubstituted arylamine, and one or two or more are selected from the group consisting of aryl groups, silyl groups, alkyl groups, cycloalkyl groups, and arylamine groups.
  • the substituent is substituted or unsubstituted.
  • styrylamine, styryldiamine, styryltriamine, styryltetraamine, and the like but are not limited thereto.
  • examples of the metal complex include an iridium complex and a platinum complex, but are not limited thereto.
  • the hole injection layer is a layer that receives holes from the electrode. It is preferable that the hole injection material has the ability to transport holes and thus has a hole receiving effect from the anode and an excellent hole injection effect for the light emitting layer or the light emitting material. In addition, a material having excellent ability to prevent movement of the exciton generated in the light emitting layer to the electron injection layer or the electron injection material is preferable. Also, a material having excellent thin film formation ability is preferred. In addition, it is preferable that the high-occupied molecular orbital (HOMO) of the hole injection material is between the work function of the positive electrode material and the HOMO of the surrounding organic material layer.
  • HOMO high-occupied molecular orbital
  • the hole injection material include metal porphyrins, oligothiophenes, and arylamine-based organic materials; Hexanitrile hexaaza triphenylene series organics; Quinacridone-based organic matter; Perylene-based organic substances; Polythiophene-based conductive polymers such as anthraquinone and polyaniline, but are not limited thereto.
  • the hole transport layer is a layer that receives holes from the hole injection layer and transports the holes to the light emitting layer.
  • a material capable of receiving holes from the anode or the hole injection layer and transferring them to the light emitting layer is preferably a material having high mobility for holes. Specific examples include, but are not limited to, arylamine-based organic materials, conductive polymers, and block copolymers having a conjugated portion and a non-conjugated portion.
  • the electron transport layer is a layer that receives electrons from the electron injection layer and transports electrons to the light emitting layer.
  • the electron transport material a material capable of receiving electrons well from the cathode and transferring them to the light emitting layer, a material having high mobility for electrons is preferable. Specific examples include the Al complex of 8-hydroxyquinoline; Complexes including Alq 3 ; Organic radical compounds; Hydroxyflavone-metal complexes, and the like, but are not limited thereto.
  • the electron transport layer can be used with any desired negative electrode material, as used according to the prior art. Particularly, a suitable negative electrode material has a low work function and is a conventional material followed by an aluminum layer or a silver layer. Specifically, there are cesium, barium, calcium, ytterbium, and samarium, and in each case, an aluminum layer or a silver layer follows.
  • the electron injection layer is a layer that receives electrons from an electrode. It is preferable that the electron injecting agent has an excellent electron transporting ability and an electron receiving effect from the second electrode, and an excellent electron injection effect for the light emitting layer or the light emitting material. In addition, a material that prevents exciton generated in the light emitting layer from moving to the hole injection layer and has excellent thin film formation ability is preferable.
  • fluorenone anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylenetetracarboxylic acid, preorenylidene methane, anthrone and the like and their derivatives, Metal complex compounds, nitrogen-containing 5-membered ring derivatives, and the like, but are not limited thereto.
  • the metal complex compound includes 8-hydroxyquinolinato lithium, bis(8-hydroxyquinolinato) zinc, bis(8-hydroxyquinolinato) copper, and bis(8-hydroxyquinolinato) manganese , Tris(8-hydroxyquinolinato)aluminum, tris(2-methyl-8-hydroxyquinolinato)aluminum, tris(8-hydroxyquinolinato)gallium, bis(10-hydroxybenzo[h ]Quinolinato) beryllium, bis(10-hydroxybenzo[h]quinolinato) zinc, bis(2-methyl-8-quinolinato)chlorogallium, bis(2-methyl-8-quinolinato) (o-cresolato) gallium, bis(2-methyl-8-quinolinato)(1-naphtholato)aluminum, bis(2-methyl-8-quinolinato)(2-naphtolato)gallium, etc. , But is not limited thereto.
  • the electron blocking layer is a layer capable of improving the life and efficiency of the device by preventing electrons injected from the electron injection layer from entering the hole injection layer through the light emitting layer.
  • Known materials can be used without limitation, and can be formed between the light emitting layer and the hole injection layer, or between the light emitting layer and the layer simultaneously performing hole injection and hole transport.
  • the hole blocking layer is a layer that blocks reaching the cathode of the hole, and may be generally formed under the same conditions as the electron injection layer. Specifically, there are oxadiazole derivatives, triazole derivatives, phenanthroline derivatives, aluminum complexes, and the like, but are not limited thereto.
  • the organic light emitting device may be a front emission type, a back emission type, or a double-sided emission type, depending on the material used.
  • t Bu means tert-butyl group.
  • the emission wavelength of the compound is a value shifted by the Stokes shift from the absorption wavelength, and the degree of the emission wavelength can be predicted as the absorption wavelength.
  • the radiative transition probability (f) is a measure of fluorescence quantum efficiency and is calculated by the following equation. The greater the value of the radiation transition probability (f), the greater the luminous efficiency.
  • Comparative Example 4 when the bridge alkyl of Formula 1 is not included (when C is H and H), the energy value of singlet(S 1 ) is 3.14 eV. As in Comparative Examples 1 to 3, when C is replaced with NPh, O, and S, respectively, it can be seen that the S 1 energy value becomes very large and the f value also decreases to 0.15 or less. A large S 1 energy value means that the maximum emission wavelength is a short wavelength, and a smaller f value means that the luminous efficiency is reduced.
  • a glass substrate coated with a thin film of indium tin oxide (ITO) at a thickness of 1300 ⁇ was placed in distilled water in which detergent was dissolved and washed with ultrasonic waves.
  • Fischer Fischer Co.
  • distilled water filtered secondarily by a filter of Millipore Co. was used as distilled water.
  • ultrasonic washing was repeated for 10 minutes by repeating it twice with distilled water.
  • ultrasonic cleaning was performed with a solvent of isopropyl alcohol, acetone, and methanol, dried, and then transported to a plasma cleaner.
  • the substrate was washed for 5 minutes using oxygen plasma, and then transferred to a vacuum evaporator.
  • the following compound HAT was thermally vacuum-deposited to a thickness of 50 Pa to form a hole injection layer. Then, the following compound HT-A 1000 ⁇ was vacuum-deposited as a first hole transport layer, and subsequently the following compound HT-B 100 ⁇ was deposited as a second hole transport layer.
  • the host BH-A and the dopant Compound A-2 were vacuum-deposited at a weight ratio of 97: 3 to form a 200-mm thick light emitting layer.
  • the deposition rate of the organic matter was maintained at 0.4 to 1.0 ⁇ /sec, and the deposition rate of silver and magnesium was maintained at 2 ⁇ /sec.
  • the vacuum degree during deposition was 5 ⁇ 10 -8 to 1 ⁇ 10 -7 torr.
  • An organic light-emitting device was manufactured in the same manner as in Example 3, except that the host and dopant compounds shown in Table 3 below were used as the light-emitting layer material in Example 3.
  • An organic light-emitting device was manufactured in the same manner as in Example 3, except that the host and dopant compounds shown in Table 3 below were used as the light-emitting layer material in Example 3.
  • the organic light emitting devices manufactured by Examples 3 to 13 and Comparative Examples 7 to 9 were measured for luminous efficiency (cd/A) at a current density of 10 mA/cm 2 , and the results are shown in Table 2 below.
  • the lifetime was measured at 20 mA/cm 2 , which is 97% of the initial luminance (T97).
  • the device including the compound represented by Chemical Formula 1 of the present invention has excellent luminous efficiency and long life.
  • the compound represented by the formula (1) is a compound having a longer life property than the compound X-8, which is higher in efficiency than the compound X-7 in which R1 and R2 in the formula 1 of the present invention are both alkyl groups.
  • Example 3 a dopant compound shown in Table 4 was used as a light emitting layer material, and the organic light emitting device was manufactured in the same manner as in Example 3, except that the host and the dopant were vacuum deposited in a weight ratio of 99:1 to 95:5. Was prepared.
  • the organic light-emitting device manufactured by Example 14 and Comparative Example 10 was measured for the light emission efficiency (EQE) at a current density of 10 mA/cm 2 .
  • the luminous efficiency according to the doping concentration of Compound A-2 (Example 14) is illustrated in FIG. 4, and the luminous efficiency according to the doping concentration of Compound X-7 (Comparative Example 10) is illustrated in FIG. 5.

Abstract

The present specification relates to a compound represented by chemical formula 1 and an organic light emitting diode comprising same.

Description

화합물 및 이를 포함하는 유기 발광 소자Compound and organic light emitting device comprising same
본 명세서는 화합물 및 이를 포함하는 유기 발광 소자에 관한 것이다. The present specification relates to a compound and an organic light emitting device including the same.
본 출원은 2019년 01월 18일 한국특허청에 제출된 한국 특허 출원 제10-2019-0006918호의 출원일의 이익을 주장하며, 그 내용 전부는 본 명세서에 포함된다.This application claims the benefit of the filing date of Korean Patent Application No. 10-2019-0006918 filed with the Korean Intellectual Property Office on January 18, 2019, the entire contents of which are incorporated herein.
일반적으로 유기 발광 현상이란 유기 물질을 이용하여 전기에너지를 빛에너지로 전환시켜주는 현상을 말한다. 유기 발광 현상을 이용하는 유기 발광 소자는 통상 양극과 음극 및 이 사이에 유기물층을 포함하는 구조를 가진다. 여기서 유기물층은 유기 발광 소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공 주입층, 정공 수송층, 발광층, 전자 수송층, 전자 주입층 등으로 이루어 질 수 있다. 이러한 유기 발광 소자의 구조에서 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공이, 음극에서는 전자가 유기물층에 주입되게 되고, 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 다시 바닥상태로 떨어질 때 빛이 나게 된다. In general, the organic light emitting phenomenon refers to a phenomenon that converts electrical energy into light energy using an organic material. An organic light emitting device using an organic light emitting phenomenon usually has a structure including an anode and a cathode and an organic material layer therebetween. Here, in order to increase the efficiency and stability of the organic light emitting device, the organic material layer is often composed of a multi-layered structure composed of different materials, for example, may be formed of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, and the like. When a voltage is applied between two electrodes in the structure of the organic light emitting device, holes are injected at the anode, and electrons are injected at the cathode, and an exciton is formed when the injected holes meet the electrons. When it falls to the ground again, it will shine.
상기와 같은 유기 발광 소자를 위한 새로운 재료의 개발이 계속 요구되고 있다. The development of new materials for such organic light-emitting devices continues to be required.
[특허문헌] WO2017-018326 A1[Patent Document] WO2017-018326 A1
본 명세서는 화합물 및 이를 포함하는 유기 발광 소자를 제공하고자 한다. This specification is intended to provide a compound and an organic light emitting device comprising the same.
본 명세서는 하기 화학식 1로 표시되는 화합물을 제공한다.The present specification provides a compound represented by Formula 1 below.
[화학식 1][Formula 1]
Figure PCTKR2020000947-appb-I000001
Figure PCTKR2020000947-appb-I000001
상기 화학식 1에 있어서,In Chemical Formula 1,
A1 내지 A3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 방향족 탄화수소고리; 또는 치환 또는 비치환된 방향족 헤테로고리이며,A1 to A3 are the same as or different from each other, and each independently an substituted or unsubstituted aromatic hydrocarbon ring; Or a substituted or unsubstituted aromatic heterocycle,
X는 B 또는 N이고,X is B or N,
Y는 N(R11)이면서, Z는 O; S; 또는 N(R12)이거나,Y is N(R11), Z is O; S; Or N(R12),
Y는 O; S; 또는 N(R11)이면서, Z는 N(R12)이고,Y is O; S; Or N(R11), Z is N(R12),
R1은 치환 또는 비치환된 아릴기이고,R1 is a substituted or unsubstituted aryl group,
R2는 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이며,R2 is a substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group,
R11은 -(L11)n11-Ar1이고,R11 is -(L11)n11-Ar1,
R12은 -(L12)n12-Ar2이고,R12 is -(L12)n12-Ar2,
L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 치환 또는 비치환된 아릴렌기; 또는 치환 또는 비치환된 2가의 헤테로고리기이고,L11 and L12 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted divalent heterocyclic group,
Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소; 할로겐기; 니트릴기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 할로알킬기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이고,Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Halogen group; Nitrile group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted haloalkyl group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
n11 및 n12는 서로 동일하거나 상이하고, 각각 독립적으로 1 또는 2이고, n11 and n12 are the same as or different from each other, and each independently 1 or 2,
n11이 2인 경우 L11은 서로 동일하거나 상이하고,When n11 is 2, L11 is the same as or different from each other,
n12가 2인 경우 L12는 서로 동일하거나 상이하다.When n12 is 2, L12 is the same as or different from each other.
또한, 본 명세서는 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상은 상기 화학식 1로 표시되는 화합물을 포함하는 것인 유기 발광 소자를 제공한다.In addition, the present specification is a first electrode; A second electrode provided to face the first electrode; And an organic light emitting device including at least one layer of an organic material provided between the first electrode and the second electrode, wherein at least one layer of the organic material layer includes a compound represented by Chemical Formula 1 do.
본 명세서의 일 실시상태에 따른 화합물은 유기 발광 소자에 사용되어, 유기 발광 소자의 구동전압을 낮출 수 있으며, 광효율을 향상시킬 수 있다. 또한, 화합물의 열적 안정성에 의하여 소장의 수명 특성을 향상시킬 수 있다. The compound according to the exemplary embodiment of the present specification is used in an organic light emitting device, so that a driving voltage of the organic light emitting device can be lowered and light efficiency can be improved. In addition, the lifespan characteristics of the small intestine can be improved by the thermal stability of the compound.
도 1 내지 도 3은 본 명세서의 일 실시상태에 따른 유기 발광 소자의 예를 도시한 것이다.1 to 3 show an example of an organic light emitting device according to an exemplary embodiment of the present specification.
도 4는 본 명세서의 일 실시상태에 따른 화합물 A-2의 도핑 농도에 따른 발광 효율(실시예 14)을 도시한 것이다.Figure 4 shows the luminous efficiency (Example 14) according to the doping concentration of the compound A-2 according to an exemplary embodiment of the present specification.
도 5는 비교 화합물 X-7의 도핑 농도에 따른 발광 효율(비교예 10)을 도시한 것이다.5 shows the luminous efficiency (Comparative Example 10) according to the doping concentration of Comparative Compound X-7.
[부호의 설명][Description of codes]
101: 기판101: substrate
102: 양극102: anode
103: 정공 주입층103: hole injection layer
104: 정공 수송층104: hole transport layer
105: 전자 차단층105: electron blocking layer
106: 발광층106: emitting layer
107: 정공 차단층107: hole blocking layer
108: 전자 수송층108: electron transport layer
109: 전자 주입층109: electron injection layer
110: 음극110: cathode
이하, 본 명세서에 대하여 더욱 상세하게 설명한다.Hereinafter, the present specification will be described in more detail.
상기 화학식 1로 표시되는 화합물은 다환고리가 축합된 구조로, A1 고리 및 A2 고리가 탄소(브릿지 알킬 자리)로 연결되어 있다. 두 고리를 연결함으로써, 구조의 전체적 유동성을 낮추고 좁은 반치폭의 발광 파장을 얻을 수 있다. 또한, 브릿지 알킬 자리에 알킬기 및 아릴기 등의 다양한 치환기를 도입하여 발광 파장을 조절할 수 있다. 또한, 다환 구조는 안정성이 뛰어나, 유기 발광 소자의 발광층의 도펀트로 사용될 때 장수명 및 고효율의 특성이 있다.The compound represented by Chemical Formula 1 has a structure in which a polycyclic ring is condensed, and the A1 ring and the A2 ring are connected by carbon (bridge alkyl site). By connecting the two rings, it is possible to lower the overall fluidity of the structure and obtain a narrow half-width light emission wavelength. In addition, by introducing various substituents such as an alkyl group and an aryl group at the bridge alkyl site, the emission wavelength can be adjusted. In addition, the polycyclic structure is excellent in stability, and when used as a dopant in the light emitting layer of the organic light emitting device has long life and high efficiency characteristics.
브릿지 알킬 자리에, 하나 이상의 아릴기가 연결됨으로써, 알킬기 만 연결된 구조에 비해 분자의 입체 구조 부피가 커지므로(bulky) 청색 유기발광 소자의 호스트와 도펀트의 도핑 시스템에서 분자의 오리엔테이션이 증가하여 소자의 효율을 높일 수 있고, 호스트와 도펀트 사이의 상호작용이 적어지게 되어 소자의 수명이 개선되는 효과가 있다.By linking one or more aryl groups to the bridge alkyl site, the bulk of the three-dimensional structure of the molecule is bulky compared to the structure in which only the alkyl group is connected (bulky). It is possible to increase, and the interaction between the host and the dopant is reduced, thereby improving the life of the device.
본 명세서에서 치환기의 예시들은 아래에서 설명하나, 이에 한정되는 것은 아니다. Examples of the substituent in this specification are described below, but are not limited thereto.
본 명세서에 있어서,
Figure PCTKR2020000947-appb-I000002
는 연결되는 부위를 의미한다.
In this specification,
Figure PCTKR2020000947-appb-I000002
Means the site to be connected.
본 명세서에 있어서, Cn은 탄소수 n개를 말한다.In the present specification, Cn refers to n carbon atoms.
본 명세서에 있어서, Cn-Cm은 탄소수 n 내지 m개를 말한다.In the present specification, Cn-Cm refers to n to m carbon atoms.
상기 "치환"이라는 용어는 화합물의 탄소 원자에 결합된 수소 원자가 다른 치환기로 바뀌는 것을 의미하며, 치환되는 위치는 수소 원자가 치환되는 위치 즉, 치환기가 치환 가능한 위치라면 한정하지 않으며, 2 이상 치환되는 경우, 2 이상의 치환기는 서로 동일하거나 상이할 수 있다.The term "substitution" means that the hydrogen atom bonded to the carbon atom of the compound is replaced with another substituent, and the position to be substituted is not limited to a position where the hydrogen atom is substituted, that is, a position where the substituent is substitutable, and when two or more are substituted , 2 or more substituents may be the same or different from each other.
본 명세서에서 "치환 또는 비치환된" 이라는 용어는 중수소; 할로겐기; 니트릴기; 알킬기; 알콕시기; 시클로알킬기; 아민기; 실릴기; 아릴기; 및 헤테로고리기기로 이루어진 군에서 선택된 1 또는 2 이상의 치환기로 치환되었거나 상기 예시된 치환기 중 2 이상의 치환기가 연결된 치환기로 치환되거나, 또는 어떠한 치환기도 갖지 않는 것을 의미한다. The term "substituted or unsubstituted" in this specification is deuterium; Halogen group; Nitrile group; Alkyl groups; Alkoxy groups; Cycloalkyl group; Amine group; Silyl group; Aryl group; And one or two or more substituents selected from the group consisting of heterocyclic groups, or substituted with two or more substituents among the above-described substituents, or having no substituents.
본 명세서의 일 실시상태에 있어서, "치환 또는 비치환된" 이라는 용어는 중수소; 할로겐기; C1-C10의 알킬기; C1-C10의 알콕시기; C3-C30의 시클로알킬기; 아민기; 실릴기; C6-C30의 아릴기; 및 N, O, 또는 S를 포함하는 C2-C30의 헤테로고리기기로 이루어진 군에서 선택된 1 이상의 치환기로 치환되거나. 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환되거나, 또는 어떠한 치환기도 갖지 않는 것을 의미한다.In one embodiment of the present specification, the term "substituted or unsubstituted" is deuterium; Halogen group; C1-C10 alkyl group; C1-C10alkoxy group; C3-C30 cycloalkyl group; Amine group; Silyl group; C6-C30Aryl group; And N, O, or substituted with one or more substituents selected from the group consisting of C2-C30 heterocyclic group containing S or. It means that two or more groups selected from the above group are substituted with linked substituents or have no substituents.
본 명세서의 일 실시상태에 있어서, "치환 또는 비치환된" 이라는 용어는 중수소; 할로겐기; C1-C10의 알킬기; 아민기; 실릴기; C6-C30의 아릴기; 및 N, O, 또는 S를 포함하는 C2-C30의 헤테로고리기기로 이루어진 군에서 선택된 1 이상의 치환기로 치환되거나. 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환되거나, 또는 어떠한 치환기도 갖지 않는 것을 의미한다.In one embodiment of the present specification, the term "substituted or unsubstituted" is deuterium; Halogen group; C1-C10 alkyl group; Amine group; Silyl group; C6-C30Aryl group; And N, O, or substituted with one or more substituents selected from the group consisting of C2-C30 heterocyclic group containing S or. It means that two or more groups selected from the above group are substituted with linked substituents or have no substituents.
본 명세서에 있어서, 2 이상의 치환기가 연결된다는 것은 어느 하나의 치환기의 수소가 다른 치환기와 연결된 것을 말한다. 예를 들어, 이소프로필기와 페닐기가 연결되어
Figure PCTKR2020000947-appb-I000003
또는
Figure PCTKR2020000947-appb-I000004
의 치환기가 될 수 있다.
In the present specification, two or more substituents are connected means that hydrogen of one substituent is connected to another substituent. For example, an isopropyl group and a phenyl group are connected
Figure PCTKR2020000947-appb-I000003
or
Figure PCTKR2020000947-appb-I000004
It can be a substituent of.
본 명세서에 있어서, 3개의 치환기가 연결되는 것은 (치환기 1)-(치환기 2)-(치환기 3)이 연속하여 연결되는 것뿐만 아니라, (치환기 1)에 (치환기 2) 및 (치환기 3)이 연결되는 것도 포함한다. 예를 들어, 2개의 페닐기 및 이소프로필기가 연결되어
Figure PCTKR2020000947-appb-I000005
또는
Figure PCTKR2020000947-appb-I000006
의 치환기가 될 수 있다. 4 이상의 치환기가 연결되는 것에도 전술한 것과 동일하게 적용된다.
In the present specification, (substituent 1)-(substituent 2)-(substituent 3) is not only continuously connected, but also (substituent 1) (substituent 2) and (substituent 3) are connected Includes connections. For example, two phenyl groups and isopropyl groups are connected
Figure PCTKR2020000947-appb-I000005
or
Figure PCTKR2020000947-appb-I000006
It can be a substituent of. The same applies to those above which four or more substituents are connected.
본 명세서에 있어서, 할로겐기의 예로는 불소, 염소, 브롬, 또는 요오드가 있다. In the present specification, examples of the halogen group include fluorine, chlorine, bromine, or iodine.
본 명세서에 있어서, 알킬기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나 1 내지 50인 것이 바람직하고, 1 내지 30이 더욱 바람직하다. 구체적인 예로는 메틸, 에틸, 프로필, n-프로필, 이소프로필, 부틸, n-부틸, 이소부틸, tert-부틸, sec-부틸, 1-메틸부틸, 1-에틸부틸, 펜틸, n-펜틸, 이소펜틸, 네오펜틸, tert-펜틸, 헥실, n-헥실, 2-메틸펜틸, 4-메틸펜틸, 3,3-디메틸부틸, 2-에틸부틸, 헵틸, n-헵틸, 1-메틸헥실, 시클로펜틸메틸, 시클로헥실메틸, 옥틸, n-옥틸, tert-옥틸, 2-에틸헥실, 2-프로필펜틸, n-노닐, 2,2-디메틸헵틸, 1-에틸프로필, 1,1-디메틸프로필, 이소헥실, 4-메틸헥실, 5-메틸헥실 등이 있으나, 이에 한정되는 것은 아니다. In the present specification, the alkyl group may be straight chain or branched chain, and the number of carbon atoms is not particularly limited, but is preferably 1 to 50, more preferably 1 to 30. Specific examples are methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, sec-butyl, 1-methylbutyl, 1-ethylbutyl, pentyl, n-pentyl, iso Pentyl, neopentyl, tert-pentyl, hexyl, n-hexyl, 2-methylpentyl, 4-methylpentyl, 3,3-dimethylbutyl, 2-ethylbutyl, heptyl, n-heptyl, 1-methylhexyl, cyclopentyl Methyl, cyclohexylmethyl, octyl, n-octyl, tert-octyl, 2-ethylhexyl, 2-propylpentyl, n-nonyl, 2,2-dimethylheptyl, 1-ethylpropyl, 1,1-dimethylpropyl, iso Hexyl, 4-methylhexyl, 5-methylhexyl, and the like, but is not limited thereto.
본 명세서에 있어서, 시클로알킬기는 특별히 한정되지 않으나, 탄소수 3 내지 60인 것이 바람직하며, 3 내지 30이 더욱 바람직하다. 구체적으로, 시클로프로필, 시클로부틸, 시클로펜틸, 3-메틸시클로펜틸, 2,3-디메틸시클로펜틸, 시클로헥실, 3-메틸시클로헥실, 4-메틸시클로헥실, 2,3-디메틸시클로헥실, 3,4,5-트리메틸시클로헥실, 4-tert-부틸시클로헥실, 시클로헵틸, 시클로옥틸 등이 있으나, 이에 한정되는 것은 아니다.In the present specification, the cycloalkyl group is not particularly limited, but is preferably 3 to 60 carbon atoms, and more preferably 3 to 30 carbon atoms. Specifically, cyclopropyl, cyclobutyl, cyclopentyl, 3-methylcyclopentyl, 2,3-dimethylcyclopentyl, cyclohexyl, 3-methylcyclohexyl, 4-methylcyclohexyl, 2,3-dimethylcyclohexyl, 3 ,4,5-trimethylcyclohexyl, 4-tert-butylcyclohexyl, cycloheptyl, cyclooctyl, and the like, but is not limited thereto.
본 명세서에 있어서, 할로알킬기는 직쇄 또는 분지쇄일수 있고, 상기 전술한 알킬기의 수소가 1 또는 2 이상의 할로겐기로 치환된 것을 말한다. 탄소수는 특별히 한정되지 않으나 1 내지 30; 1 내지 20; 1 내지 10; 또는 1 내지 5인 것이 바람직하다. 알킬기에는 전술한 알킬기에 관한 설명이 적용될 수 있다. 할로알킬기의 구체적인 예로는 플루오로메틸기, 디플루오로메틸기, 트리플루오로메틸기, 클로로메틸기, 디클로로메틸기, 트리클로로메틸기, 브로모메틸기, 디브로모메틸기, 트리브로모메틸기 등이 있으나, 이들에 한정되지 않는다.In the present specification, the haloalkyl group may be a straight chain or a branched chain, and the hydrogen of the aforementioned alkyl group is substituted with one or two or more halogen groups. Carbon number is not particularly limited, but is 1 to 30; 1 to 20; 1 to 10; Or it is preferably 1 to 5. The description of the alkyl group described above may be applied to the alkyl group. Specific examples of haloalkyl groups include, but are not limited to, fluoromethyl groups, difluoromethyl groups, trifluoromethyl groups, chloromethyl groups, dichloromethyl groups, trichloromethyl groups, bromomethyl groups, dibromomethyl groups, tribromomethyl groups, and the like. Does not work.
본 명세서에 있어서, 실릴기는 Si를 포함하고 상기 Si 원자가 라디칼로서 직접 연결되는 치환기이며, -SiR201R202R203로 표시되고, R201 내지 R203은 서로 같거나 상이하며, 각각 독립적으로 수소; 중수소; 할로겐기; 알킬기; 알케닐기; 알콕시기; 시클로알킬기; 아릴기; 및 헤테로고리기 중 적어도 하나로 이루어진 치환기일 수 있다. 실릴기의 구체적인 예로는 트리메틸실릴기, 트리에틸실릴기, t-부틸디메틸실릴기, 비닐디메틸실릴기, 프로필디메틸실릴기, 트리페닐실릴기, 디페닐실릴기, 페닐실릴기 등이 있으나, 이에 한정되는 것은 아니다.In the present specification, the silyl group includes Si and the Si atom is a substituent directly connected as a radical, and is represented by -SiR 201 R 202 R 203 , R 201 to R 203 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; Alkyl groups; Alkenyl group; Alkoxy groups; Cycloalkyl group; Aryl group; And a heterocyclic group. Specific examples of the silyl group include trimethylsilyl group, triethylsilyl group, t-butyldimethylsilyl group, vinyldimethylsilyl group, propyldimethylsilyl group, triphenylsilyl group, diphenylsilyl group, phenylsilyl group, and the like. It is not limited.
본 명세서에서 아릴기가 단환식 아릴기인 경우 탄소수는 특별히 한정되지 않으나, 탄소수 6 내지 50인 것이 바람직하고, 6 내지 30이 더욱 바람직하다. 구체적으로, 단환식 아릴기로는 페닐기, 비페닐기, 터페닐기, 쿼터페닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다. In the present specification, when the aryl group is a monocyclic aryl group, the number of carbon atoms is not particularly limited, but is preferably 6 to 50 carbon atoms, more preferably 6 to 30 carbon atoms. Specifically, the monocyclic aryl group may be a phenyl group, a biphenyl group, a terphenyl group, a quarterphenyl group, and the like, but is not limited thereto.
상기 아릴기가 다환식 아릴기인 경우 탄소수는 특별히 한정되지 않으나. 탄소수 10 내지 50인 것이 바람직하고, 10 내지 30이 더욱 바람직하다. 구체적으로, 다환식 아릴기로는 나프틸기, 안트라세닐기, 페난트릴기, 파이레닐기, 페릴레닐기, 트리페닐기, 크라이세닐기, 플루오레닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다.When the aryl group is a polycyclic aryl group, the number of carbon atoms is not particularly limited. It is preferable that it is 10-50 carbon atoms, and 10-30 is more preferable. Specifically, the polycyclic aryl group may be a naphthyl group, anthracenyl group, phenanthryl group, pyrenyl group, perylenyl group, triphenyl group, chrysenyl group, fluorenyl group, but is not limited thereto.
본 명세서에 있어서, 상기 플루오레닐기는 치환될 수 있으며, 인접한 치환기들이 서로 결합하여 고리를 형성할 수 있다.In the present specification, the fluorenyl group may be substituted, and adjacent substituents may combine with each other to form a ring.
상기 플루오레닐기가 치환되는 경우, 9번 탄소의 치환기가 고리를 형성하여 스피로구조를 형성할 수 있다. 스피로비플루오레닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다.When the fluorenyl group is substituted, the substituent of carbon 9 may form a ring to form a spiro structure. Spirobifluorenyl group, and the like, but is not limited thereto.
본 명세서에 있어서, 헤테로아릴기는 이종원자로 N, O, S, Si 및 Se 중 1개 이상을 포함하는 것으로서, 탄소수는 특별히 한정되지 않으나 탄소수 2 내지 60인 것이 바람직하고, 2 내지 30인 것이 더욱 바람직하다. 헤테로아릴기의 예로는, 티오펜기, 퓨란기, 피롤기, 이미다졸기, 티아졸기, 옥사졸기, 옥사디아졸기, 트리아졸기, 피리딘기, 비피리딘기, 피리미딘기, 트리아진기, 아크리딘기, 피리다진기, 피라진기, 퀴놀린기, 퀴나졸린기, 퀴녹살린기, 프탈라진기(phthalazine), 프테리딘기(pteridine), 피리도 피리미딘기(pyrido pyrimidine), 피리도 피라진기(pyrido pyrazine), 피라지노 피라진기(pyrazino pyrazine), 이소퀴놀린기, 인돌기, 피리도 인돌기(pyrido indole), 인데노 피리미딘(5H-indeno pyrimidine), 카바졸기, 벤즈옥사졸기, 벤즈이미다졸기, 벤조티아졸기, 벤조카바졸기, 벤조티오펜기, 디벤조티오펜기, 벤조퓨란기, 디벤조퓨란기, 페난쓰롤린기(phenanthroline), 티아졸릴기, 이소옥사졸릴기, 옥사디아졸릴기 및 티아디아졸릴기 등이 있으나, 이들에만 한정되는 것은 아니다. In the present specification, the heteroaryl group is a heteroatom containing at least one of N, O, S, Si, and Se, and carbon number is not particularly limited, but is preferably 2 to 60 carbon atoms, and more preferably 2 to 30 carbon atoms. Do. Examples of the heteroaryl group include thiophene group, furan group, pyrrol group, imidazole group, thiazole group, oxazole group, oxadiazole group, triazole group, pyridine group, bipyridine group, pyrimidine group, triazine group, and acry Dean group, pyridazine group, pyrazine group, quinoline group, quinazoline group, quinoxaline group, phthalazine group, phthalazine, pteridine group, pyrido pyrimidine group, pyridodo pyrimidine group, pyridodo pyridine group pyrazine), pyrazino pyrazine, isoquinoline, indole, pyrido indole, indo pyrimidine, carbazole, benzoxazole, benzimidazole , Benzothiazole group, benzocarbazole group, benzothiophene group, dibenzothiophene group, benzofuran group, dibenzofuran group, phenanthroline, thiazolyl group, isooxazolyl group, oxadiazolyl group and Thiadiazolyl groups, and the like, but are not limited to these.
본 명세서에 있어서, 아민기는 -NR301R302의 화학식으로 표시될 수 있고, 상기 R301 및 R302는 각각 수소; 중수소; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기일 수 있다. 상기 아민기는 알킬아민기; 아릴알킬아민기; 아릴아민기; 아릴헤테로아릴아민기; 알킬헤테로아릴아민기; 및 헤테로아릴아민기로 이루어진 군으로부터 선택될 수 있으며, 보다 구체적으로 디메틸아민기; 디페닐아민기; 등일 수 있으나, 이들에만 한정되는 것은 아니다.In the present specification, the amine group may be represented by the formula of -NR 301 R 302 , wherein R 301 and R 302 are each hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted aryl group; Or it may be a substituted or unsubstituted heterocyclic group. The amine group is an alkylamine group; Arylalkylamine groups; Arylamine group; Aryl heteroarylamine group; Alkyl heteroarylamine groups; And a heteroarylamine group, and more specifically, a dimethylamine group; Diphenylamine group; And the like, but is not limited to these.
본 명세서에 있어서, 아릴아민기는 아민의 질소 원자가 아릴기로 치환된 기를 의미한다. 아릴아민기의 예로는 치환 또는 비치환된 모노아릴아민기; 또는 치환 또는 비치환된 디아릴아민기가 있다. 상기 아릴아민기 중의 아릴기는 단환식 아릴기일 수 있고, 다환식 아릴기일 수 있다. 상기 2 이상의 아릴기를 포함하는 아릴아민기는 단환식 아릴기; 또는 다환식 아릴기를 포함하거나, 단환식아릴기와 다환식 아릴기를 동시에 포함할 수 있다.In the present specification, the arylamine group means a group in which the nitrogen atom of the amine is substituted with an aryl group. Examples of the arylamine group include a substituted or unsubstituted monoarylamine group; Or a substituted or unsubstituted diarylamine group. The aryl group in the arylamine group may be a monocyclic aryl group or a polycyclic aryl group. An arylamine group including the two or more aryl groups is a monocyclic aryl group; Or it may contain a polycyclic aryl group, or may include a monocyclic aryl group and a polycyclic aryl group at the same time.
아릴아민기의 구체적인 예로는 페닐아민, 나프틸아민, 비페닐아민, 안트라세닐아민, 디페닐아민기, 페닐나프틸아민기, 디톨릴아민기, 페닐톨릴아민기 등이 있으나, 이에 한정되는 것은 아니다.Specific examples of the arylamine group include phenylamine, naphthylamine, biphenylamine, anthracenylamine, diphenylamine group, phenylnaphthylamine group, ditolylamine group, phenyltolylamine group, and the like. no.
본 명세서에 있어서, 헤테로아릴아민기는 아민의 질소 원자가 헤테로아릴기로 치환된 기를 의미한다. 헤테로아릴아민기는 예를 들어, 치환 또는 비치환된 모노헤테로아릴아민기; 또는 치환 또는 비치환된 디헤테로아릴아민기일 수 있다. 상기 헤테로아릴아민기 중의 헤테로아릴기는 단환식 헤테로아릴기일 수 있고, 다환식헤테로아릴기일 수 있다. 상기 2 이상의 헤테로아릴기를 포함하는 헤테로아릴아민기는 단환식 헤테로아릴기; 또는 다환식 헤테로아릴기를 포함하거나, 단환식 헤테로아릴기와 다환식 헤테로아릴기를 동시에 포함할 수 있다.In this specification, a heteroarylamine group means a group in which the nitrogen atom of the amine is substituted with a heteroaryl group. The heteroarylamine group is, for example, a substituted or unsubstituted monoheteroarylamine group; Or it may be a substituted or unsubstituted diheteroarylamine group. The heteroaryl group in the heteroarylamine group may be a monocyclic heteroaryl group or a polycyclic heteroaryl group. The heteroarylamine group including the two or more heteroaryl groups is a monocyclic heteroaryl group; Or it may include a polycyclic heteroaryl group, or may include a monocyclic heteroaryl group and a polycyclic heteroaryl group at the same time.
본 명세서에 있어서, 아릴헤테로아릴아민기는 아릴기 및 헤테로아릴기로 치환된 아민기를 의미한다.In the present specification, the aryl heteroarylamine group means an amine group substituted with an aryl group and a heteroaryl group.
본 명세서에 있어서, 아랄킬아민기는 아릴기 및 알킬기로 치환된 아민기를 의미한다.In the present specification, the aralkylamine group means an amine group substituted with an aryl group or an alkyl group.
본 명세서에 있어서, 아랄킬아민기 및 알킬아릴기 중의 알킬기에는 전술한 알킬기에 관한 설명이 적용될 수 있다.In the present specification, the description of the aforementioned alkyl group may be applied to the alkyl group in the aralkylamine group and the alkylaryl group.
본 명세서에 있어서, 아릴헤테로아릴아민기, 아랄킬아민기 및 아릴아민기 중의 아릴기에는 전술한 아릴기에 관한 설명이 적용될 수 있다.In the present specification, the aryl group in the aryl heteroarylamine group, the aralkylamine group, and the arylamine group may be applied to the aryl group described above.
본 명세서에 있어서, 아릴헤테로아릴아민기 중의 헤테로아릴기에는 전술한 헤테로아릴기에 관한 설명이 적용될 수 있다.In the present specification, the description of the heteroaryl group described above may be applied to the heteroaryl group in the arylheteroarylamine group.
본 명세서에 있어서, 아릴렌기는 아릴기에 결합 위치가 두 개 있는 것 즉 2가기를 의미한다. 이들은 각각 2가기인 것을 제외하고는 전술한 아릴기의 설명이 적용될 수 있다.In the present specification, the arylene group means that the aryl group has two bonding positions, that is, a divalent group. These may be applied to the description of the aryl group described above, except that each is a divalent group.
본 명세서에 있어서, 헤테로아릴렌기는 헤테로아릴기에 결합 위치가 두 개 있는 것 즉 2가기를 의미한다. 이들은 각각 2가기인 것을 제외하고는 전술한 헤테로아릴기의 설명이 적용될 수 있다.In the present specification, the heteroarylene group means that the heteroaryl group has two bonding positions, that is, a divalent group. These may be applied to the description of the heteroaryl group described above, except that each is a divalent group.
본 명세서에 있어서, "인접한" 기는 해당 치환기가 치환된 원자와 직접 연결된 원자에 치환된 치환기, 해당 치환기와 입체구조적으로 가장 가깝게 위치한 치환기, 또는 해당 치환기가 치환된 원자에 치환된 다른 치환기를 의미할 수 있다. 예컨대, 벤젠고리에서 오르토(ortho)위치로 치환된 2개의 치환기 및 지방족 고리에서 동일 탄소에 치환된 2개의 치환기는 서로 "인접한" 기로 해석될 수 있다.In the present specification, the “adjacent” group refers to a substituent substituted on an atom directly connected to an atom in which the substituent is substituted, a substituent positioned closest to the substituent and the other substituent substituted on the atom in which the substituent is substituted. Can. For example, two substituents substituted in the ortho position on the benzene ring and two substituents substituted on the same carbon in the aliphatic ring may be interpreted as "adjacent" groups to each other.
본 명세서에 있어서, 인접한 기가 서로 결합하여 형성되는 치환 또는 비치환된 고리에서, "고리"는 치환 또는 비치환된 탄화수소고리; 또는 치환 또는 비치환된 헤테로고리를 의미한다.In the present specification, in a substituted or unsubstituted ring formed by bonding adjacent groups to each other, "ring" is a substituted or unsubstituted hydrocarbon ring; Or substituted or unsubstituted heterocyclic ring.
본 명세서에 있어서, 탄화수소고리는 방향족, 지방족 또는 방향족과 지방족의 축합고리일 수 있으며, 상기 1가가 아닌 것을 제외하고 상기 시클로알킬기 또는 아릴기의 예시 중에서 선택될 수 있다.In the present specification, the hydrocarbon ring may be an aromatic, aliphatic or aromatic and aliphatic condensed ring, and may be selected from examples of the cycloalkyl group or aryl group except for the non-monovalent.
본 명세서에 있어서, 방향족고리는 단환 또는 다환일 수 있으며, 1가가 아닌 것을 제외하고 상기 아릴기의 예시 중에서 선택될 수 있다.In the present specification, the aromatic ring may be monocyclic or polycyclic, and may be selected from examples of the aryl group, except that it is not monovalent.
본 명세서에 있어서, 헤테로고리는 탄소가 아닌 원자, 이종원자를 1 이상 포함하는 것으로서, 구체적으로 상기 이종 원자는 O, N, Se 및 S 등으로 이루어진 군에서 선택되는 원자를 1 이상 포함할 수 있다. 상기 헤테로고리는 단환 또는 다환일 수 있으며, 방향족, 지방족 또는 방향족과 지방족의 축합고리일 수 있으며, 1가가 아닌 것을 제외하고 상기 헤테로아릴기의 예시 중에서 선택될 수 있다.In the present specification, the heterocycle is a non-carbon atom, and contains one or more heteroatoms. Specifically, the hetero atom may include one or more atoms selected from the group consisting of O, N, Se, and S. The heterocycle may be monocyclic or polycyclic, may be aromatic, aliphatic or aromatic and aliphatic condensed ring, and may be selected from examples of the heteroaryl group except for non-monovalent.
본 명세서에 있어서, 아다만틸기(adamantly group)은 시클로알킬기의 일종으로, 시클로헥산 고리가 브릿지 형태로 축합되어 있다. 아다만테인(adamantane, C10H16)에서 수소 하나가 다른 연결기에 연결되며,
Figure PCTKR2020000947-appb-I000007
또는
Figure PCTKR2020000947-appb-I000008
으로 표시될 수 있다.
In the present specification, the adamantyl group (adamantly group) is a type of cycloalkyl group, and the cyclohexane ring is condensed in a bridge form. In adamantane (C 10 H 16 ), one hydrogen is connected to the other linker,
Figure PCTKR2020000947-appb-I000007
or
Figure PCTKR2020000947-appb-I000008
It can be displayed as.
이하, 상기 화학식 1로 표시되는 화합물에 관하여 상세히 설명한다.Hereinafter, the compound represented by Chemical Formula 1 will be described in detail.
본 명세서의 일 실시상태에 있어서, A1 내지 A3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 방향족 탄화수소고리; 또는 치환 또는 비치환된 방향족 헤테로고리이다.In one embodiment of the present specification, A1 to A3 are the same as or different from each other, and each independently an substituted or unsubstituted aromatic hydrocarbon ring; Or a substituted or unsubstituted aromatic heterocycle.
본 명세서의 일 실시상태에 있어서, A1 내지 A3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 C6-C30의 방향족 탄화수소고리; 또는 치환 또는 비치환된 C2-C30의 방향족 헤테로고리이다.In one embodiment of the present specification, A1 to A3 are the same as or different from each other, and each independently substituted or unsubstituted C6-C30 aromatic hydrocarbon ring; Or a substituted or unsubstituted C2-C30 aromatic heterocycle.
본 명세서의 일 실시상태에 있어서, A1 내지 A3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 C6-C20의 방향족 탄화수소고리; 또는 치환 또는 비치환된 C2-C20의 방향족 헤테로고리이다.In one embodiment of the present specification, A1 to A3 are the same as or different from each other, and each independently substituted or unsubstituted C6-C20 aromatic hydrocarbon ring; Or a substituted or unsubstituted C2-C20 aromatic heterocycle.
본 명세서의 일 실시상태에 있어서, A1 내지 A3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 단환 내지 3환의 방향족 탄화수소고리; 또는 치환 또는 비치환된 단환 내지 3환의 방향족 헤테로고리이다.In one embodiment of the present specification, A1 to A3 are the same as or different from each other, and each independently a substituted or unsubstituted monocyclic to tricyclic aromatic hydrocarbon ring; Or a substituted or unsubstituted monocyclic to tricyclic aromatic heterocycle.
본 명세서의 일 실시상태에 있어서, A1 내지 A3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 단환 내지 2환의 방향족 탄화수소고리; 또는 치환 또는 비치환된 단환 내지 2환의 방향족 헤테로고리이다.In one embodiment of the present specification, A1 to A3 are the same as or different from each other, and each independently a substituted or unsubstituted monocyclic to bicyclic aromatic hydrocarbon ring; Or a substituted or unsubstituted monocyclic to bicyclic aromatic heterocycle.
본 명세서의 일 실시상태에 있어서, A1 내지 A3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 단환의 방향족 탄화수소고리; 또는 치환 또는 비치환된 단환의 방향족 헤테로고리이다.In one embodiment of the present specification, A1 to A3 are the same as or different from each other, and each independently a substituted or unsubstituted monocyclic aromatic hydrocarbon ring; Or a substituted or unsubstituted monocyclic aromatic heterocycle.
본 명세서의 일 실시상태에 있어서, A1 내지 A3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 단환 내지 2환의 방향족 탄화수소고리이다. In one embodiment of the present specification, A1 to A3 are the same as or different from each other, and each independently a substituted or unsubstituted monocyclic to bicyclic aromatic hydrocarbon ring.
본 명세서의 일 실시상태에 있어서, A1 내지 A3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 벤젠고리이다.In one embodiment of the present specification, A1 to A3 are the same or different from each other, and each independently a substituted or unsubstituted benzene ring.
본 명세서의 일 실시상태에 있어서, A1 내지 A3는 벤젠고리이다.In one embodiment of the present specification, A1 to A3 are benzene rings.
본 명세서의 일 실시상태에 있어서, A1 내지 A3는 Q로 치환 또는 비치환될 수 있다.In one embodiment of the present specification, A1 to A3 may be substituted or unsubstituted by Q.
본 명세서의 일 실시상태에 있어서, Q는 수소; 중수소; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 아민기; 치환 또는 비치환된 아릴아민기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이다.In one embodiment of the present specification, Q is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted amine group; A substituted or unsubstituted arylamine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
본 명세서의 일 실시상태에 있어서, Q는 수소; 중수소; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 아릴아민기; 또는 치환 또는 비치환된 아릴기이다.In one embodiment of the present specification, Q is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted arylamine group; Or a substituted or unsubstituted aryl group.
본 명세서의 일 실시상태에 있어서, Q는 수소; 중수소; 할로겐기; 치환 또는 비치환된 C1-C20의 알킬기; 치환 또는 비치환된 C1-C20의 알콕시기; 치환 또는 비치환된 C1-C20의 아민기; 치환 또는 비치환된 C6-C60의 아릴아민기; 치환 또는 비치환된 C6-C30의 아릴기; 또는 치환 또는 비치환된 C2-C30의 헤테로고리기이다.In one embodiment of the present specification, Q is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted C1-C20 alkyl group; A substituted or unsubstituted C1-C20 alkoxy group; A substituted or unsubstituted C1-C20 amine group; A substituted or unsubstituted C6-C60 arylamine group; A substituted or unsubstituted C6-C30 aryl group; Or a substituted or unsubstituted C2-C30 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Q는 수소; 중수소; 할로겐기; 치환 또는 비치환된 C1-C10의 알킬기; 치환 또는 비치환된 C1-C10의 알콕시기; 치환 또는 비치환된 C1-C20의 아민기; 치환 또는 비치환된 C6-C40의 아릴아민기; 치환 또는 비치환된 C6-C20의 아릴기; 또는 치환 또는 비치환된 C2-C20의 헤테로고리기이다.In one embodiment of the present specification, Q is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C1-C10 alkoxy group; A substituted or unsubstituted C1-C20 amine group; A substituted or unsubstituted C6-C40 arylamine group; A substituted or unsubstituted C6-C20 aryl group; Or a substituted or unsubstituted C2-C20 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Q는 수소; 중수소; 할로겐기; 치환 또는 비치환된 C1-C10의 알킬기; 치환 또는 비치환된 C1-C10의 알콕시기; 치환 또는 비치환된 C6-C40의 아릴아민기; 또는 치환 또는 비치환된 C6-C20의 아릴기이다.In one embodiment of the present specification, Q is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C1-C10 alkoxy group; A substituted or unsubstituted C6-C40 arylamine group; Or a substituted or unsubstituted C6-C20 aryl group.
본 명세서의 일 실시상태에 있어서, Q가 치환된 아릴기인 경우, 중수소; C1-C10의 알킬기; C1-C5의 알킬기; 메틸기; 또는 t-부틸기로 치환될 수 있다.In one embodiment of the present specification, when Q is a substituted aryl group, deuterium; C1-C10 alkyl group; C1-C5 alkyl group; Methyl group; Or it may be substituted with a t-butyl group.
본 명세서의 일 실시상태에 있어서, Q가 치환된 알콕시기인 경우, 할로겐기; 더욱 바람직하게는 불소로 치환될 수 있다.In one embodiment of the present specification, when Q is a substituted alkoxy group, a halogen group; More preferably, it may be substituted with fluorine.
본 명세서의 일 실시상태에 있어서, Q는 수소; 중수소; 불소; 메틸기; t-부틸기; -OCF3; 디페닐아민기; 중수소 또는 t-부틸기로 치환 또는 비치환된 페닐기로 치환된 아민기; 또는 카바졸기이다.In one embodiment of the present specification, Q is hydrogen; heavy hydrogen; Fluorine; Methyl group; t-butyl group; -OCF 3 ; Diphenylamine group; An amine group substituted with a phenyl group unsubstituted or substituted with deuterium or t-butyl group; Or carbazole.
본 명세서의 일 실시상태에 있어서, X는 B 또는 N이다.In one embodiment of the present specification, X is B or N.
본 명세서의 일 실시상태에 있어서, X는 B이다.In one embodiment of the present specification, X is B.
본 명세서의 일 실시상태에 있어서, R1은 치환 또는 비치환된 아릴기이다.In one embodiment of the present specification, R1 is a substituted or unsubstituted aryl group.
본 명세서의 일 실시상태에 있어서, R1은 치환 또는 비치환된 C6-C30의 아릴기이다.In one embodiment of the present specification, R1 is a substituted or unsubstituted C6-C30 aryl group.
본 명세서의 일 실시상태에 있어서, R1은 치환 또는 비치환된 C6-C20의 아릴기이다.In one embodiment of the present specification, R1 is a substituted or unsubstituted C6-C20 aryl group.
본 명세서의 일 실시상태에 있어서, R1가 치환된 아릴기인 경우, 중수소; C1-C10의 알킬기; 또는 C1-C5의 알킬기로 치환될 수 있다.In one embodiment of the present specification, when R1 is a substituted aryl group, deuterium; C1-C10 alkyl group; Or it may be substituted with a C1-C5 alkyl group.
본 명세서의 일 실시상태에 있어서, R1은 중수소 또는 알킬기로 치환 또는 비치환된 C6-C20의 아릴기이다. In one embodiment of the present specification, R1 is a C6-C20 aryl group unsubstituted or substituted with a deuterium or alkyl group.
본 명세서의 일 실시상태에 있어서, R1은 중수소 또는 C1-C5의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 C6-C20의 아릴기이다. In one embodiment of the present specification, R1 is a C6-C20 aryl group unsubstituted or substituted with one or more substituents selected from the group consisting of deuterium or C1-C5 alkyl groups or two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, R1은 중수소 또는 C1-C5의 알킬기로 치환 또는 비치환된 C6-C20의 아릴기이다. In one embodiment of the present specification, R1 is a C6-C20 aryl group unsubstituted or substituted with deuterium or a C1-C5 alkyl group.
본 명세서의 일 실시상태에 있어서, R1은 중수소 또는 메틸기로 치환 또는 비치환된 페닐기이다.In one embodiment of the present specification, R1 is a phenyl group unsubstituted or substituted with a deuterium or methyl group.
본 명세서의 일 실시상태에 있어서, R2는 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이다.In one embodiment of the present specification, R2 is a substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
본 명세서의 일 실시상태에 있어서, R2는 치환 또는 비치환된 C1-C10의 알킬기; 또는 치환 또는 비치환된 C6-C30의 아릴기이다.In one embodiment of the present specification, R2 is a substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted C6-C30 aryl group.
본 명세서의 일 실시상태에 있어서, R2는 치환 또는 비치환된 C1-C5의 알킬기; 또는 치환 또는 비치환된 C6-C20의 아릴기이다.In one embodiment of the present specification, R2 is a substituted or unsubstituted C1-C5 alkyl group; Or a substituted or unsubstituted C6-C20 aryl group.
본 명세서의 일 실시상태에 있어서, R2가 치환된 알킬기인 경우, 중수소로 치환될 수 있다.In one embodiment of the present specification, when R2 is a substituted alkyl group, it may be substituted with deuterium.
본 명세서의 일 실시상태에 있어서, R2가 치환된 아릴기인 경우, 중수소; C1-C10의 알킬기; 또는 C1-C5의 알킬기로 치환될 수 있다.In one embodiment of the present specification, when R2 is a substituted aryl group, deuterium; C1-C10 alkyl group; Or it may be substituted with a C1-C5 alkyl group.
본 명세서의 일 실시상태에 있어서, R2는 중수소로 치환 또는 비치환된 C1-C5의 알킬기; 또는 중수소 또는 C1-C5의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 C6-C20의 아릴기이다. In one embodiment of the present specification, R2 is a substituted or unsubstituted C1-C5 alkyl group; Or a C6-C20 aryl group which is unsubstituted or substituted with one or more substituents selected from the group consisting of deuterium or C1-C5 alkyl groups or two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, R2는 중수소로 치환 또는 비치환된 C1-C5의 알킬기; 또는 중수소 또는 C1-C5의 알킬기로 치환 또는 비치환된 C6-C20의 아릴기이다. In one embodiment of the present specification, R2 is a substituted or unsubstituted C1-C5 alkyl group; Or a C6-C20 aryl group unsubstituted or substituted with deuterium or a C1-C5 alkyl group.
본 명세서의 일 실시상태에 있어서, R2는 메틸기; 또는 중수소 또는 메틸기로 치환 또는 비치환된 페닐기이다.In one embodiment of the present specification, R2 is a methyl group; Or a phenyl group unsubstituted or substituted with deuterium or methyl groups.
본 명세서의 일 실시상태에 있어서, R1 및 R2는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 C6-C30의 아릴기이다.In one embodiment of the present specification, R1 and R2 are the same or different from each other, and are each independently a substituted or unsubstituted C6-C30 aryl group.
본 명세서의 일 실시상태에 있어서, R1 및 R2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소 또는 C1-C5의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 C6-C20의 아릴기이다. In one embodiment of the present specification, R1 and R2 are the same as or different from each other, and each independently substituted with one or more substituents selected from the group consisting of deuterium or C1-C5 alkyl groups or two or more groups selected from the group, or It is an unsubstituted C6-C20 aryl group.
본 명세서의 일 실시상태에 있어서, Y는 O; S; 또는 N(R11)이다.In one embodiment of the present specification, Y is O; S; Or N(R11).
본 명세서의 일 실시상태에 있어서, Z는 O; S; 또는 N(R12)이다.In one embodiment of the present specification, Z is O; S; Or N(R12).
본 명세서의 일 실시상태에 있어서, Y는 N(R11)이다.In one embodiment of the present specification, Y is N(R11).
본 명세서의 일 실시상태에 있어서, Y는 N(R11)이고, Z는 O; S; 또는 N(R12)이다.In one embodiment of the present specification, Y is N(R11), Z is O; S; Or N(R12).
본 명세서의 일 실시상태에 있어서, Z는 N(R12)이고, Y는 O; S; 또는 N(R11)이다.In one embodiment of the present specification, Z is N(R12), Y is O; S; Or N(R11).
본 명세서의 일 실시상태에 있어서, R11은 -(L11)n11-Ar1이다.In one embodiment of the present specification, R11 is -(L11)n11-Ar1.
본 명세서의 일 실시상태에 있어서, R12은 -(L12)n12-Ar2이다.In one embodiment of the present specification, R12 is -(L12)n12-Ar2.
본 명세서의 일 실시상태에 있어서, L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 치환 또는 비치환된 아릴렌기; 또는 치환 또는 비치환된 2가의 헤테로고리기이다.In one embodiment of the present specification, L11 and L12 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted divalent heterocyclic group.
본 명세서의 일 실시상태에 있어서, L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 치환 또는 비치환된 C6-C30의 아릴렌기; 또는 치환 또는 비치환된 C2-C30의 2가의 헤테로고리기이다. In one embodiment of the present specification, L11 and L12 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted C6-C30 arylene group; Or a substituted or unsubstituted C2-C30 divalent heterocyclic group.
본 명세서의 일 실시상태에 있어서, L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 치환 또는 비치환된 C6-C20의 아릴렌기; 또는 치환 또는 비치환된 C2-C20의 2가의 헤테로고리기이다.In one embodiment of the present specification, L11 and L12 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted C6-C20 arylene group; Or a substituted or unsubstituted C2-C20 divalent heterocyclic group.
본 명세서의 일 실시상태에 있어서, L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 또는 치환 또는 비치환된 C6-C20의 아릴렌기이다.In one embodiment of the present specification, L11 and L12 are the same as or different from each other, and each independently a direct bond; Or a substituted or unsubstituted C6-C20 arylene group.
본 명세서의 일 실시상태에 있어서, L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 또는 치환 또는 비치환된 페닐렌기이다.In one embodiment of the present specification, L11 and L12 are the same as or different from each other, and each independently a direct bond; Or a substituted or unsubstituted phenylene group.
본 명세서의 일 실시상태에 있어서, L11 또는 L12가 치환된 아릴렌기인 경우, 알킬기; C1-C10의 알킬기; C1-C5의 알킬기; 헤테로고리기; C6-C30의 헤테로고리기; 또는 C6-C20의 헤테로고리기로 치환될 수 있다.In one embodiment of the present specification, when L11 or L12 is a substituted arylene group, an alkyl group; C1-C10 alkyl group; C1-C5 alkyl group; Heterocyclic group; C6-C30 heterocyclic group; Or it may be substituted with a C6-C20 heterocyclic group.
본 명세서의 일 실시상태에 있어서, L11 또는 L12가 치환된 아릴렌기인 경우, 중수소; 및 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환될 수 있다. 더욱 바람직하게는 상기 L1 또는 L2의 아릴렌기는 중수소; 및 C1-C5의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환될 수 있다.In one embodiment of the present specification, when L11 or L12 is a substituted arylene group, deuterium; And one or more substituents selected from the group consisting of alkyl groups or two or more groups selected from the group. More preferably, the arylene group of L1 or L2 is deuterium; And it may be substituted with one or more substituents selected from the group consisting of C1-C5 alkyl group or two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, L11 또는 L12가 치환된 2가의 헤테로고리기인 경우, 알킬기; C1-C10의 알킬기; C1-C5의 알킬기; 아릴기; C6-C30의 아릴기; 또는 C6-C20의 아릴기로 치환될 수 있다.In one embodiment of the present specification, when L11 or L12 is a substituted divalent heterocyclic group, an alkyl group; C1-C10 alkyl group; C1-C5 alkyl group; Aryl group; C6-C30Aryl group; Or it may be substituted with an aryl group of C6-C20.
본 명세서의 일 실시상태에 있어서, L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; C1-C5의 알킬기 또는 C2-C20의 헤테로고리기로 치환 또는 비치환된 C6-C20의 아릴렌기; 또는 C1-C5의 알킬기 또는 C6-C20의 아릴기로 치환 또는 비치환된 C2-C20의 2가의 헤테로고리기이다.In one embodiment of the present specification, L11 and L12 are the same as or different from each other, and each independently a direct bond; A C6-C20 arylene group unsubstituted or substituted with a C1-C5 alkyl group or a C2-C20 heterocyclic group; Or a C2-C20 divalent heterocyclic group unsubstituted or substituted with a C1-C5 alkyl group or a C6-C20 aryl group.
본 명세서의 일 실시상태에 있어서, L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 또는 C1-C5의 알킬기로 치환 또는 비치환된 C6-C20의 아릴렌기이다.In one embodiment of the present specification, L11 and L12 are the same as or different from each other, and each independently a direct bond; Or a C6-C20 arylene group unsubstituted or substituted with a C1-C5 alkyl group.
본 명세서의 일 실시상태에 있어서, L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 메틸기 또는 t-부틸기로 치환 또는 비치환된 페닐렌기; 나프틸렌기; 메틸기로 치환된 플루오레닐렌기; 터페닐렌기; 페닐기로 치환 또는 비치환된 2가의 피리딘기; 2가의 디벤조퓨란기; 또는 2가의 디벤조티오펜기이다.In one embodiment of the present specification, L11 and L12 are the same as or different from each other, and each independently a direct bond; A phenylene group unsubstituted or substituted with a methyl group or a t-butyl group; Naphthylene group; A fluorenylene group substituted with a methyl group; Terphenylene group; A divalent pyridine group unsubstituted or substituted with a phenyl group; Divalent dibenzofuran group; Or a divalent dibenzothiophene group.
본 명세서의 일 실시상태에 있어서, L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 또는 메틸기 또는 t-부틸기로 치환 또는 비치환된 페닐렌기이다.In one embodiment of the present specification, L11 and L12 are the same as or different from each other, and each independently a direct bond; Or a phenylene group unsubstituted or substituted with a methyl group or a t-butyl group.
본 명세서의 일 실시상태에 있어서, n11은 1 또는 2이다.In one embodiment of the present specification, n11 is 1 or 2.
본 명세서의 일 실시상태에 있어서, n12는 1 또는 2이다.In one embodiment of the present specification, n12 is 1 or 2.
본 명세서의 일 실시상태에 있어서, n11은 1이다.In one embodiment of the present specification, n11 is 1.
본 명세서의 일 실시상태에 있어서, n12는 1이다.In one embodiment of the present specification, n12 is 1.
본 명세서의 일 실시상태에 있어서, n11이 2인 경우 L11은 서로 동일하거나 상이하고, n12가 2인 경우 L12는 서로 동일하거나 상이하다.In one embodiment of the present specification, when n11 is 2, L11 is the same or different from each other, and when n12 is 2, L12 is the same or different from each other.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소; 할로겐기; 니트릴기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 할로알킬기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Halogen group; Nitrile group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted haloalkyl group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소; 할로겐기; 니트릴기; 치환 또는 비치환된 C1-C20의 알킬기; 치환 또는 비치환된 C3-C30의 시클로알킬기; 치환 또는 비치환된 C1-C20의 할로알킬기; 치환 또는 비치환된 C1-C60의 실릴기; 치환 또는 비치환된 C6-C30의 아릴기; 또는 치환 또는 비치환된 C2-C30의 헤테로고리기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Halogen group; Nitrile group; A substituted or unsubstituted C1-C20 alkyl group; A substituted or unsubstituted C3-C30 cycloalkyl group; A substituted or unsubstituted C1-C20 haloalkyl group; A substituted or unsubstituted C1-C60 silyl group; A substituted or unsubstituted C6-C30 aryl group; Or a substituted or unsubstituted C2-C30 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소; 할로겐기; 니트릴기; 치환 또는 비치환된 C1-C10의 알킬기; 치환 또는 비치환된 C3-C20의 시클로알킬기; 치환 또는 비치환된 C1-C10의 할로알킬기; 치환 또는 비치환된 C1-C40의 실릴기; 치환 또는 비치환된 C6-C20의 아릴기; 또는 치환 또는 비치환된 C2-C20의 헤테로고리기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Halogen group; Nitrile group; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C3-C20 cycloalkyl group; A substituted or unsubstituted C1-C10 haloalkyl group; A substituted or unsubstituted C1-C40 silyl group; A substituted or unsubstituted C6-C20 aryl group; Or a substituted or unsubstituted C2-C20 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 C3-C30의 시클로알킬기; 치환 또는 비치환된 C6-C30의 아릴기; 또는 치환 또는 비치환된 C2-C30의 헤테로고리기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently a substituted or unsubstituted C3-C30 cycloalkyl group; A substituted or unsubstituted C6-C30 aryl group; Or a substituted or unsubstituted C2-C30 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 C3-C20의 시클로알킬기; 치환 또는 비치환된 C6-C20의 아릴기; 또는 치환 또는 비치환된 C2-C20의 헤테로고리기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently a substituted or unsubstituted C3-C20 cycloalkyl group; A substituted or unsubstituted C6-C20 aryl group; Or a substituted or unsubstituted C2-C20 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 알킬기인 경우, 중수소; 또는 할로겐기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted alkyl group, deuterium; Or it may be substituted with a halogen group.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 실릴기인 경우, 알킬기; C1-C10의 알킬기; C1-C5의 알킬기; 메틸기; 아릴기; C6-C30의 아릴기; C6-C20의 아릴기; 또는 페닐기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted silyl group, an alkyl group; C1-C10 alkyl group; C1-C5 alkyl group; Methyl group; Aryl group; C6-C30Aryl group; C6-C20Aryl group; Or it may be substituted with a phenyl group.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 아릴기인 경우, 중수소; 할로겐기; 알킬기; 중수소로 치환된 알킬기; 할로알킬기; 실릴기; 및 헤테로고리기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted aryl group, deuterium; Halogen group; Alkyl groups; An alkyl group substituted with deuterium; Haloalkyl group; Silyl group; And one or more substituents selected from the group consisting of heterocyclic groups or two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 아릴기인 경우, 중수소; 할로겐기; 알킬기; 중수소로 치환된 알킬기; 할로알킬기; 알킬기로 치환된 실릴기; 또는 헤테로고리기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted aryl group, deuterium; Halogen group; Alkyl groups; An alkyl group substituted with deuterium; Haloalkyl group; A silyl group substituted with an alkyl group; Or it may be substituted with a heterocyclic group.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 아릴기인 경우, 중수소; 할로겐기; C1-C10의 알킬기; 중수소로 치환된 C1-C10의 알킬기; C1-C10의 할로알킬기; C1-C10의 알킬기로 치환된 실릴기; 또는 C2-C30의 헤테로고리기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted aryl group, deuterium; Halogen group; C1-C10 alkyl group; A C1-C10 alkyl group substituted with deuterium; C1-C10 haloalkyl group; A silyl group substituted with a C1-C10 alkyl group; Or it may be substituted with a heterocyclic group of C2-C30.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 아릴기인 경우, 중수소; 할로겐기; C1-C5의 알킬기; 중수소로 치환된 C1-C5의 알킬기; C1-C5의 할로알킬기; C1-C5의 알킬기로 치환된 실릴기; 및 C2-C20의 헤테로고리기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted aryl group, deuterium; Halogen group; C1-C5 alkyl group; A C1-C5 alkyl group substituted with deuterium; C1-C5 haloalkyl group; A silyl group substituted with an alkyl group of C1-C5; And C2-C20 heterocyclic groups, or one or more substituents selected from the group, or two or more groups selected from the group, may be substituted with linked substituents.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 아릴기인 경우, 중수소; 할로겐기; C1-C5의 알킬기; 중수소로 치환된 C1-C5의 알킬기; C1-C5의 할로알킬기; 또는 C2-C20의 헤테로고리기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted aryl group, deuterium; Halogen group; C1-C5 alkyl group; A C1-C5 alkyl group substituted with deuterium; C1-C5 haloalkyl group; Or it may be substituted with a C2-C20 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 아릴기인 경우, 중수소; 및 C1-C5의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 2 이상의 기가 연결된 치환기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted aryl group, deuterium; And C1-C5 alkyl group may be substituted with one or more substituents selected from the group consisting of two or more substituents.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 아릴기인 경우, 중수소; C1-C5의 알킬기; 또는 중수소로 치환된 C1-C5의 알킬기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted aryl group, deuterium; C1-C5 alkyl group; Or it may be substituted with a C1-C5 alkyl group substituted with deuterium.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 아릴기인 경우, 중수소; 할로겐기; 메틸기; 에틸기; 프로필기; t-부틸기; CD3; CF3; 피리딘기; 피리미딘기; 디벤조퓨란기; 디벤조티오펜기; 또는 카바졸기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted aryl group, deuterium; Halogen group; Methyl group; Ethyl group; Propyl group; t-butyl group; CD 3 ; CF 3 ; Pyridine group; Pyrimidine group; Dibenzofuran group; Dibenzothiophene group; Or it may be substituted with a carbazole group.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 아릴기인 경우, 중수소; 중수소로 치환 또는 비치환된 메틸기; t-부틸기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted aryl group, deuterium; A methyl group unsubstituted or substituted with deuterium; It may be substituted with a t-butyl group.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 헤테로고리기인 경우, 중수소; 할로겐기; 알킬기; 중수소로 치환된 알킬기; 할로알킬기; 또는 아릴기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted heterocyclic group, deuterium; Halogen group; Alkyl groups; An alkyl group substituted with deuterium; Haloalkyl group; Or it may be substituted with an aryl group.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 헤테로고리기인 경우, 중수소; 할로겐기; C1-C10의 알킬기; 중수소로 치환된 C1-C10의 알킬기; C1-C10의 할로알킬기; 또는 C6-C30의 아릴기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted heterocyclic group, deuterium; Halogen group; C1-C10 alkyl group; A C1-C10 alkyl group substituted with deuterium; C1-C10 haloalkyl group; Or it may be substituted with an aryl group of C6-C30.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 헤테로고리기인 경우, 중수소; 할로겐기; C1-C5의 알킬기; 중수소로 치환된 C1-C5의 알킬기; C1-C5의 할로알킬기; 및 C6-C20의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted heterocyclic group, deuterium; Halogen group; C1-C5 alkyl group; A C1-C5 alkyl group substituted with deuterium; C1-C5 haloalkyl group; And a C6-C20 aryl group, or one or more substituents selected from the group or two or more groups selected from the group may be substituted with linked substituents.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 헤테로고리기인 경우, 중수소; 할로겐기; C1-C5의 알킬기; 중수소로 치환된 C1-C5의 알킬기; C1-C5의 할로알킬기; 또는 C6-C20의 아릴기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted heterocyclic group, deuterium; Halogen group; C1-C5 alkyl group; A C1-C5 alkyl group substituted with deuterium; C1-C5 haloalkyl group; Or it may be substituted with an aryl group of C6-C20.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 헤테로고리기인 경우, 중수소; 할로겐기; 메틸기; 에틸기; 프로필기; t-부틸기; CD3; CF3; 페닐기; 비페닐기; 나프틸기; 터페닐기; 또는 플루오레닐기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted heterocyclic group, deuterium; Halogen group; Methyl group; Ethyl group; Propyl group; t-butyl group; CD 3 ; CF 3 ; Phenyl group; Biphenyl group; Naphthyl group; Terphenyl group; Or it may be substituted with a fluorenyl group.
본 명세서의 일 실시상태에 있어서, Ar1 또는 Ar2가 치환된 헤테로고리기인 경우, 중수소; 중수소로 치환 또는 비치환된 메틸기; t-부틸기로 치환될 수 있다.In one embodiment of the present specification, when Ar1 or Ar2 is a substituted heterocyclic group, deuterium; A methyl group unsubstituted or substituted with deuterium; It may be substituted with a t-butyl group.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 C3-C20의 시클로알킬기; 치환 또는 비치환된 C6-C20의 아릴기; 또는 치환 또는 비치환된 C2-C20의 헤테로고리기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently a C3-C20 cycloalkyl group; A substituted or unsubstituted C6-C20 aryl group; Or a substituted or unsubstituted C2-C20 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 C3-C30의 시클로알킬기; 중수소, 할로겐기, C1-C5의 알킬기, 중수소로 치환된 C1-C5의 알킬기, C1-C5의 할로알킬기, C1-C5의 알킬기로 치환된 실릴기, 및 C2-C20의 헤테로고리기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 C6-C20의 아릴기; 또는 중수소, 할로겐기, C1-C5의 알킬기, 중수소로 치환된 C1-C5의 알킬기, C1-C5의 할로알킬기, C1-C5의 알킬기로 치환된 실릴기, 및 C6-C20의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 C2-C20의 헤테로고리기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently a C3-C30 cycloalkyl group; In the group consisting of deuterium, halogen groups, C1-C5 alkyl groups, C1-C5 alkyl groups substituted with deuterium, C1-C5 haloalkyl groups, C1-C5 alkyl group-substituted silyl groups, and C2-C20 heterocyclic groups. A C6-C20 aryl group, which is unsubstituted or substituted with one or more substituents selected or two or more groups selected from the group; Or in the group consisting of deuterium, halogen group, C1-C5 alkyl group, C1-C5 alkyl group substituted with deuterium, C1-C5 haloalkyl group, C1-C5 alkyl group-substituted silyl group, and C6-C20 aryl group. It is a C2-C20 heterocyclic group unsubstituted or substituted with one or more substituents selected or two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 C3-C30의 시클로알킬기; 중수소, 할로겐기, C1-C5의 알킬기, 중수소로 치환된 C1-C5의 알킬기, C1-C5의 할로알킬기, C1-C5의 알킬기로 치환된 실릴기, 및 C2-C20의 헤테로고리기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 C6-C20의 아릴기; 또는 중수소, C1-C5의 알킬기, 중수소로 치환된 C1-C5의 알킬기, 및 C6-C20의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 C2-C20의 헤테로고리기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently a C3-C30 cycloalkyl group; In the group consisting of deuterium, halogen groups, C1-C5 alkyl groups, C1-C5 alkyl groups substituted with deuterium, C1-C5 haloalkyl groups, C1-C5 alkyl group-substituted silyl groups, and C2-C20 heterocyclic groups. A C6-C20 aryl group, which is unsubstituted or substituted with one or more substituents selected or two or more groups selected from the group; Or C2 substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium, an alkyl group of C1-C5, an alkyl group of C1-C5 substituted with deuterium, and an aryl group of C6-C20, or two or more groups selected from the group. -C20 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소 및 C1-C5의 알킬기 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 C6-C20의 아릴기; 또는 C2-C20의 헤테로고리기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently substituted or substituted with one or more substituents selected from the group consisting of deuterium and C1-C5 alkyl groups or two or more groups selected from the group. A substituted C6-C20 aryl group; Or a C2-C20 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 아다만틸기; 중수소, 플루오로기, 메틸기, t-부틸기, 트리플루오로메틸기, 트리메틸실릴기 또는 피리딘기로 치환 또는 비치환된 페닐기; 중수소, 플루오로기, t-부틸기 또는 트리플루오로메틸기로 치환 또는 비치환된 비페닐기; 중수소 또는 트리플루오로메틸기로 치환 또는 비치환된 터페닐기; 나프틸기; 메틸기로 치환 또는 비치환된 플루오레닐기; 메틸기, 중수소로 치환된 메틸기, 또는 페닐기로 치환 또는 비치환된 피리딘기; t-부틸기로 치환 또는 비치환된 디벤조퓨란기; 또는 t-부틸기로 치환 또는 비치환된 디벤조티오펜기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently an adamantyl group; A phenyl group unsubstituted or substituted with deuterium, fluoro, methyl, t-butyl, trifluoromethyl, trimethylsilyl or pyridine groups; A biphenyl group unsubstituted or substituted with deuterium, fluoro, t-butyl or trifluoromethyl; A terphenyl group unsubstituted or substituted with a deuterium or trifluoromethyl group; Naphthyl group; A fluorenyl group unsubstituted or substituted with a methyl group; A methyl group, a methyl group substituted with deuterium, or a pyridine group unsubstituted or substituted with a phenyl group; a dibenzofuran group unsubstituted or substituted with a t-butyl group; Or a dibenzothiophene group unsubstituted or substituted with a t-butyl group.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소, 메틸기 또는 t-부틸기로 치환 또는 비치환된 페닐기; 중수소 또는 t-부틸기로 치환 또는 비치환된 비페닐기; 또는 디벤조퓨란기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently a phenyl group unsubstituted or substituted with deuterium, a methyl group, or a t-butyl group; A biphenyl group unsubstituted or substituted with deuterium or t-butyl group; Or dibenzofuran group.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소; 할로겐기; 중수소로 치환 또는 비치환된 C1-C10의 알킬기; C3-C20의 시클로알킬기; CF3; 트리메틸실릴기; 중수소 또는 C1-C10의 알킬기로 치환 또는 비치환된 C6-C20의 아릴기; 또는 CD3 또는 C1-C10의 알킬기로 치환 또는 C2-C20의 헤테로고리기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Halogen group; A C1-C10 alkyl group unsubstituted or substituted with deuterium; C3-C20 cycloalkyl group; CF 3 ; Trimethylsilyl group; C6-C20 aryl group unsubstituted or substituted with deuterium or C1-C10 alkyl group; Or a substituted group of CD 3 or C1-C10 alkyl group or C2-C20 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소; 불소; 메틸기; t-부틸기; CD3; 아다만틸기; CF3; 트리메틸실릴기; 중수소, 불소, 메틸기, t-부틸기, CD3, CF3, 또는 피리딘기로 치환 또는 비치환된 페닐기; 나프틸기; 중수소로 치환 또는 비치환된 터페닐기; 메틸기로 치환 또는 비치환된 플루오레닐기; t-부틸기로 치환 또는 비치환된 디벤조퓨란기; t-부틸기로 치환 또는 비치환된 디벤조티오펜기; 페닐기로 치환 또는 비치환된 카바졸기; 또는 메틸기, CD3, 또는 CF3로 치환 또는 비치환된 피리딘기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Fluorine; Methyl group; t-butyl group; CD 3 ; Adamantyl group; CF 3 ; Trimethylsilyl group; A phenyl group unsubstituted or substituted with deuterium, fluorine, methyl group, t-butyl group, CD 3 , CF 3 , or pyridine group; Naphthyl group; A terphenyl group unsubstituted or substituted with deuterium; A fluorenyl group unsubstituted or substituted with a methyl group; a dibenzofuran group unsubstituted or substituted with a t-butyl group; a dibenzothiophene group unsubstituted or substituted with a t-butyl group; A carbazole group unsubstituted or substituted with a phenyl group; Or a pyridine group unsubstituted or substituted with a methyl group, CD 3 , or CF 3 .
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소; 불소; 메틸기; t-부틸기; CD3; 아다만틸기; CF3; 트리메틸실릴기; 중수소로 치환 또는 비치환된 페닐기; 나프틸기; 메틸기로 치환 또는 비치환된 플루오레닐기; 디벤조퓨란기; 디벤조티오펜기; 페닐기로 치환 또는 비치환된 카바졸기; 또는 메틸기, CD3, 또는 CF3로 치환 또는 비치환된 피리딘기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Fluorine; Methyl group; t-butyl group; CD 3 ; Adamantyl group; CF 3 ; Trimethylsilyl group; A phenyl group unsubstituted or substituted with deuterium; Naphthyl group; A fluorenyl group unsubstituted or substituted with a methyl group; Dibenzofuran group; Dibenzothiophene group; A carbazole group unsubstituted or substituted with a phenyl group; Or a pyridine group unsubstituted or substituted with a methyl group, CD 3 , or CF 3 .
본 명세서의 일 실시상태에 있어서, Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소; 불소; 메틸기; t-부틸기; CD3; 아다만틸기; CF3; 트리메틸실릴기; 페닐기; 나프틸기; 플루오레닐기; 디벤조퓨란기; 디벤조티오펜기; 카바졸기; 또는 피리딘기이다.In one embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Fluorine; Methyl group; t-butyl group; CD 3 ; Adamantyl group; CF 3 ; Trimethylsilyl group; Phenyl group; Naphthyl group; Fluorenyl group; Dibenzofuran group; Dibenzothiophene group; Carbazole; Or a pyridine group.
본 명세서의 일 실시상태에 있어서, 상기 화학식 1은 하기 화학식 2로 표시된다. In one embodiment of the present specification, Chemical Formula 1 is represented by Chemical Formula 2 below.
[화학식 2][Formula 2]
Figure PCTKR2020000947-appb-I000009
Figure PCTKR2020000947-appb-I000009
상기 화학식 2에 있어서,In Chemical Formula 2,
R1, R2 및 X 내지 Z의 정의는 화학식 1에서 정의한 바와 같고,R1, R2 and X to Z are the same as defined in Formula 1,
Q1 내지 Q3는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 아민기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이고,Q1 to Q3 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted amine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
q1 내지 q3는 각각 0 내지 3의 정수이고, q1 내지 q3가 각각 2 이상인 경우, 괄호 내의 치환기는 서로 동일하거나 상이하다.q1 to q3 are each an integer of 0 to 3, and when q1 to q3 are each 2 or more, the substituents in parentheses are the same or different from each other.
본 명세서의 일 실시상태에 있어서, Q1 내지 Q3의 정의는 상기 Q의 정의와 동일하다.In one embodiment of the present specification, definitions of Q1 to Q3 are the same as those of the Q.
본 명세서의 일 실시상태에 있어서, Q1 내지 Q3는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 치환 또는 비치환된 C1-C10의 알킬기; 치환 또는 비치환된 C1-C10의 알콕시기; 치환 또는 비치환된 C6-C40의 아릴아민기; 치환 또는 비치환된 C6-C20의 아릴기; 또는 치환 또는 비치환된 C2-C20의 헤테로고리기이다.In one embodiment of the present specification, Q1 to Q3 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C1-C10 alkoxy group; A substituted or unsubstituted C6-C40 arylamine group; A substituted or unsubstituted C6-C20 aryl group; Or a substituted or unsubstituted C2-C20 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Q1 및 Q2는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 C1-C10의 알킬기; 또는 치환 또는 비치환된 C6-C30의 아릴기이다.In one embodiment of the present specification, Q1 and Q2 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted C6-C30 aryl group.
본 명세서의 일 실시상태에 있어서, Q1 및 Q2는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 중수소로 치환 또는 비치환된 C1-C10의 알킬기; 또는 중수소 또는 할로겐기로 치환 또는 비치환된 C6-C30의 아릴기이다.In one embodiment of the present specification, Q1 and Q2 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A C1-C10 alkyl group unsubstituted or substituted with deuterium; Or a C6-C30 aryl group unsubstituted or substituted with deuterium or halogen groups.
본 명세서의 일 실시상태에 있어서, Q1 및 Q2는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; C1-C5의 알킬기; 또는 할로겐기로 치환 또는 비치환된 C6-C20의 아릴기이다.In one embodiment of the present specification, Q1 and Q2 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; C1-C5 alkyl group; Or a C6-C20 aryl group unsubstituted or substituted with a halogen group.
본 명세서의 일 실시상태에 있어서, Q1 및 Q2는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 메틸기; 또는 플루오로기로 치환 또는 비치환된 페닐기이다.In one embodiment of the present specification, Q1 and Q2 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Methyl group; Or a phenyl group unsubstituted or substituted with a fluoro group.
본 명세서의 일 실시상태에 있어서, Q3는 수소; 중수소; 할로겐기; C1-C10의 알킬기; C1-C10의 알콕시기; C1-C30의 트리알킬실릴기; C6-C60의 아릴아민기; C6-C30의 아릴기; 및 C2-C30의 헤테로고리기로 이루어진 군에서 선택된 1 이상의 치환기, 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기이다.In one embodiment of the present specification, Q3 is hydrogen; heavy hydrogen; Halogen group; C1-C10 alkyl group; C1-C10alkoxy group; C1-C30 trialkylsilyl group; C6-C60 arylamine group; C6-C30Aryl group; And a C2-C30 heterocyclic group, or one or more substituents selected from the group, or two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, Q3는 수소; 중수소; 할로겐기; C1-C10의 알킬기; C1-C30의 트리알킬실릴기; C6-C60의 아릴아민기; C6-C30의 아릴기; 및 C2-C30의 헤테로고리기로 이루어진 군에서 선택된 1 이상의 치환기, 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기이다.In one embodiment of the present specification, Q3 is hydrogen; heavy hydrogen; Halogen group; C1-C10 alkyl group; C1-C30 trialkylsilyl group; C6-C60 arylamine group; C6-C30Aryl group; And a C2-C30 heterocyclic group, or one or more substituents selected from the group, or two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, Q3는 수소; 중수소; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 아릴아민기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이다.In one embodiment of the present specification, Q3 is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted arylamine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
본 명세서의 일 실시상태에 있어서, Q3는 수소; 중수소; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴아민기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이다.In one embodiment of the present specification, Q3 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; A substituted or unsubstituted arylamine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
본 명세서의 일 실시상태에 있어서, Q3는 수소; 중수소; 할로겐기; 치환 또는 비치환된 C1-C10의 알킬기; 치환 또는 비치환된 C1-C10의 알콕시기; 치환 또는 비치환된 C6-C60의 아릴아민기; 치환 또는 비치환된 C6-C30의 아릴기; 또는 치환 또는 비치환된 C2-C30의 헤테로고리기이다.In one embodiment of the present specification, Q3 is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C1-C10 alkoxy group; A substituted or unsubstituted C6-C60 arylamine group; A substituted or unsubstituted C6-C30 aryl group; Or a substituted or unsubstituted C2-C30 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Q3는 수소; 중수소; 치환 또는 비치환된 C1-C10의 알킬기; 치환 또는 비치환된 C6-C60의 아릴아민기; 치환 또는 비치환된 C6-C30의 아릴기; 또는 치환 또는 비치환된 C2-C30의 헤테로고리기이다.In one embodiment of the present specification, Q3 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C6-C60 arylamine group; A substituted or unsubstituted C6-C30 aryl group; Or a substituted or unsubstituted C2-C30 heterocyclic group.
본 명세서의 일 실시상태에 있어서, Q3는 수소; 중수소; 할로겐기; 중수소로 치환 또는 비치환된 C1-C10의 알킬기; 할로겐기로 치환 또는 비치환된 C1-C10의 알콕시기; 중수소 또는 C1-C30의 트리알킬실릴기로 치환 또는 비치환된 C6-C60의 아릴아민기; 중수소, 할로겐기 또는 C1-10의 알킬기로 치환 또는 비치환된 C6-C30의 아릴기; 또는 중수소 또는 C1-10의 알킬기로 치환 또는 비치환된 C2-C30의 헤테로고리기이다.In one embodiment of the present specification, Q3 is hydrogen; heavy hydrogen; Halogen group; A C1-C10 alkyl group unsubstituted or substituted with deuterium; A C1-C10 alkoxy group unsubstituted or substituted with a halogen group; C6-C60 arylamine group unsubstituted or substituted with deuterium or C1-C30 trialkylsilyl group; C6-C30 aryl group unsubstituted or substituted with deuterium, halogen group or C1-10 alkyl group; Or a C2-C30 heterocyclic group unsubstituted or substituted with deuterium or a C1-10 alkyl group.
본 명세서의 일 실시상태에 있어서, Q3는 수소; 중수소; 할로겐기; 중수소로 치환 또는 비치환된 C1-C10의 알킬기; 중수소 또는 C1-C30의 트리알킬실릴기로 치환 또는 비치환된 C6-C40의 아릴아민기; 중수소, 할로겐기 또는 C1-10의 알킬기로 치환 또는 비치환된 C6-C20의 아릴기; 또는 중수소 또는 C1-10의 알킬기로 치환 또는 비치환된 C2-C20의 헤테로고리기이다.In one embodiment of the present specification, Q3 is hydrogen; heavy hydrogen; Halogen group; A C1-C10 alkyl group unsubstituted or substituted with deuterium; C6-C40 arylamine group unsubstituted or substituted with deuterium or C1-C30 trialkylsilyl group; C6-C20 aryl group unsubstituted or substituted with deuterium, halogen group or C1-10 alkyl group; Or a C2-C20 heterocyclic group unsubstituted or substituted with deuterium or a C1-10 alkyl group.
본 명세서의 일 실시상태에 있어서, Q3는 수소; 중수소; 할로겐기; 중수소로 치환 또는 비치환된 C1-C5의 알킬기; 중수소 또는 C1-C15의 트리알킬실릴기로 치환 또는 비치환된 C6-C40의 아릴아민기; 중수소, 할로겐기 또는 C1-C5의 알킬기로 치환 또는 비치환된 C6-C20의 아릴기; 또는 중수소 또는 C1-C5의 알킬기로 치환 또는 비치환된 C2-C20의 헤테로고리기이다.In one embodiment of the present specification, Q3 is hydrogen; heavy hydrogen; Halogen group; A C1-C5 alkyl group unsubstituted or substituted with deuterium; C6-C40 arylamine group unsubstituted or substituted with deuterium or C1-C15 trialkylsilyl group; C6-C20 aryl group unsubstituted or substituted with deuterium, halogen group or C1-C5 alkyl group; Or a C2-C20 heterocyclic group unsubstituted or substituted with deuterium or a C1-C5 alkyl group.
본 명세서의 일 실시상태에 있어서, Q3는 수소; 중수소; 플루오로기; 메틸기; t-부틸기; 트리플루오로메톡시기; 중수소 또는 트리메틸실릴기로 치환 또는 비치환된 디페닐아민기; 중수소, 플루오로기, 또는 t-부틸기로 치환 또는 비치환된 페닐기; 또는 t-부틸기로 치환 또는 비치환된 카바졸기이다.In one embodiment of the present specification, Q3 is hydrogen; heavy hydrogen; Fluoro groups; Methyl group; t-butyl group; Trifluoromethoxy group; A diphenylamine group unsubstituted or substituted with deuterium or trimethylsilyl group; A phenyl group unsubstituted or substituted with deuterium, a fluoro group, or a t-butyl group; Or a carbazole group unsubstituted or substituted with a t-butyl group.
본 명세서의 일 실시상태에 있어서, Q3는 수소; 중수소; 메틸기; t-부틸기; 중수소 또는 트리메틸실릴기로 치환 또는 비치환된 디페닐아민기; 중수소, 플루오로기, 또는 t-부틸기로 치환 또는 비치환된 페닐기; 또는 t-부틸기로 치환 또는 비치환된 카바졸기이다.In one embodiment of the present specification, Q3 is hydrogen; heavy hydrogen; Methyl group; t-butyl group; A diphenylamine group unsubstituted or substituted with deuterium or trimethylsilyl group; A phenyl group unsubstituted or substituted with deuterium, a fluoro group, or a t-butyl group; Or a carbazole group unsubstituted or substituted with a t-butyl group.
본 명세서의 일 실시상태에 있어서, Q3는 수소; 중수소; 치환 또는 비치환된 C1-C10의 알킬기; 치환 또는 비치환된 C6-C40의 아릴아민기; 치환 또는 비치환된 C6-C20의 아릴기; 또는 치환 또는 비치환된 C2-C20의 헤테로고리기이다.In one embodiment of the present specification, Q3 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted C6-C40 arylamine group; A substituted or unsubstituted C6-C20 aryl group; Or a substituted or unsubstituted C2-C20 heterocyclic group.
본 명세서의 일 실시상태에 있어서, q1은 0 내지 3의 정수이다.In one embodiment of the present specification, q1 is an integer from 0 to 3.
본 명세서의 일 실시상태에 있어서, q2은 0 내지 3의 정수이다.In one embodiment of the present specification, q2 is an integer from 0 to 3.
본 명세서의 일 실시상태에 있어서, q3은 0 내지 3의 정수이다.In one embodiment of the present specification, q3 is an integer from 0 to 3.
본 명세서의 일 실시상태에 있어서, q1은 1 이다.In one embodiment of the present specification, q1 is 1.
본 명세서의 일 실시상태에 있어서, q2은 1 이다.In one embodiment of the present specification, q2 is 1.
본 명세서의 일 실시상태에 있어서, q3은 1 이다.In one embodiment of the present specification, q3 is 1.
본 명세서의 일 실시상태에 있어서, q1가 2 이상인 경우 복수 개의 Q1은 서로 동일하거나 상이하다. 또 하나의 일 실시상태에 있어서, q2가 2 이상인 경우 복수개의 Q2는 서로 동일하거나 상이하다. 또 하나의 일 실시상태에 있어서, q3가 2 이상인 경우 복수개의 Q3는 서로 동일하거나 상이하다.In one embodiment of the present specification, when q1 is 2 or more, a plurality of Q1s are the same or different from each other. In another exemplary embodiment, when q2 is 2 or more, a plurality of Q2s are the same or different from each other. In another exemplary embodiment, when q3 is 2 or more, a plurality of Q3s are the same or different from each other.
본 명세서의 일 실시상태에 있어서, 상기 화학식 3은 하기 화학식 301 내지 303 중 어느 하나로 표시된다.In one embodiment of the present specification, Chemical Formula 3 is represented by any one of the following Chemical Formulas 301 to 303.
[화학식 301][Chemical Formula 301]
Figure PCTKR2020000947-appb-I000010
Figure PCTKR2020000947-appb-I000010
[화학식 302][Chemical Formula 302]
Figure PCTKR2020000947-appb-I000011
Figure PCTKR2020000947-appb-I000011
[화학식 303][Formula 303]
Figure PCTKR2020000947-appb-I000012
Figure PCTKR2020000947-appb-I000012
상기 화학식 301 내지 303에 있어서,In the above formulas 301 to 303,
R1, R2, L11, L12, Ar1, Ar2, n11 및 n12의 정의는 화학식 1에서 정의한 바와 같고,The definitions of R1, R2, L11, L12, Ar1, Ar2, n11 and n12 are as defined in Formula 1,
Y1은 O; 또는 S이고,Y1 is O; Or S,
Z1은 O; 또는 S이고,Z1 is O; Or S,
Q1 내지 Q3은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 아민기; 치환 또는 비치환된 아릴아민기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이고.Q1 to Q3 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted amine group; A substituted or unsubstituted arylamine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
q1 내지 q3는 각각 0 내지 3의 정수이고, q1 내지 q3가 각각 2 이상인 경우, 괄호 내의 치환기는 서로 동일하거나 상이하다.q1 to q3 are each an integer of 0 to 3, and when q1 to q3 are each 2 or more, the substituents in parentheses are the same or different from each other.
본 명세서의 일 실시상태에 있어서, Y1은 O이다.In one embodiment of the present specification, Y1 is O.
본 명세서의 일 실시상태에 있어서, Y1은 S이다.In one embodiment of the present specification, Y1 is S.
본 명세서의 일 실시상태에 있어서, Z1은 O이다.In one embodiment of the present specification, Z1 is O.
본 명세서의 일 실시상태에 있어서, Z1은 S이다.In one embodiment of the present specification, Z1 is S.
본 명세서의 일 실시상태에 있어서, 상기 화학식 301 내지 303의 Q1 내지 Q3는 상기 화학식 2의 Q1 내지 Q3의 정의와 동일하다.In one embodiment of the present specification, Q1 to Q3 in Chemical Formulas 301 to 303 are the same as the definitions of Q1 to Q3 in Chemical Formula 2.
본 명세서의 일 실시상태에 있어서, 상기 화학식 301 내지 303의 q1 내지 q3는 상기 화학식 2의 q1 내지 q3의 정의와 동일하다.In one embodiment of the present specification, q1 to q3 in Chemical Formulas 301 to 303 are the same as the definitions of q1 to q3 in Chemical Formula 2.
본 명세서의 일 실시상태에 있어서, A1 내지 A3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 벤젠고리이고,In one embodiment of the present specification, A1 to A3 are the same as or different from each other, and each independently a substituted or unsubstituted benzene ring,
X는 B이고,X is B,
L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 또는 C1-C5의 알킬기로 치환 또는 비치환된 C6-C20의 아릴렌기이고,L11 and L12 are the same as or different from each other, and each independently a direct bond; Or a C6-C20 arylene group unsubstituted or substituted with a C1-C5 alkyl group,
Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소 및 C1-C5의 알킬기 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 C6-C20의 아릴기; 또는 C2-C20의 헤테로고리기이다.Ar1 and Ar2 are the same or different from each other, and each independently a deuterium and a C1-C5 aryl group which is unsubstituted or substituted with one or more substituents selected from the group consisting of alkyl groups of C1-C5 or two or more groups selected from the group; Or a C2-C20 heterocyclic group.
본 명세서의 일 실시상태에 있어서, 상기 화학식 1로 표시되는 화합물은 하기 화합물 중에서 선택되는 어느 하나이다. In one embodiment of the present specification, the compound represented by Chemical Formula 1 is any one selected from the following compounds.
Figure PCTKR2020000947-appb-I000013
Figure PCTKR2020000947-appb-I000013
Figure PCTKR2020000947-appb-I000014
Figure PCTKR2020000947-appb-I000014
Figure PCTKR2020000947-appb-I000015
Figure PCTKR2020000947-appb-I000015
Figure PCTKR2020000947-appb-I000016
Figure PCTKR2020000947-appb-I000016
Figure PCTKR2020000947-appb-I000017
Figure PCTKR2020000947-appb-I000017
Figure PCTKR2020000947-appb-I000018
Figure PCTKR2020000947-appb-I000018
Figure PCTKR2020000947-appb-I000019
Figure PCTKR2020000947-appb-I000019
Figure PCTKR2020000947-appb-I000020
Figure PCTKR2020000947-appb-I000020
Figure PCTKR2020000947-appb-I000021
Figure PCTKR2020000947-appb-I000021
Figure PCTKR2020000947-appb-I000022
Figure PCTKR2020000947-appb-I000022
Figure PCTKR2020000947-appb-I000023
Figure PCTKR2020000947-appb-I000023
Figure PCTKR2020000947-appb-I000024
Figure PCTKR2020000947-appb-I000024
Figure PCTKR2020000947-appb-I000025
Figure PCTKR2020000947-appb-I000025
Figure PCTKR2020000947-appb-I000026
Figure PCTKR2020000947-appb-I000026
Figure PCTKR2020000947-appb-I000027
Figure PCTKR2020000947-appb-I000027
Figure PCTKR2020000947-appb-I000028
Figure PCTKR2020000947-appb-I000028
Figure PCTKR2020000947-appb-I000029
Figure PCTKR2020000947-appb-I000029
본 명세서의 일 실시상태에 따른 화합물은 후술하는 제조 방법으로 제조될 수 있다. 필요에 따라, 치환기를 추가하거나 제외할 수 있으며, 치환기의 위치를 변경할 수 있다. 또한, 당기술분야에 알려져 있는 기술을 기초로, 출발물질, 반응물질, 반응 조건 등을 변경할 수 있다. The compound according to one embodiment of the present specification may be prepared by a manufacturing method described later. If necessary, a substituent may be added or excluded, and the position of the substituent may be changed. In addition, starting materials, reactants, reaction conditions, etc. can be changed based on techniques known in the art.
예컨대, 상기 화학식 1로 표시되는 화합물은 하기 일반식 1과 같이 코어 구조가 제조될 수 있다. 치환기는 당기술분야에 알려져 있는 방법에 의하여 결합될 수 있으며, 치환기의 종류, 위치 또는 개수는 당기술분야에 알려져 있는 기술에 따라 변경될 수 있다. 하기 일반식 1과 같이 치환기를 결합시킬 수 있으나, 이에 한정되는 것은 아니다.For example, the compound represented by Formula 1 may have a core structure as shown in Formula 1 below. Substituents can be combined by methods known in the art, and the type, location, or number of substituents can be changed according to techniques known in the art. Substituents may be combined as shown in Formula 1 below, but are not limited thereto.
[일반식 1][Formula 1]
Figure PCTKR2020000947-appb-I000030
Figure PCTKR2020000947-appb-I000030
상기 일반식 1에 있어서, A1 내지 A3, R11, R12, Y 및 R2에 대한 정의는 상기 화학식 1에서 정의한 바와 동일하다. In Formula 1, A1 to A3, R11, R12, Y and R2 are defined as defined in Formula 1.
중간체 IM-1와 중간체 IM-2의 Pd 촉매를 이용한 커플링 반응 또는 산을 이용한 고리 형성 또는 SNAr 반응으로 중간체 IM-3을 얻을 수 있고, 이 과정에서, 화학식 1의 R2이 페닐기인 경우만 기재되어 있으나, 페닐기 이외의 아릴기를 사용하여 R2이 페닐기 이외의 아릴기인 중간체 IM-3를 합성할 수 있다. 중간체 IM-3에서부터 Li-X 교환(exchange) 반응 및 뒤이은 붕소 첨가 반응으로 화학식 1을 가지는 화합물을 합성 할 수 있다.Intermediate IM-3 can be obtained by coupling reaction using Pd catalyst of intermediate IM-1 and intermediate IM-2 or ring formation or SNAr reaction using acid, and in this process, only when R2 of formula 1 is phenyl group However, the intermediate IM-3 in which R2 is an aryl group other than a phenyl group can be synthesized using an aryl group other than a phenyl group. From the intermediate IM-3, a compound having Formula 1 can be synthesized by a Li-X exchange reaction followed by a boron addition reaction.
본 명세서는 상기 전술한 화합물을 포함하는 유기 발광 소자를 제공한다.The present specification provides an organic light emitting device comprising the above-described compound.
본 명세서는 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1 층 이상은 상기 화학식 1로 표시되는 화합물을 포함하는 것인 유기 발광 소자를 제공한다.This specification is the first electrode; A second electrode provided to face the first electrode; And an organic light emitting device including at least one layer of an organic material provided between the first electrode and the second electrode, wherein at least one layer of the organic material layer includes a compound represented by Chemical Formula 1 do.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 상기 화학식 1로 표시되는 화합물을 포함한다.According to an exemplary embodiment of the present specification, the organic material layer includes a light emitting layer, the light emitting layer includes a compound represented by the formula (1).
본 명세서에서 어떤 부재가 다른 부재 "상에" 위치하고 있다고 할 때, 이는 어떤 부재가 다른 부재에 접해 있는 경우뿐 아니라 두 부재 사이에 또 다른 부재가 존재하는 경우도 포함한다.When a member is referred to herein as being “on” another member, this includes not only the case where one member abuts another member, but also the case where another member exists between the two members.
본 명세서에서 어떤 부분이 어떤 구성요소를 "포함" 한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다. In the present specification, when a part “includes” a certain component, it means that the component may further include other components, not to exclude other components, unless specifically stated otherwise.
본 명세서에 있어서, 상기 '층'은 본 기술분야에 주로 사용되는 '필름'과 호환되는 의미이며, 목적하는 영역을 덮는 코팅을 의미한다. 상기 '층'의 크기는 한정되지 않으며, 각각의 '층'은 그 크기가 동일하거나 상이할 수 있다. 일 실시상태에 있어서, '층'의 크기는 전체 소자와 같을 수 있고, 특정 기능성 영역의 크기에 해당할 수 있으며, 단일 서브픽셀(sub-pixel)만큼 작을 수도 있다. In the present specification, the'layer' is a meaning compatible with the'film' mainly used in the technical field, and refers to a coating covering a desired area. The size of the'layer' is not limited, and each'layer' may have the same or different sizes. In an exemplary embodiment, the size of the'layer' may be the same as that of the entire device, may correspond to the size of a specific functional area, or may be as small as a single sub-pixel.
본 명세서에 있어서, 특정한 A 물질이 B층에 포함된다는 의미는 i) 1종 이상의 A 물질이 하나의 B층에 포함되는 것과 ii) B층이 1층 이상으로 구성되고, A 물질이 다층의 B층 중 1층 이상에 포함되는 것을 모두 포함한다.In the present specification, the meaning that a specific A material is included in the B layer means i) one or more A materials are included in one B layer, and ii) the B layer is composed of one or more layers, and the A material is a multilayer B. All of the layers included in one or more layers are included.
본 명세서에 있어서, 특정한 A 물질이 C층 또는 D층에 포함된다는 의미는 i) 1층 이상의 C층 중 1층 이상에 포함되거나, ii) 1층 이상의 D층 중 1층 이상에 포함되거나, iii) 1층 이상의 C층 및 1층 이상의 D층에 각각 포함되는 것을 모두 의미하는 것이다. In the present specification, the meaning that a specific A material is included in the C layer or the D layer includes i) one or more of the C layers of one or more layers, ii) one or more of the D layers of one or more layers, or iii ) It means both included in each of the C layer of one or more layers and the D layer of one or more layers.
본 명세서에 따른 유기 발광 소자는 상기 발광층 이외에 추가의 유기물층을 포함할 수 있다.The organic light emitting device according to the present specification may include an additional organic material layer in addition to the light emitting layer.
본 명세서의 유기 발광 소자의 유기물층은 단층 구조로 이루어질 수도 있으나, 2층 이상의 유기물층이 적층된 다층 구조로 이루어질 수 있다. 예컨대, 정공 주입층, 정공 수송층, 발광층, 전자 수송층, 전자 주입층, 전자 차단층, 정공 차단층 등을 포함하는 구조를 가질 수 있다. 그러나 유기 발광 소자의 구조는 이에 한정되지 않고 더 적은 수의 유기층을 포함할 수 있다.The organic material layer of the organic light emitting device of the present specification may have a single layer structure, but may have a multi-layer structure in which two or more organic material layers are stacked. For example, it may have a structure including a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, an electron blocking layer, a hole blocking layer, and the like. However, the structure of the organic light emitting device is not limited to this, and may include fewer organic layers.
본 명세서의 일 실시상태에 따른 유기 발광 소자는 발광층을 포함하고, 상기 발광층은 상기 화학식 1로 표시되는 화합물 및 하기 화학식 H로 표시되는 화합물을 포함한다. The organic light emitting diode according to the exemplary embodiment of the present specification includes a light emitting layer, and the light emitting layer includes a compound represented by Formula 1 and a compound represented by Formula H below.
[화학식 H][Formula H]
Figure PCTKR2020000947-appb-I000031
Figure PCTKR2020000947-appb-I000031
상기 화학식 H에 있어서,In the formula H,
L21 및 L22는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 치환 또는 비치환된 아릴렌기; 또는 치환 또는 비치환된 헤테로아릴렌기이고,L21 and L22 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted heteroarylene group,
R21 내지 R28은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 포스핀옥사이드기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로아릴기이고,R21 to R28 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted silyl group; A substituted or unsubstituted phosphine oxide group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heteroaryl group,
Ar101 및 Ar102는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로아릴기이다.Ar101 and Ar102 are the same as or different from each other, and each independently a substituted or unsubstituted aryl group; Or a substituted or unsubstituted heteroaryl group.
본 명세서의 일 실시상태에 있어서, L21 및 L22는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 치환 또는 비치환된 아릴렌기; 또는 치환 또는 비치환된 헤테로아릴렌기이다.In one embodiment of the present specification, L21 and L22 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted heteroarylene group.
본 명세서의 일 실시상태에 있어서, L21 및 L22는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 치환 또는 비치환된 C6-C30의 아릴렌기; 또는 치환 또는 비치환되고 N, O, 또는 S를 포함하는 C2-C30의 헤테로아릴렌기이다.In one embodiment of the present specification, L21 and L22 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted C6-C30 arylene group; Or a substituted or unsubstituted C2-C30 heteroarylene group containing N, O, or S.
본 명세서의 일 실시상태에 있어서, L21 및 L22는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; C6-C20의 아릴렌기; 또는 N, O, 또는 S를 포함하는 C2-C20의 헤테로아릴렌기이다. 상기 아릴렌기 또는 헤테로아릴렌기는 C1-C10의 알킬기, C6-C20의 아릴기 또는 C2-C20의 헤테로아릴기로 치환되거나 비치환된다. 또 하나의 일 실시상태에 있어서, 상기 '치환 또는 비치환된'은 C1-C10의 알킬기, C6-C20의 아릴기 또는 C2-C20의 헤테로아릴기로 치환되거나 어떠한 치환기도 갖지 않는 것을 말한다.In one embodiment of the present specification, L21 and L22 are the same as or different from each other, and each independently a direct bond; C6-C20arylene group; Or a C2-C20 heteroarylene group containing N, O, or S. The arylene group or heteroarylene group is substituted or unsubstituted with a C1-C10 alkyl group, a C6-C20 aryl group, or a C2-C20 heteroaryl group. In another exemplary embodiment, the'substituted or unsubstituted' refers to a C1-C10 alkyl group, a C6-C20 aryl group, or a C2-C20 heteroaryl group, or no substituent.
본 명세서의 일 실시상태에 있어서, L21 및 L22는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 치환 또는 비치환된 페닐렌기; 치환 또는 비치환된 나프틸렌기; 또는 치환 또는 비치환된 티오페닐렌기이다.In one embodiment of the present specification, L21 and L22 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted phenylene group; A substituted or unsubstituted naphthylene group; Or a substituted or unsubstituted thiophenylene group.
본 명세서의 일 실시상태에 있어서, L21 및 L22는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 페닐렌기; 나프틸렌기; 또는 티오페닐렌기이다.In one embodiment of the present specification, L21 and L22 are the same as or different from each other, and each independently a direct bond; Phenylene group; Naphthylene group; Or a thiophenylene group.
본 명세서의 일 실시상태에 있어서, L21 및 L22는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 페닐렌기; 또는 나프틸렌기이다.In one embodiment of the present specification, L21 and L22 are the same as or different from each other, and each independently a direct bond; Phenylene group; Or a naphthylene group.
본 명세서의 일 실시상태에 있어서, L21 및 L22는 직접결합이다.In one embodiment of the present specification, L21 and L22 are a direct bond.
본 명세서의 일 실시상태에 있어서, Ar101 및 Ar102는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로아릴기이다.In one embodiment of the present specification, Ar101 and Ar102 are the same as or different from each other, and each independently a substituted or unsubstituted aryl group; Or a substituted or unsubstituted heteroaryl group.
본 명세서의 일 실시상태에 있어서, Ar101 및 Ar102는 서로 동일하거나 상이하고, 각각 독립적으로 Y1로 치환 또는 비치환된 C6-C30의 아릴기; 또는 Y1로 치환 또는 비치환된 C2-C30의 헤테로아릴기이다.In one embodiment of the present specification, Ar101 and Ar102 are the same as or different from each other, and each independently a substituted or unsubstituted C6-C30 aryl group; Or a C2-C30 heteroaryl group unsubstituted or substituted with Y1.
본 명세서의 일 실시상태에 있어서, Ar101 및 Ar102는 서로 동일하거나 상이하고, 각각 독립적으로 Y1로 치환 또는 비치환된 C6-C20의 아릴기; 또는 Y1로 치환 또는 비치환된 C2-C20의 헤테로아릴기이다.In one embodiment of the present specification, Ar101 and Ar102 are the same as or different from each other, and each independently a substituted or unsubstituted C6-C20 aryl group with Y1; Or a C2-C20 heteroaryl group unsubstituted or substituted with Y1.
본 명세서의 일 실시상태에 있어서, Ar101 및 Ar102는 서로 동일하거나 상이하고, 각각 독립적으로 Y1로 치환 또는 비치환된 단환 내지 4환의 아릴기; 또는 Y1로 치환 또는 비치환된 단환 내지 4환의 헤테로아릴기이다.In one embodiment of the present specification, Ar101 and Ar102 are the same as or different from each other, and each independently a monocyclic to 4 ring aryl group which is unsubstituted or substituted with Y1; Or a monocyclic to 4 ring heteroaryl group unsubstituted or substituted with Y1.
본 명세서의 일 실시상태에 있어서, Ar101 및 Ar102는 서로 동일하거나 상이하고, 각각 독립적으로 페닐기; 비페닐기; 나프틸기; 또는 디벤조퓨란기이다.In one embodiment of the present specification, Ar101 and Ar102 are the same as or different from each other, and each independently a phenyl group; Biphenyl group; Naphthyl group; Or dibenzofuran group.
본 명세서의 일 실시상태에 있어서, Y1는 중수소; 할로겐기; 니트릴기; C1-C10의 알킬기; 탄소수 3 내지 20의 시클로알킬기; C1-C10의 알킬기가 치환된 실릴기; 또는 C6-C30의 아릴기이다.In one embodiment of the present specification, Y1 is deuterium; Halogen group; Nitrile group; C1-C10 alkyl group; A cycloalkyl group having 3 to 20 carbon atoms; A silyl group substituted with an alkyl group of C1-C10; Or it is a C6-C30 aryl group.
본 명세서의 일 실시상태에 있어서, Y1는 중수소; 할로겐기; 니트릴기; C1-C5의 알킬기; 탄소수 3 내지 10의 시클로알킬기; C1-C5의 알킬기가 치환된 실릴기; 또는 C6-C20의 아릴기이다.In one embodiment of the present specification, Y1 is deuterium; Halogen group; Nitrile group; C1-C5 alkyl group; A cycloalkyl group having 3 to 10 carbon atoms; C1-C5 alkyl group substituted silyl group; Or it is a C6-C20 aryl group.
본 명세서의 일 실시상태에 있어서, Y1는 중수소; 할로겐기; 니트릴기; 메틸기; 시클로헥실기; 트리메틸실릴기; 또는 페닐기이다.In one embodiment of the present specification, Y1 is deuterium; Halogen group; Nitrile group; Methyl group; Cyclohexyl group; Trimethylsilyl group; Or a phenyl group.
본 명세서의 일 실시상태에 있어서, Y1는 중수소; 불소; 니트릴기; 메틸기; 시클로헥실기; 또는 트리메틸실릴기이다.In one embodiment of the present specification, Y1 is deuterium; Fluorine; Nitrile group; Methyl group; Cyclohexyl group; Or a trimethylsilyl group.
본 명세서의 일 실시상태에 있어서, R21 내지 R28은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 포스핀옥사이드기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로아릴기이다.In one embodiment of the present specification, R21 to R28 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted silyl group; A substituted or unsubstituted phosphine oxide group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heteroaryl group.
본 명세서의 일 실시상태에 있어서, R21 내지 R28은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 C1-C10의 알킬기; 치환 또는 비치환된 탄소수 3 내지 20의 시클로알킬기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 포스핀옥사이드기; 치환 또는 비치환된 C6-C30의 아릴기; 또는 치환 또는 비치환된 C2-C30의 헤테로아릴기이다.In one embodiment of the present specification, R21 to R28 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted cycloalkyl group having 3 to 20 carbon atoms; A substituted or unsubstituted silyl group; A substituted or unsubstituted phosphine oxide group; A substituted or unsubstituted C6-C30 aryl group; Or a substituted or unsubstituted C2-C30 heteroaryl group.
본 명세서의 일 실시상태에 있어서, R21 내지 R28은 각각 수소; 또는 중수소이다.In one embodiment of the present specification, R21 to R28 are each hydrogen; Or deuterium.
본 명세서의 일 실시상태에 있어서, R21 내지 R28은 수소이다.In one embodiment of the present specification, R21 to R28 are hydrogen.
본 명세서의 일 실시상태에 있어서, R21 내지 R28은 중수소이다.In one embodiment of the present specification, R21 to R28 are deuterium.
본 명세서의 일 실시상태에 있어서, 상기 화학식 H로 표시되는 화합물은 하기 화합물 중 선택된 어느 하나이다. In one embodiment of the present specification, the compound represented by Chemical Formula H is any one selected from the following compounds.
Figure PCTKR2020000947-appb-I000032
Figure PCTKR2020000947-appb-I000032
본 명세서의 일 실시상태에 따른 유기 발광 소자는 발광층을 포함하고, 상기 발광층은 상기 화학식 1로 표시되는 화합물을 발광층의 도펀트로서 포함하고, 상기 화학식 H로 표시되는 화합물을 발광층의 호스트로서 포함한다.The organic light emitting device according to an exemplary embodiment of the present specification includes a light emitting layer, the light emitting layer includes a compound represented by Formula 1 as a dopant in the light emitting layer, and a compound represented by Formula H as a host of the light emitting layer.
본 명세서의 일 실시상태에 있어서, 상기 화학식 H로 표시되는 화합물의 중량 100 중량부 기준으로, 상기 화학식 1로 표시되는 화합물의 함량은 0.01 중량부 내지 30 중량부; 0.1 중량부 내지 20 중량부; 또는 0.5 중량부 내지 10 중량부이다.In one embodiment of the present specification, based on 100 parts by weight of the compound represented by Formula H, the content of the compound represented by Formula 1 is 0.01 parts by weight to 30 parts by weight; 0.1 to 20 parts by weight; Or 0.5 to 10 parts by weight.
본 명세서의 일 실시상태에 있어서, 상기 발광층은 상기 화학식 H로 표시되는 화합물 이외에 호스트 물질을 하나 더 포함할 수 있다. 이때, 더 포함되는 호스트 재료(혼합 호스트 화합물)는 축합 방향족환 유도체 또는 헤테로환 함유 화합물 등이 있다. 구체적으로, 축합 방향족환 유도체로는 안트라센 유도체, 피렌 유도체, 나프탈렌 유도체, 펜타센 유도체, 페난트렌 화합물, 플루오란텐 화합물 등이 있고, 헤테로환 함유 화합물로는 디벤조퓨란 유도체, 래더형 퓨란 화합물, 피리미딘 유도체 등이 있으나, 이에 한정되는 것은 아니다. In one embodiment of the present specification, the emission layer may further include a host material in addition to the compound represented by Chemical Formula H. At this time, the host material (mixed host compound) further included may be a condensed aromatic ring derivative or a heterocyclic compound. Specifically, condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, fluoranthene compounds, etc., and heterocyclic compounds include dibenzofuran derivatives, ladder-type furan compounds, Pyrimidine derivatives, and the like, but are not limited thereto.
상기 화학식 H로 표시되는 화합물 및 상기 혼합 호스트 화합물의 혼합비는 95:5 내지 5:95 이다.The mixing ratio of the compound represented by Formula H and the mixed host compound is 95:5 to 5:95.
본 명세서의 일 실시상태에 있어서, 상기 화학식 1로 표시되는 화합물 및 상기 화학식 H로 표시되는 화합물을 포함한 발광층은 청색을 띤다.In one embodiment of the present specification, the light emitting layer including the compound represented by Chemical Formula 1 and the compound represented by Chemical Formula H has a blue color.
본 명세서의 일 실시상태에 따른 유기 발광 소자는 2층 이상의 발광층을 포함하고, 상기 2층 이상의 발광층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물 및 상기 화학식 H로 표시되는 화합물을 포함한다. 상기 화학식 1로 표시되는 화합물 및 상기 화학식 H로 표시되는 화합물을 포함한 발광층은 청색을 띠며, 상기 화학식 1로 표시되는 화합물 및 상기 화학식 H로 표시되는 화합물을 포함하지 않은 발광층은 당업계에 알려진 청색, 적색 또는 녹색 발광 화합물을 포함할 수 있다.The organic light emitting diode according to the exemplary embodiment of the present specification includes two or more light emitting layers, and at least one of the two or more light emitting layers includes a compound represented by Formula 1 and a compound represented by Formula H. The light emitting layer including the compound represented by Formula 1 and the compound represented by Formula H has a blue color, and the light emitting layer not containing the compound represented by Formula 1 and the compound represented by Formula H is blue known in the art, Red or green light-emitting compounds.
본 명세서의 일 실시상태에 있어서, 상기 유기물층은 정공 주입층 또는 정공 수송층을 포함한다. In one embodiment of the present specification, the organic material layer includes a hole injection layer or a hole transport layer.
본 명세서의 일 실시상태에 있어서, 상기 유기물층은 전자 주입층 또는 전자 수송층을 포함한다. In one embodiment of the present specification, the organic material layer includes an electron injection layer or an electron transport layer.
본 명세서의 일 실시상태에 있어서, 상기 유기물층은 전자 차단층을 포함한다. In one embodiment of the present specification, the organic material layer includes an electron blocking layer.
본 명세서의 일 실시상태에 있어서, 상기 유기물층은 정공 차단층을 포함한다. In one embodiment of the present specification, the organic material layer includes a hole blocking layer.
본 명세서의 일 실시상태에 있어서, 상기 유기 발광 소자는 정공 주입층, 정공 수송층. 발광층, 전자 수송층, 전자 주입층, 정공 차단층 및 전자 차단층으로 이루어진 군에서 선택되는 1층 또는 2층 이상을 더 포함한다.In one embodiment of the present specification, the organic light emitting device is a hole injection layer, a hole transport layer. It further includes at least one layer or two or more layers selected from the group consisting of a light emitting layer, an electron transport layer, an electron injection layer, a hole blocking layer, and an electron blocking layer.
본 명세서의 일 실시상태에 있어서, 상기 유기 발광 소자는 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 상기 제1 전극과 상기 제2 전극 사이에 구비된 발광층; 및 상기 발광층과 상기 제1 전극 사이, 또는 상기 발광층과 상기 제2 전극 사이에 구비된 2층 이상의 유기물층을 포함한다. In one embodiment of the present specification, the organic light emitting device includes a first electrode; A second electrode provided to face the first electrode; A light emitting layer provided between the first electrode and the second electrode; And two or more organic material layers provided between the light emitting layer and the first electrode, or between the light emitting layer and the second electrode.
본 명세서의 일 실시상태에 있어서, 상기 2층 이상의 유기물층은 발광층, 정공 수송층, 정공 주입층, 정공 수송과 정공 주입을 동시에 하는 층 및 전자 차단층으로 이루어진 군에서 2 이상이 선택될 수 있다. In one embodiment of the present specification, two or more organic material layers may be selected from the group consisting of a light emitting layer, a hole transport layer, a hole injection layer, a layer simultaneously performing hole transport and hole injection, and an electron blocking layer.
본 명세서의 일 실시상태에 있어서, 상기 유기 발광 소자는 기판 상에 양극, 1층 이상의 유기물층 및 음극이 순차적으로 적층된 구조(normal type)의 유기 발광 소자일 수 있다. In one embodiment of the present specification, the organic light emitting device may be an organic light emitting device having a structure in which an anode, one or more organic material layers, and a cathode are sequentially stacked on a substrate.
본 명세서의 일 실시상태에 있어서, 상기 유기 발광 소자는 기판 상에 양극, 1층 이상의 유기물층 및 음극이 순차적으로 적층된 역방향 구조(inverted type)의 유기 발광 소자일 수 있다.In one embodiment of the present specification, the organic light emitting device may be an inverted type organic light emitting device in which an anode, one or more organic material layers, and a cathode are sequentially stacked on a substrate.
예컨대, 본 명세서의 일 실시상태에 따른 유기 발광 소자의 구조가 도 1 내지 3에 예시되어 있다. 상기 도 1 내지 도 3은 유기 발광 소자를 예시한 것이며 이에 한정되는 것은 아니다. For example, the structure of the organic light emitting device according to the exemplary embodiment of the present specification is illustrated in FIGS. 1 to 3. 1 to 3 illustrate an organic light emitting device and are not limited thereto.
도 1에는 기판(101) 위에 양극(102), 발광층(106) 및 음극(110)이 순차적으로 적층된 유기 발광 소자의 구조가 예시되어 있다. 상기 화학식 1로 표시되는 화합물은 발광층에 포함된다. 본 명세서의 일 실시상태에 따르면, 상기 화학식 H로 표시되는 화합물은 발광층에 추가로 포함될 수 있다.In FIG. 1, a structure of an organic light emitting device in which an anode 102, a light emitting layer 106, and a cathode 110 are sequentially stacked on a substrate 101 is illustrated. The compound represented by Chemical Formula 1 is included in the light emitting layer. According to an exemplary embodiment of the present specification, the compound represented by the formula (H) may be further included in the light emitting layer.
도 2에는 기판(101) 위에 양극(102), 정공 주입층(103), 정공 수송층(104), 발광층(106), 음극(110)이 순차적으로 적층된 유기 발광 소자의 구조가 예시되어 있다. 본 명세서의 일 실시상태에 따르면, 상기 화학식 1로 표시되는 화합물은 발광층에 포함된다. 본 명세서의 일 실시상태에 따르면, 상기 화학식 H로 표시되는 화합물은 발광층에 추가로 포함될 수 있다. 또 다른 일 실시상태에 따르면, 상기 화학식 1로 표시되는 화합물은 정공 주입층 또는 정공 수송층에 포함된다.2 illustrates a structure of an organic light emitting device in which an anode 102, a hole injection layer 103, a hole transport layer 104, a light emitting layer 106, and a cathode 110 are sequentially stacked on a substrate 101. According to the exemplary embodiment of the present specification, the compound represented by Chemical Formula 1 is included in the light emitting layer. According to an exemplary embodiment of the present specification, the compound represented by the formula (H) may be further included in the light emitting layer. According to another exemplary embodiment, the compound represented by Chemical Formula 1 is included in a hole injection layer or a hole transport layer.
도 3에는 기판(101) 위에 양극(102), 정공 주입층(103), 정공 수송층(104), 전자 차단층(105), 발광층(106), 정공 차단층(107), 전자 수송층(108), 전자 주입층(109), 음극(110)이 순차적으로 적층된 유기 발광 소자의 구조가 예시되어 있다. 본 명세서의 일 실시상태에 따르면, 상기 화학식 1로 표시되는 화합물은 발광층에 포함된다. 본 명세서의 일 실시상태에 따르면, 상기 화학식 H로 표시되는 화합물은 발광층에 추가로 포함될 수 있다. 또 다른 일 실시상태에 따르면, 상기 화학식 1로 표시되는 화합물은 정공 주입층, 정공 수송층, 전자 차단층, 정공 차단층, 전자 수송층 또는 전자 주입층에 포함된다.3, the anode 102, the hole injection layer 103, the hole transport layer 104, the electron blocking layer 105, the light emitting layer 106, the hole blocking layer 107, the electron transport layer 108 on the substrate 101 , The structure of the organic light emitting device in which the electron injection layer 109 and the cathode 110 are sequentially stacked is illustrated. According to the exemplary embodiment of the present specification, the compound represented by Chemical Formula 1 is included in the light emitting layer. According to an exemplary embodiment of the present specification, the compound represented by the formula (H) may be further included in the light emitting layer. According to another exemplary embodiment, the compound represented by Chemical Formula 1 is included in a hole injection layer, a hole transport layer, an electron blocking layer, a hole blocking layer, an electron transport layer, or an electron injection layer.
본 명세서의 유기 발광 소자는 발광층이 상기 화합물, 즉 상기 화학식 1로 표시되는 화합물 및 상기 화학식 H로 표시되는 화합물을 포함하는 것을 제외하고는 당 기술분야에 알려져 있는 재료와 방법으로 제조될 수 있다. The organic light emitting device of the present specification may be made of materials and methods known in the art, except that the light emitting layer includes the compound, that is, the compound represented by Formula 1 and the compound represented by Formula H.
상기 유기 발광 소자가 복수개의 유기물층을 포함하는 경우, 상기 유기물층은 동일한 물질 또는 다른 물질로 형성될 수 있다. When the organic light emitting device includes a plurality of organic material layers, the organic material layers may be formed of the same material or different materials.
예컨대, 본 명세서의 유기 발광 소자는 기판 상에 제1 전극, 유기물층 및 제2 전극을 순차적으로 적층시킴으로써 제조할 수 있다. 이 때, 스퍼터링법(sputtering)이나 전자빔 증발법(e-beam evaporation)과 같은 PVD(physical Vapor Deposition)방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공 주입층, 정공 수송층, 발광층 및 전자 수송층을 포함하는 유기물층을 형성한 후, 그 위에 음극로 사용할 수 있는 물질을 증착시킴으로써 제조될 수 있다. 이와 같은 방법 외에도, 기판 상에 음극 물질, 유기물층 및 양극 물질을 차례로 증착시켜 유기 발광 소자를 제조할 수 있다. For example, the organic light emitting device of the present specification can be manufactured by sequentially laminating a first electrode, an organic material layer, and a second electrode on a substrate. At this time, a positive electrode is deposited by depositing a metal or conductive metal oxide or an alloy thereof on a substrate using a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation. It can be produced by forming and forming an organic material layer including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer thereon, and then depositing a material that can be used as a cathode thereon. In addition to this method, an organic light emitting device may be manufactured by sequentially depositing a cathode material, an organic material layer, and an anode material on a substrate.
또한, 상기 화학식 1로 표시되는 화합물 또는 상기 화학식 H로 표시되는 화합물은 유기 발광 소자의 제조시 진공 증착법 뿐만 아니라 용액 도포법에 의하여 유기물층으로 형성될 수 있다. 여기서, 용액 도포법이라 함은 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯프린팅, 스크린 프린팅, 스프레이법, 롤 코팅 등을 의미하나, 이에 한정되는 것은 아니다. In addition, the compound represented by the formula (1) or the compound represented by the formula (H) may be formed into an organic material layer by a solution coating method as well as a vacuum deposition method when manufacturing an organic light emitting device. Here, the solution application method means spin coating, dip coating, doctor blading, inkjet printing, screen printing, spraying, roll coating, and the like, but is not limited thereto.
이와 같은 방법 외에도, 기판 상에 음극 물질로부터 유기물층, 양극 물질을 차례로 증착시켜 유기 발광 소자를 만들 수도 있다. 다만, 제조 방법이 이에 한정되는 것은 아니다. In addition to this method, an organic light emitting device may be made by sequentially depositing an organic material layer and a cathode material from a cathode material on a substrate. However, the manufacturing method is not limited thereto.
본 명세서의 일 실시상태에 있어서, 상기 제1 전극은 양극이고, 상기 제2 전극은 음극이다. In one embodiment of the present specification, the first electrode is an anode, and the second electrode is a cathode.
또 하나의 실시상태에 있어서, 상기 제1 전극은 음극이고, 상기 제2 전극은 양극이다. In another exemplary embodiment, the first electrode is a cathode, and the second electrode is an anode.
상기 양극 물질로는 통상 유기물층으로 정공 주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 예를 들어, 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연 산화물, 인듐 산화물, 인듐주석 산화물(ITO), 인듐아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2 : Sb와 같은 금속과 산화물의 조합; 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDOT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자 등이 있으나, 이에 한정되는 것은 아니다. The positive electrode material is usually a material having a large work function to facilitate hole injection into the organic material layer. Metals such as vanadium, chromium, copper, zinc, gold or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO:Al or SnO 2 : combination of metal and oxide such as Sb; Conductive polymers such as poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDOT), polypyrrole, and polyaniline, but are not limited thereto.
상기 음극 물질로는 통상 유기물층으로 전자 주입이 용이하도록 일함수가 작은 물질인 것이 바람직하다. 예를 들어, 마그네슘, 칼슘, 나트륨, 칼륨, 티타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석 및 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이에 한정되는 것은 아니다.The cathode material is preferably a material having a small work function to facilitate electron injection into an organic material layer. Metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin and lead or alloys thereof; A multilayer structure material such as LiF/Al or LiO 2 /Al, and the like, but is not limited thereto.
본 명세서에 따른 유기 발광 소자는 상기 화학식 1로 표시되는 화합물 또는 상기 화학식 H로 표시되는 화합물을 포함하는 발광층 이외의 추가의 발광층을 포함할 수 있다. 추가의 발광층은 호스트 재료 및 도펀트 재료를 포함할 수 있다. 호스트 재료는 축합 방향족환 유도체 또는 헤테로환 함유 화합물 등이 있다. 구체적으로, 축합 방향족환 유도체로는 안트라센 유도체, 피렌 유도체, 나프탈렌 유도체, 펜타센 유도체, 페난트렌 화합물, 플루오란텐 화합물 등이 있고, 헤테로환 함유 화합물로는 디벤조퓨란 유도체, 래더형 퓨란 화합물, 피리미딘 유도체 등이 있으나, 이에 한정되는 것은 아니다. The organic light emitting device according to the present specification may include an additional light emitting layer other than the light emitting layer including the compound represented by Chemical Formula 1 or the compound represented by Chemical Formula H. The additional emissive layer can include a host material and a dopant material. The host material may be a condensed aromatic ring derivative or a heterocyclic compound. Specifically, condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, fluoranthene compounds, etc., and heterocyclic compounds include dibenzofuran derivatives, ladder-type furan compounds, Pyrimidine derivatives, and the like, but are not limited thereto.
상기 도펀트 재료로는 방향족 아민 유도체, 스트릴아민 화합물, 붕소 착체, 플루오란텐 화합물, 금속 착체 등이 있다. 구체적으로, 방향족 아민 유도체로는 치환 또는 비치환된 아릴아민기를 갖는 축합 방향족환 유도체로서, 아릴아민기를 갖는 피렌, 안트라센, 크리센, 페리플란텐 등이 있다. 또한, 스티릴아민 화합물은 치환 또는 비치환된 아릴아민에 적어도 1개의 아릴비닐기가 치환되어 있는 화합물로, 아릴기, 실릴기, 알킬기, 시클로알킬기 및 아릴아민기로 이루어진 군에서 1 또는 2 이상 선택되는 치환기가 치환 또는 비치환된다. 구체적으로 스티릴아민, 스티릴디아민, 스티릴트리아민, 스티릴테트라아민 등이 있으나, 이에 한정되지 않는다. 또한, 금속 착체로는 이리듐 착체, 백금 착체 등이 있으나, 이에 한정되는 것은 아니다. Examples of the dopant material include aromatic amine derivatives, strylamine compounds, boron complexes, fluoranthene compounds, and metal complexes. Specifically, examples of the aromatic amine derivative include condensed aromatic ring derivatives having substituted or unsubstituted arylamine groups, such as pyrene, anthracene, chrysene, and periplanene having an arylamine group. In addition, the styrylamine compound is a compound in which at least one arylvinyl group is substituted with a substituted or unsubstituted arylamine, and one or two or more are selected from the group consisting of aryl groups, silyl groups, alkyl groups, cycloalkyl groups, and arylamine groups. The substituent is substituted or unsubstituted. Specifically, styrylamine, styryldiamine, styryltriamine, styryltetraamine, and the like, but are not limited thereto. In addition, examples of the metal complex include an iridium complex and a platinum complex, but are not limited thereto.
상기 정공 주입층은 전극으로부터 정공을 수취하는 층이다. 정공 주입 물질은 정공을 수송하는 능력을 가져 양극으로부터 정공 수취 효과 및 발광층 또는 발광 재료에 대하여 우수한 정공 주입 효과를 갖는 것이 바람직하다. 또한, 발광층에서 생성된 엑시톤의 전자 주입층 또는 전자 주입 재료에의 이동을 방지할 수 있는 능력이 우수한 물질이 바람직하다. 또한, 박막 형성 능력이 우수한 물질이 바람직하다. 또한, 정공 주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물층의 HOMO 사이인 것이 바람직하다. 정공 주입 물질의 구체적인 예로는, 금속 포피린(porphyrin), 올리고티오펜, 아릴아민 계열의 유기물; 헥사니트릴헥사아자트리페닐렌 계열의 유기물; 퀴나크리돈(quinacridone)계열의 유기물; 페릴렌(perylene) 계열의 유기물; 안트라퀴논, 폴리아닐린과 같은 폴리티오펜 계열의 전도성 고분자 등이 있으나, 이에 한정 되는 것은 아니다. The hole injection layer is a layer that receives holes from the electrode. It is preferable that the hole injection material has the ability to transport holes and thus has a hole receiving effect from the anode and an excellent hole injection effect for the light emitting layer or the light emitting material. In addition, a material having excellent ability to prevent movement of the exciton generated in the light emitting layer to the electron injection layer or the electron injection material is preferable. Also, a material having excellent thin film formation ability is preferred. In addition, it is preferable that the high-occupied molecular orbital (HOMO) of the hole injection material is between the work function of the positive electrode material and the HOMO of the surrounding organic material layer. Specific examples of the hole injection material include metal porphyrins, oligothiophenes, and arylamine-based organic materials; Hexanitrile hexaaza triphenylene series organics; Quinacridone-based organic matter; Perylene-based organic substances; Polythiophene-based conductive polymers such as anthraquinone and polyaniline, but are not limited thereto.
상기 정공 수송층은 정공 주입층으로부터 정공을 수취하여 발광층까지 정공을 수송하는 층이다. 정공 수송 물질로는 양극이나 정공 주입층으로부터 정공을 수취하여 발광층으로 옮겨줄 수 있는 물질로 정공에 대한 이동성이 큰 물질이 바람직하다. 구체적인 예로는, 아릴아민 계열의 유기물, 전도성 고분자, 및 공액 부분과 비공액 부분이 함께 있는 블록 공중합체 등이 있으나, 이에 한정되는 것은 아니다.The hole transport layer is a layer that receives holes from the hole injection layer and transports the holes to the light emitting layer. As the hole transport material, a material capable of receiving holes from the anode or the hole injection layer and transferring them to the light emitting layer is preferably a material having high mobility for holes. Specific examples include, but are not limited to, arylamine-based organic materials, conductive polymers, and block copolymers having a conjugated portion and a non-conjugated portion.
상기 전자 수송층은 전자 주입층으로부터 전자를 수취하여 발광층까지 전자를 수송하는 층이다. 전자 수송 물질로는 음극으로부터 전자를 잘 주입 받아 발광층으로 옮겨줄 수 있는 물질로서, 전자에 대한 이동성이 큰 물질이 바람직하다. 구체적인 예로는, 8-히드록시퀴놀린의 Al착물; Alq3를 포함한 착물; 유기 라디칼 화합물; 히드록시플라본-금속 착물 등이 있으나, 이에 한정되는 것은 아니다. 전자 수송층은 종래기술에 따라 사용된 바와 같이, 임의의 원하는 음극 물질과 함께 사용할 수 있다. 특히, 적절한 음극 물질은 낮은 일함수를 가지며, 알루미늄층 또는 실버층이 뒤따르는 통상적인 물질이다. 구체적으로, 세슘, 바륨, 칼슘, 이테르븀 및 사마륨 등이 있고, 각 경우 알루미늄층 또는 실버층이 뒤따른다.The electron transport layer is a layer that receives electrons from the electron injection layer and transports electrons to the light emitting layer. As the electron transport material, a material capable of receiving electrons well from the cathode and transferring them to the light emitting layer, a material having high mobility for electrons is preferable. Specific examples include the Al complex of 8-hydroxyquinoline; Complexes including Alq 3 ; Organic radical compounds; Hydroxyflavone-metal complexes, and the like, but are not limited thereto. The electron transport layer can be used with any desired negative electrode material, as used according to the prior art. Particularly, a suitable negative electrode material has a low work function and is a conventional material followed by an aluminum layer or a silver layer. Specifically, there are cesium, barium, calcium, ytterbium, and samarium, and in each case, an aluminum layer or a silver layer follows.
상기 전자 주입층은 전극으로부터 전자를 수취하는 층이다. 전자 주입물로는 전자를 수송하는 능력이 우수하고, 제2 전극으로부터의 전자 수취 효과, 발광층 또는 발광 재료에 대하여 우수한 전자주입 효과를 갖는 것이 바람직하다. 또한, 발광층에서 생성된 엑시톤이 정공 주입층으로 이동하는 것을 방지하고, 박막 형성 능력이 우수한 물질이 바람직하다. 구체적으로는, 플루오레논, 안트라퀴노다이메탄, 다이페노퀴논, 티오피란 다이옥사이드, 옥사졸, 옥사다이아졸, 트리아졸, 이미다졸, 페릴렌테트라카복실산, 프레오레닐리덴 메탄, 안트론 등과 그들의 유도체, 금속 착체 화합물 및 함질소 5원환 유도체 등이 있으나, 이에 한정되는 것은 아니다. The electron injection layer is a layer that receives electrons from an electrode. It is preferable that the electron injecting agent has an excellent electron transporting ability and an electron receiving effect from the second electrode, and an excellent electron injection effect for the light emitting layer or the light emitting material. In addition, a material that prevents exciton generated in the light emitting layer from moving to the hole injection layer and has excellent thin film formation ability is preferable. Specifically, fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylenetetracarboxylic acid, preorenylidene methane, anthrone and the like and their derivatives, Metal complex compounds, nitrogen-containing 5-membered ring derivatives, and the like, but are not limited thereto.
상기 금속 착체 화합물로는 8-히드록시퀴놀리나토 리튬, 비스(8-히드록시퀴놀리나토)아연, 비스(8-히드록시퀴놀리나토)구리, 비스(8-히드록시퀴놀리나토)망간, 트리스(8-히드록시퀴놀리나토)알루미늄, 트리스(2-메틸-8-히드록시퀴놀리나토)알루미늄, 트리스(8-히드록시퀴놀리나토)갈륨, 비스(10-히드록시벤조[h]퀴놀리나토)베릴륨, 비스(10-히드록시벤조[h]퀴놀리나토)아연, 비스(2-메틸-8-퀴놀리나토)클로로갈륨, 비스(2-메틸-8-퀴놀리나토)(o-크레졸라토)갈륨, 비스(2-메틸-8-퀴놀리나토)(1-나프톨라토)알루미늄, 비스(2-메틸-8-퀴놀리나토)(2-나프톨라토)갈륨 등이 있으나, 이에 한정되는 것은 아니다.The metal complex compound includes 8-hydroxyquinolinato lithium, bis(8-hydroxyquinolinato) zinc, bis(8-hydroxyquinolinato) copper, and bis(8-hydroxyquinolinato) manganese , Tris(8-hydroxyquinolinato)aluminum, tris(2-methyl-8-hydroxyquinolinato)aluminum, tris(8-hydroxyquinolinato)gallium, bis(10-hydroxybenzo[h ]Quinolinato) beryllium, bis(10-hydroxybenzo[h]quinolinato) zinc, bis(2-methyl-8-quinolinato)chlorogallium, bis(2-methyl-8-quinolinato) (o-cresolato) gallium, bis(2-methyl-8-quinolinato)(1-naphtholato)aluminum, bis(2-methyl-8-quinolinato)(2-naphtolato)gallium, etc. , But is not limited thereto.
상기 전자 차단층은 전자 주입층으로부터 주입된 전자가 발광층을 지나 정공 주입층으로 진입하는 것을 방지하여 소자의 수명과 효율을 향상시킬 수 있는 층이다. 공지된 재료는 제한 없이 사용 가능하며, 발광층과 정공 주입층 사이에, 또는 발광층과 정공 주입 및 정공 수송을 동시에 하는 층 사이에 형성될 수 있다. The electron blocking layer is a layer capable of improving the life and efficiency of the device by preventing electrons injected from the electron injection layer from entering the hole injection layer through the light emitting layer. Known materials can be used without limitation, and can be formed between the light emitting layer and the hole injection layer, or between the light emitting layer and the layer simultaneously performing hole injection and hole transport.
상기 정공 차단층은 정공의 음극으로 도달을 저지하는 층으로, 일반적으로 전자 주입층과 동일한 조건으로 형성될 수 있다. 구체적으로, 옥사디아졸 유도체나 트리아졸 유도체, 페난트롤린 유도체, 알루미늄 착물 (aluminum complex) 등이 있으나, 이에 한정되는 것은 아니다. The hole blocking layer is a layer that blocks reaching the cathode of the hole, and may be generally formed under the same conditions as the electron injection layer. Specifically, there are oxadiazole derivatives, triazole derivatives, phenanthroline derivatives, aluminum complexes, and the like, but are not limited thereto.
본 명세서에 따른 유기 발광 소자는 사용되는 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다.The organic light emitting device according to the present specification may be a front emission type, a back emission type, or a double-sided emission type, depending on the material used.
이하, 본 명세서를 구체적으로 설명하기 위해 실시예 및 비교예 등을 들어 상세하게 설명하기로 한다. 그러나, 본 명세서에 따른 실시예 및 비교예는 여러 가지 다른 형태로 변형될 수 있으며, 본 명세서의 범위가 아래에서 상술하는 실시예 및 비교예에 한정되는 것으로 해석되지 않는다. 본 명세서의 실시예 및 비교예는 당업계에서 평균적인 지식을 가진 자에게 본 명세서를 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, examples and comparative examples will be described in detail to specifically describe the present specification. However, the examples and comparative examples according to the present specification may be modified in various other forms, and the scope of the present specification is not interpreted to be limited to the examples and comparative examples described below. The examples and comparative examples in the present specification are provided to more fully describe the present specification to those skilled in the art.
합성예Synthetic example
합성예 1.Synthesis Example 1.
Figure PCTKR2020000947-appb-I000033
Figure PCTKR2020000947-appb-I000033
시작 물질 S-1(10g), S-2 (20.6g, 1.1당량), Pd(PtBu3)2 (0.31 g, 0.02당량), NaOtBu (8.8g, 3당량) 및 톨루엔 (300ml)이 들어간 플라스크를 110℃에서 가열하고, 16시간 동안 교반하였다. 반응액을 실온까지 냉각시키고, 물 및 톨루엔을 가하여 분액한 후, 용매를 감압하에서 증류 제거하였다. 실리카겔 컬럼 크로마토그래피법 (eluent:toluene/hexane)으로 정제하여 화합물 S-3(9.7g)을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=781에서 피크가 확인되었다.Starting materials S-1 (10 g), S-2 (20.6 g, 1.1 eq), Pd (P t Bu 3 ) 2 (0.31 g, 0.02 eq), NaO t Bu (8.8 g, 3 eq) and toluene (300 ml) The flask containing) was heated at 110° C. and stirred for 16 hours. The reaction solution was cooled to room temperature, water and toluene were added for separation, and the solvent was distilled off under reduced pressure. Purified by silica gel column chromatography (eluent:toluene/hexane) to obtain compound S-3 (9.7 g). As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H] + =781.
여기서, tBu은 tert-부틸기를 의미한다.Here, t Bu means tert-butyl group.
합성예 2.Synthesis Example 2.
Figure PCTKR2020000947-appb-I000034
Figure PCTKR2020000947-appb-I000034
중간체 S-3 (8 g) 및 톨루엔 (70 ml)이 들어간 플라스크에, 질소 분위기 하, 0℃에서 n-부틸리튬펜탄 용액 (8.2ml, 2.5M in hexane, 2당량)을 가하였다. 적하 종료 후, 50℃로 승온하여 2시간 동안 교반하였다. -40℃로 냉각하고 삼브롬화 붕소 (1.5 ml, 1.5당량)를 가하고, 실온으로 승온하며 4시간 동안 교반하였다. 그 후, 다시 0℃까지 냉각하고 Sat.aq.NaHCO3 및 에틸아세테이트를 가하여 분액한 후, 용매를 감압 하에서 증류 제거하였다. 실리카겔 컬럼 크로마토그래피 (전개액: 헥산/톨루엔)로 정제하여, 화합물 A-2 (1.2g)를 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=711에서 피크가 확인되었다.To a flask containing intermediate S-3 (8 g) and toluene (70 ml), a solution of n-butyllithium pentane (8.2 ml, 2.5 M in hexane, 2 equivalents) was added at 0° C. under a nitrogen atmosphere. After completion of dropping, the mixture was heated to 50°C and stirred for 2 hours. After cooling to -40°C, boron tribromide (1.5 ml, 1.5 eq.) was added, the temperature was raised to room temperature and stirred for 4 hours. Thereafter, the mixture was cooled to 0° C. again, and Sat.aq.NaHCO 3 and ethyl acetate were added for separation, and then the solvent was distilled off under reduced pressure. Purification by silica gel column chromatography (developer: hexane/toluene) gave compound A-2 (1.2 g). As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H]+=711.
합성예 3.Synthesis Example 3.
Figure PCTKR2020000947-appb-I000035
Figure PCTKR2020000947-appb-I000035
합성예 1에서 화합물 S-3을 만드는 방법과 동일한 방법으로 S-4(20.6g)을 이용하여 중간체 S-5 11.8 g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=997에서 피크가 확인되었다.In Synthesis Example 1, 11.8 g of Intermediate S-5 was obtained using S-4 (20.6 g) in the same manner as the method for preparing Compound S-3. As a result of the mass spectrum measurement of the obtained solid, a peak was confirmed at [M+H] + =997.
합성예 4.Synthesis Example 4.
Figure PCTKR2020000947-appb-I000036
Figure PCTKR2020000947-appb-I000036
합성예 2에서 화합물 A-2을 만드는 방법과 동일한 방법으로 S-5 (10g)을 이용하여 화합물 A-5 1.2g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=927에서 피크가 확인되었다.In Synthesis Example 2, 1.2 g of Compound A-5 was obtained using S-5 (10 g) in the same manner as the method for preparing Compound A-2. As a result of the mass spectrum measurement of the obtained solid, a peak was confirmed at [M+H] + =927.
합성예 5.Synthesis Example 5.
Figure PCTKR2020000947-appb-I000037
Figure PCTKR2020000947-appb-I000037
합성예 1에서 화합물 S-3을 만드는 방법과 동일한 방법으로 S-6(10g), S-1(22.2g)을 이용하여 중간체 S-7 11.4 g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=757에서 피크가 확인되었다.In Synthesis Example 1, 11.4 g of Intermediate S-7 was obtained by using S-6 (10 g) and S-1 (22.2 g) in the same manner as the method for preparing Compound S-3. As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H] + =757.
합성예 6.Synthesis Example 6.
Figure PCTKR2020000947-appb-I000038
Figure PCTKR2020000947-appb-I000038
중간체 S-7(9.5g), S-8 (3.7g, 1.05당량), Pd(PtBu3)2 (0.13g, 0.02당량), NaOtBu (1.8g, 1.5당량) 및 톨루엔 (40ml)이 들어간 플라스크를 110℃에서 가열하고, 4시간 동안 교반하였다. 반응액을 실온까지 냉각시키고, 물 및 톨루엔을 가하여 분액한 후, 용매를 감압하에서 증류 제거하였다. 재결정(ethyl acetate/hexane)으로 정제하여 화합물 S-9 (10.5g)을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=1001에서 피크가 확인되었다.Intermediate S-7 (9.5 g), S-8 (3.7 g, 1.05 eq), Pd (P t Bu 3 ) 2 (0.13 g, 0.02 eq), NaO t Bu (1.8 g, 1.5 eq) and toluene (40 ml) The flask containing) was heated at 110° C. and stirred for 4 hours. The reaction solution was cooled to room temperature, water and toluene were added for separation, and the solvent was distilled off under reduced pressure. Purification by recrystallization (ethyl acetate/hexane) gave compound S-9 (10.5 g). As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H] + =1001.
합성예 7.Synthesis Example 7.
Figure PCTKR2020000947-appb-I000039
Figure PCTKR2020000947-appb-I000039
합성예 1에서 화합물 S-3을 만드는 방법과 동일한 방법으로 S-6(10g), S-10(25.7g)을 이용하여 중간체 S-11 12.9 g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=853에서 피크가 확인되었다.In Synthesis Example 1, 12.9 g of Intermediate S-11 was obtained using S-6 (10 g) and S-10 (25.7 g) in the same manner as the method for preparing Compound S-3. As a result of the mass spectrum measurement of the obtained solid, a peak was confirmed at [M+H] + =853.
합성예 8.Synthesis Example 8.
Figure PCTKR2020000947-appb-I000040
Figure PCTKR2020000947-appb-I000040
합성예 6에서 화합물 S-9을 만드는 방법과 동일한 방법으로 S-11(11g), S-12(3.3g)을 이용하여 중간체 S-13 10.6g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=1058에서 피크가 확인되었다.In Synthesis Example 6, 10.6 g of Intermediate S-13 was obtained using S-11 (11 g) and S-12 (3.3 g) in the same manner as the method for preparing Compound S-9. As a result of the mass spectrum measurement of the obtained solid, a peak was confirmed at [M+H] + =1058.
합성예 9.Synthesis Example 9.
Figure PCTKR2020000947-appb-I000041
Figure PCTKR2020000947-appb-I000041
중간체 S-9 (9.0 g) 및 톨루엔 (60 ml)이 들어간 플라스크에, 질소 분위기 하, 0℃에서 1.7M의 tert-부틸리튬펜탄 용액 (21.1 ml, 4당량)을 가하였다. 적하 종료 후, 70℃로 승온하여 2시간 동안 교반하였다. -40℃로 냉각하고 삼브롬화 붕소 (1.7 ml, 2당량)를 가하고, 상온으로 승온하며 4시간 동안 교반하였다. 반응 종료되면 sat.aq. Na2S2O3 및 sat.aq. NaHCO3를 가하여 분액한 후, 용매를 감압하에서 증류 제거하였다. 재결정(헥산/톨루엔)로 정제하여, 화합물 A-4 (1.4 g)를 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=975에서 피크가 확인되었다.To a flask containing intermediate S-9 (9.0 g) and toluene (60 ml), a 1.7 M tert-butyllithium pentane solution (21.1 ml, 4 eq.) was added at 0° C. under a nitrogen atmosphere. After completion of dropping, the mixture was heated to 70°C and stirred for 2 hours. After cooling to -40°C, boron tribromide (1.7 ml, 2 eq.) was added, the temperature was raised to room temperature and stirred for 4 hours. Sat.aq. Na 2 S 2 O 3 and sat.aq. After adding NaHCO 3 and separating, the solvent was distilled off under reduced pressure. Purification by recrystallization (hexane/toluene) gave compound A-4 (1.4 g). As a result of the mass spectrum measurement of the obtained solid, a peak was confirmed at [M+H] + =975.
합성예 10.Synthesis Example 10.
Figure PCTKR2020000947-appb-I000042
Figure PCTKR2020000947-appb-I000042
합성예 9에서 화합물 A-4을 만드는 방법과 동일한 방법으로 S-13(9.6g)을 이용하여 화합물 A-6 0.9g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=1032에서 피크가 확인되었다.In Synthesis Example 9, 0.9 g of Compound A-6 was obtained using S-13 (9.6 g) in the same manner as the method of preparing Compound A-4. As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H] + =1032.
합성예 11.Synthesis Example 11.
Figure PCTKR2020000947-appb-I000043
Figure PCTKR2020000947-appb-I000043
합성예 1에서 화합물 S-3을 만드는 방법과 동일한 방법으로 S-2(10g), S-14(20.6g)을 이용하여 중간체 S-15 12.5 g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=933에서 피크가 확인되었다.In Synthesis Example 1, 12.5 g of Intermediate S-15 was obtained using S-2 (10 g) and S-14 (20.6 g) in the same manner as the method for preparing Compound S-3. As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H] + =933.
합성예 2에서 화합물 A-2을 만드는 방법과 동일한 방법으로 S-15 (11g)을 이용하여 화합물 A-3 2.1g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=863에서 피크가 확인되었다.In Synthesis Example 2, 2.1 g of Compound A-3 was obtained using S-15 (11 g) in the same manner as the method for preparing Compound A-2. As a result of the mass spectrum measurement of the obtained solid, a peak was confirmed at [M+H] + =863.
합성예 12.Synthesis Example 12.
Figure PCTKR2020000947-appb-I000044
Figure PCTKR2020000947-appb-I000044
합성예 1에서 화합물 S-3을 만드는 방법과 동일한 방법으로 S-2(15g), S-16(28g)을 이용하여 중간체 S-17 14.2 g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=724에서 피크가 확인되었다.In Synthesis Example 1, 14.2 g of Intermediate S-17 was obtained by using S-2 (15 g) and S-16 (28 g) in the same manner as the method for preparing Compound S-3. As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H] + =724.
합성예 2에서 화합물 A-2을 만드는 방법과 동일한 방법으로 S-17 (13g)을 이용하여 화합물 B-2 1.3g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=654에서 피크가 확인되었다.In Synthesis Example 2, 1.3 g of Compound B-2 was obtained using S-17 (13 g) in the same manner as the method of preparing Compound A-2. As a result of the mass spectrum measurement of the obtained solid, a peak was confirmed at [M+H] + =654.
합성예 13.Synthesis Example 13.
Figure PCTKR2020000947-appb-I000045
Figure PCTKR2020000947-appb-I000045
합성예 1에서 화합물 S-3을 만드는 방법과 동일한 방법으로 S-2(10g), S-18(20.9g)을 이용하여 중간체 S-19 10.6 g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=792에서 피크가 확인되었다.In Synthesis Example 1, 10.6 g of Intermediate S-19 was obtained using S-2 (10 g) and S-18 (20.9 g) in the same manner as the method for preparing Compound S-3. As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H] + =792.
합성예 2에서 화합물 A-2을 만드는 방법과 동일한 방법으로 S-19 (9.6g)을 이용하여 화합물 B-3 1.2g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=722에서 피크가 확인되었다.In Synthesis Example 2, 1.2 g of Compound B-3 was obtained using S-19 (9.6 g) in the same manner as the method of preparing Compound A-2. As a result of the mass spectrum measurement of the obtained solid, a peak was confirmed at [M+H] + =722.
합성예 14.Synthesis Example 14.
Figure PCTKR2020000947-appb-I000046
Figure PCTKR2020000947-appb-I000046
중간체 S-20 (47.1 g, 1.15당량), S-21 (20g), K2CO3 (28.3g, 2.5당량) 및 N,N-dimethylacetamide(DMAC) (400mL)이 들어간 플라스크를 160℃에서 가열하고, 12시간 동안 교반하였다. 상온으로 냉각 후 에틸아세테이트 (400mL)와 물(250mL) 가하여 분액한 후, 유기층을 aq. NaCl로 2차례 씻어주었다. 유기층의 용매를 감압 하에서 증류 제거하고, 실리카겔 컬럼 크로마토그래피 (전개액: 헥산/톨루엔)로 정제하여, 중간체 S-22 (33.8g)를 얻었다.The flask containing intermediate S-20 (47.1 g, 1.15 eq), S-21 (20 g), K 2 CO 3 (28.3 g, 2.5 eq) and N,N-dimethylacetamide (DMAC) (400 mL) was heated at 160°C And stirred for 12 hours. After cooling to room temperature, ethyl acetate (400 mL) and water (250 mL) were added for separation, and then the organic layer was aq. It was washed twice with NaCl. The solvent of the organic layer was distilled off under reduced pressure, and purified by silica gel column chromatography (developer: hexane/toluene) to obtain intermediate S-22 (33.8 g).
중간체 S-22(32g), Pd(PtBu3)2 (0.68g, 0.03당량), NaOtBu (8.5g, 2당량) 및 톨루엔 (450ml)이 들어간 플라스크를 110℃에서 가열하고, 12시간 동안 교반하였다. 반응액을 실온까지 냉각시키고, 물 및 톨루엔을 가하여 분액한 후, 용매를 감압하에서 증류 제거하였다. 재결정(ethyl acetate/hexane/acetonitrile) 으로 정제하여 화합물 S-23 (18.2g)을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=642에서 피크가 확인되었다.The flask containing intermediate S-22 (32 g), Pd (P t Bu 3 ) 2 (0.68 g, 0.03 equiv), NaO t Bu (8.5 g, 2 equiv) and toluene (450 ml) was heated at 110° C., 12 Stir for hours. The reaction solution was cooled to room temperature, water and toluene were added for separation, and the solvent was distilled off under reduced pressure. Purification by recrystallization (ethyl acetate/hexane/acetonitrile) gave compound S-23 (18.2 g). As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H] + =642.
합성예 15.Synthesis Example 15.
Figure PCTKR2020000947-appb-I000047
Figure PCTKR2020000947-appb-I000047
질소 분위기하에서 화합물 S-23(8g), S-24 (2.1g, 1.3당량) 탄산 칼륨(potassium carbonate) (62.2g, 1.5당량), 디옥산 45 mL 및 물 15 mL를 넣은 후 Pd(PtBu3)2 (0.1g, 0.0015당량), 을 첨가한 후, 120 ℃에서 가열하고 6시간 동안 교반하였다. 반응 종료 후 반응액을 실온까지 냉각시키고, 물과 에틸 아세테이트를 가하여 분액한 후 MgSO4(anhydrous) 처리하여 여과하였다. 여과한 용액을 감압하에서 증류제거하고 재결정(ethylacetate/hexane)으로 정제하여 중간체 S-25 7.2 g을 수득하였다. 얻어진 고체의 질량스펙트럼 측정결과 [M+H+]=689에서 피크가 확인되었다.Under nitrogen atmosphere, add compound S-23 (8g), S-24 (2.1g, 1.3 eq) potassium carbonate (62.2g, 1.5 eq), dioxane 45mL and water 15mL Pd(P t Bu 3 ) 2 (0.1 g, 0.0015 eq), was added, heated at 120° C. and stirred for 6 hours. After the reaction was completed, the reaction solution was cooled to room temperature, separated by adding water and ethyl acetate, and filtered through MgSO 4 (anhydrous) treatment. The filtered solution was distilled off under reduced pressure and purified by recrystallization (ethylacetate/hexane) to obtain 7.2 g of intermediate S-25. As a result of mass spectrum measurement of the obtained solid, a peak was confirmed at [M+H+] = 689.
합성예 16.Synthesis Example 16.
Figure PCTKR2020000947-appb-I000048
Figure PCTKR2020000947-appb-I000048
합성예 9에서 화합물 A-4을 만드는 방법과 동일한 방법으로 S-25(6.5g)을 이용하여 화합물 C-1 1.1g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=663에서 피크가 확인되었다.In Synthesis Example 9, 1.1 g of Compound C-1 was obtained using S-25 (6.5 g) in the same manner as in Compound A-4. As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H] + = 663.
합성예 17.Synthesis Example 17.
Figure PCTKR2020000947-appb-I000049
Figure PCTKR2020000947-appb-I000049
합성예 15에서 화합물 S-25을 만드는 방법과 동일한 방법으로 S-26(2.9g)을 이용하여 화합물 S-27 8.1g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=740에서 피크가 확인되었다.In Synthesis Example 15, 8.1 g of Compound S-27 was obtained using S-26 (2.9 g) in the same manner as the method of preparing Compound S-25. As a result of the mass spectrum measurement of the obtained solid, a peak was confirmed at [M+H] + =740.
합성예 9에서 화합물 A-4을 만드는 방법과 동일한 방법으로 S-27(7.5g)을 이용하여 화합물 C-2 1.0g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=714에서 피크가 확인되었다.In Synthesis Example 9, Compound C-2 (1.0 g) was obtained using S-27 (7.5 g) in the same manner as in Compound A-4. As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H] + =714.
합성예 18.Synthesis Example 18.
Figure PCTKR2020000947-appb-I000050
Figure PCTKR2020000947-appb-I000050
합성예 14에서 화합물 S-23을 만드는 방법과 동일한 방법으로 S-21(15g), S-28 (45g)을 이용하여 화합물 S-29 29g을 얻었고, 얻어진 S-29을 이용하여 S-30 17.9g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=778에서 피크가 확인되었다.In Synthesis Example 14, 29 g of Compound S-29 was obtained using S-21 (15 g), and S-28 (45 g) in the same manner as in Compound S-23, and S-30 17.9 using S-29 obtained. g was obtained. As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H] + =778.
합성예 19.Synthesis Example 19.
Figure PCTKR2020000947-appb-I000051
Figure PCTKR2020000947-appb-I000051
합성예 15에서 화합물 S-25을 만드는 방법과 동일한 방법으로 S-30(8.5g), S-31(2.2g)을 이용하여 화합물 S-32 7.8g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=856에서 피크가 확인되었다.In Synthesis Example 15, 7.8 g of Compound S-32 was obtained using S-30 (8.5 g) and S-31 (2.2 g) in the same manner as the method for preparing Compound S-25. As a result of the mass spectrum measurement of the obtained solid, a peak was confirmed at [M+H] + =856.
합성예 9에서 화합물 A-4을 만드는 방법과 동일한 방법으로 S-32(7g)을 이용하여 화합물 D-1 0.9g을 얻었다. 얻어진 고체의 질량스펙트럼 측정결과, [M+H]+=830에서 피크가 확인되었다.In Synthesis Example 9, 0.9 g of Compound D-1 was obtained using S-32 (7 g) in the same manner as in Compound A-4. As a result of measuring the mass spectrum of the obtained solid, a peak was confirmed at [M+H] + =830.
실험예 1.Experimental Example 1.
Figure PCTKR2020000947-appb-I000052
Figure PCTKR2020000947-appb-I000052
상기 화합물을 TD-DFT(B3LYP) method/6-31G* basis 방법을 이용하여 분자의 absorption상태에서의 HOMO. LUMO 및 singlet(S1)의 에너지 준위와 singlet의 oscillator strength(복사 전이 확률, f)를 계산하였다. 계산결과는 하기 표 1와 같다. 하기 표 1에 있어서, C, Y, Z의 치환기는 본 발명의 화학식 1에 대응되는 치환기이다. C는 화학식 1의 A1 고리 및 A2 고리 사이에 위치한 브릿지 알킬의 탄소 자리에 대응되는 치환기이다.HOMO in the absorption state of the molecule using the TD-DFT (B3LYP) method/6-31G* basis method. The energy levels of LUMO and singlet (S 1 ) and the oscillator strength of singlet (radiation transition probability, f) were calculated. The calculation results are shown in Table 1 below. In Table 1, the substituents of C, Y, and Z are substituents corresponding to Formula 1 of the present invention. C is a substituent corresponding to the carbon site of the bridge alkyl located between the A1 ring and the A2 ring of Formula 1.
비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 비교예 4Comparative Example 4
화합물 X-1Compound X-1 화합물 X-2Compound X-2 화합물 X-3Compound X-3 화합물 X-4Compound X-4
치환기Substituent Y, Z=NPhY, Z=NPh
C=NPhC=NPh C=OC=O C=SC=S C=H,HC=H,H
HOMO (eV)HOMO (eV) 4.714.71 4.914.91 4.894.89 4.744.74
LUMO (eV)LUMO (eV) 0.560.56 0.820.82 0.990.99 1.071.07
S1 (eV)S 1 (eV) 3.57 3.57 3.52 3.52 3.32 3.32 3.14 3.14
ff 0.114 0.114 0.156 0.156 0.14 0.14 0.205 0.205
실시예 1Example 1 실시예 2Example 2 비교예 5Comparative Example 5 비교예 6Comparative Example 6
화합물 A-1Compound A-1 화합물 B-1Compound B-1 화합물 X-5Compound X-5 화합물 X-6Compound X-6
치환기Substituent Y, Z=NPhY, Z=NPh C,Y,Z=OC,Y,Z=O C,Y,Z=C(CH3)2 C,Y,Z=C(CH 3 ) 2
C=C(Ph)2 C=C(Ph) 2 C=C(Ph)(CH3)C=C(Ph)(CH 3 )
HOMO (eV)HOMO (eV) 4.784.78 4.744.74 5.885.88 6.206.20
LUMO (eV)LUMO (eV) 1.081.08 0.970.97 1.411.41 1.561.56
S1 (eV)S 1 (eV) 3.16 3.16 3.24 3.24 3.903.90 4.03 4.03
ff 0.174 0.174 0.191 0.191 0.070.07 0.071 0.071
화합물의 발광파장은 흡수파장에서 Stokes shift만큼 이동한 값이며 흡수파장으로 발광파장의 정도를 예상할 수 있다.The emission wavelength of the compound is a value shifted by the Stokes shift from the absorption wavelength, and the degree of the emission wavelength can be predicted as the absorption wavelength.
복사 전이 확률(f)은 형광 양자 효율을 나타내는 척도로써, 하기 식으로 계산된다. 복사 전이 확률(f) 값이 클수록 발광효율은 크다.The radiative transition probability (f) is a measure of fluorescence quantum efficiency and is calculated by the following equation. The greater the value of the radiation transition probability (f), the greater the luminous efficiency.
Figure PCTKR2020000947-appb-I000053
Figure PCTKR2020000947-appb-I000053
비교예 1 내지 4 결과를 보면, 비교예 4와 같이 상기 화학식 1의 브릿지 알킬을 포함하지 않는 경우(C가 H, H일 때) singlet(S1)의 에너지 값이 3.14 eV 이다. 비교예 1 내지 3과 같이 C가 각각 NPh, O, S로 대체되면 S1 에너지 값이 매우 커지게 되고 f값 또한 0.15 이하로 작아지는 것을 알 수 있다. S1 에너지 값이 크다는 것은 최대 발광 파장이 단파장이 된다는 것을 의미하며 f값이 작은 것은 발광효율이 줄어든다는 것이다. Looking at the results of Comparative Examples 1 to 4, as in Comparative Example 4, when the bridge alkyl of Formula 1 is not included (when C is H and H), the energy value of singlet(S 1 ) is 3.14 eV. As in Comparative Examples 1 to 3, when C is replaced with NPh, O, and S, respectively, it can be seen that the S 1 energy value becomes very large and the f value also decreases to 0.15 or less. A large S 1 energy value means that the maximum emission wavelength is a short wavelength, and a smaller f value means that the luminous efficiency is reduced.
또한 비교예 5 내지 6에서도 C, Y, Z가 모두 탄소이거나 산소일 때, S1 에너지 값이 매우 커지게 되고 f값 또한 매우 작아지는 것을 알 수 있다. 반면 본 발명 화학식 1로 표시되는 화합물 A-1, B-1(C의 브릿지 알킬을 포함)는 화합물 X-4(브릿지 알킬을 포함하지 않음)와 유사한 S1 에너지 값과 f값을 가지는 것을 확인 할 수 있다. 후술하는 소자예를 참고하면, 본 발명의 화학식 1로 표시되는 화합물(C의 브릿지 알킬을 포함)은 브릿지 알킬을 포함하지 않는 화합물 X-8 보다 장수명의 효과를 가질 수 있다.Also, in Comparative Examples 5 to 6, when C, Y, and Z are all carbon or oxygen, it can be seen that the S 1 energy value becomes very large and the f value also becomes very small. On the other hand, it is confirmed that compounds A-1 and B-1 represented by Chemical Formula 1 of the present invention have S 1 energy values and f values similar to those of Compound X-4 (which does not include bridged alkyl). can do. Referring to the device example to be described later, the compound represented by Formula 1 of the present invention (including the bridge alkyl of C) may have a longer life effect than the compound X-8 that does not contain the bridge alkyl.
화합물 X-1,5,6의 최대 발광 파장을 보면 매우 단파장이며, 청색 유기 발광 소자에 적용하기에는 적절하지 않아 낮은 효율이 예상된다.Looking at the maximum emission wavelength of the compounds X-1,5,6, it is very short wavelength, and is not suitable for application to a blue organic light emitting device, so low efficiency is expected.
화합물compound X-1X-1 X-4X-4 X-5X-5 X-6X-6
치환기Substituent Y, Z=NPhY, Z=NPh C,Y,Z=OC,Y,Z=O C,Y,Z=C(CH3)2 C,Y,Z=C(CH 3 ) 2
C=NPhC=NPh C=H,HC=H,H
PL-max(nm)PL-max(nm) 403a(0.02mM, DCM)403 a (0.02mM, DCM) 462 b(0.02mM, DCM)462 b (0.02mM, DCM) 386 c(0.01mM, THF)386 c (0.01 mM, THF) 407 d(0.01mM, THF)407 d (0.01 mM, THF)
실험예 2. 소자예Experimental Example 2. Device Example
실시예 3.Example 3.
ITO(indium tin oxide)가 1300Å의 두께로 박막 코팅된 유리 기판을 세제를 녹인 증류수에 넣고 초음파로 세척하였다. 이 때, 세제로는 피셔사(Fischer Co.) 제품을 사용하였으며, 증류수로는 밀리포어사(Millipore Co.) 제품의 필터(Filter)로 2차로 걸러진 증류수를 사용하였다. ITO를 30분간 세척한 후 증류수로 2회 반복하여 초음파 세척을 10분간 진행하였다. 증류수 세척이 끝난 후, 이소프로필알콜, 아세톤, 및 메탄올의 용제로 초음파 세척을 하고 건조시킨 후 플라즈마 세정기로 수송시켰다. 또한, 산소 플라즈마를 이용하여 상기 기판을 5분간 세정한 후 진공 증착기로 기판을 수송시켰다.A glass substrate coated with a thin film of indium tin oxide (ITO) at a thickness of 1300 에 was placed in distilled water in which detergent was dissolved and washed with ultrasonic waves. At this time, Fischer (Fischer Co.) was used as a detergent, and distilled water filtered secondarily by a filter of Millipore Co. was used as distilled water. After washing the ITO for 30 minutes, ultrasonic washing was repeated for 10 minutes by repeating it twice with distilled water. After washing with distilled water, ultrasonic cleaning was performed with a solvent of isopropyl alcohol, acetone, and methanol, dried, and then transported to a plasma cleaner. In addition, the substrate was washed for 5 minutes using oxygen plasma, and then transferred to a vacuum evaporator.
이렇게 준비된 ITO 투명 전극 위에 하기 화합물 HAT를 50Å의 두께로 열 진공 증착하여 정공주입층을 형성하였다. 그 위에 제1 정공수송층으로 하기 화합물 HT-A 1000Å을 진공 증착하고, 연이어 제2 정공수송층으로 하기 화합물 HT-B 100Å을 증착하였다. 호스트인 BH-A와 도펀트인 화합물 A-2를 97 : 3의 중량비로 진공 증착하여 200Å두께의 발광층을 형성하였다. On the prepared ITO transparent electrode, the following compound HAT was thermally vacuum-deposited to a thickness of 50 Pa to form a hole injection layer. Then, the following compound HT-A 1000Å was vacuum-deposited as a first hole transport layer, and subsequently the following compound HT-B 100Å was deposited as a second hole transport layer. The host BH-A and the dopant Compound A-2 were vacuum-deposited at a weight ratio of 97: 3 to form a 200-mm thick light emitting layer.
그 다음에 제1 전자수송층으로 하기 화합물 ET-A 50Å을 진공 증착하고, 연이어 전자 주입 및 전자 수송을 동시에 하는 제 2 전자 수송층으로 하기 화합물 ET-B와 하기 화합물 Liq를 1:1 비율로 300Å을 증착하였고, 이 위에 순차적으로 500Å 두께로 마그네슘과 은(질량비 10:1)을 동시에 증착하여 음극을 형성하여, 유기 발광 소자를 제조하였다.Subsequently, 50 µm of the following compound ET-A was vacuum-deposited as the first electron transport layer, and 300 µm of the following compound ET-B and the following compound Liq in a 1:1 ratio as a second electron transport layer simultaneously performing electron injection and electron transport. Deposition was performed, and magnesium and silver (mass ratio 10:1) were sequentially deposited on the same surface at a thickness of 500 Pa to form a cathode, thereby manufacturing an organic light emitting device.
상기의 과정에서 유기물의 증착속도는 0.4 ~ 1.0 Å/sec를 유지하였고, 은과 마그네슘은 2 Å/sec의 증착 속도를 유지하였으며, 증착시 진공도는 5 × 10-8 내지 1 × 10-7 torr를 유지하여, 유기 발광 소자를 제작하였다.In the above process, the deposition rate of the organic matter was maintained at 0.4 to 1.0 Å/sec, and the deposition rate of silver and magnesium was maintained at 2 Å/sec. The vacuum degree during deposition was 5 × 10 -8 to 1 × 10 -7 torr. By maintaining the, an organic light emitting device was produced.
Figure PCTKR2020000947-appb-I000054
Figure PCTKR2020000947-appb-I000054
실시예 4 내지 13Examples 4 to 13
상기 실시예 3에서 발광층 물질로 하기 표 3에 기재된 호스트 및 도펀트 화합물을 사용한 것을 제외하고는 실시예 3과 동일한 방법으로 유기 발광 소자를 제조했다.An organic light-emitting device was manufactured in the same manner as in Example 3, except that the host and dopant compounds shown in Table 3 below were used as the light-emitting layer material in Example 3.
Figure PCTKR2020000947-appb-I000055
Figure PCTKR2020000947-appb-I000055
비교예 7 내지 9Comparative Examples 7 to 9
상기 실시예 3에서 발광층 물질로 하기 표 3에 기재된 호스트 및 도펀트 화합물을 사용한 것을 제외하고는 실시예 3과 동일한 방법으로 유기 발광 소자를 제조했다. An organic light-emitting device was manufactured in the same manner as in Example 3, except that the host and dopant compounds shown in Table 3 below were used as the light-emitting layer material in Example 3.
Figure PCTKR2020000947-appb-I000056
Figure PCTKR2020000947-appb-I000056
상기 실시예 3 내지 13 및 비교예 7 내지 9에 의해 제작된 유기 발광 소자를 10 mA/cm2의 전류밀도에서 발광 효율(cd/A)을 측정하였고, 그 결과를 하기 표 2에 나타내었다. 수명은 20 mA/cm2 에서 초기 휘도 대비 97%가 되는 시간(T97)을 측정하였다The organic light emitting devices manufactured by Examples 3 to 13 and Comparative Examples 7 to 9 were measured for luminous efficiency (cd/A) at a current density of 10 mA/cm 2 , and the results are shown in Table 2 below. The lifetime was measured at 20 mA/cm 2 , which is 97% of the initial luminance (T97).
  호스트(발광층)Host (light emitting layer) 도펀트(발광층)Dopant (light emitting layer) 10mA/cm2 10mA/cm 2 20mA/cm2 20mA/cm 2
발광효율(Cd/A)Luminous efficiency (Cd/A) 수명, T97(시간)Lifetime, T97 (hours)
실시예 3Example 3 BH-ABH-A A-2A-2 5.6 5.6 94 94
실시예 4Example 4 BH-ABH-A A-4A-4 5.9 5.9 95 95
실시예 5Example 5 BH-ABH-A A-5A-5 5.4 5.4 84 84
실시예 6Example 6 BH-ABH-A A-6A-6 6.2 6.2 91 91
실시예 7Example 7 BH-ABH-A B-2B-2 5.3 5.3 90 90
실시예 8Example 8 BH-ABH-A C-1C-1 5.4 5.4 86 86
실시예 9Example 9 BH-BBH-B A-2A-2 5.5 5.5 91 91
실시예 10Example 10 BH-BBH-B A-4A-4 5.7 5.7 93 93
실시예 11Example 11 BH-BBH-B A-6A-6 6.0 6.0 89 89
실시예 12Example 12 BH-BBH-B B-3B-3 5.4 5.4 87 87
실시예 13Example 13 BH-BBH-B D-1D-1 5.3 5.3 85 85
비교예 7Comparative Example 7 BH-ABH-A X-7X-7 5.0 5.0 82 82
비교예 8Comparative Example 8 BH-BBH-B X-7X-7 4.8 4.8 73 73
비교예 9Comparative Example 9 BH-BBH-B X-8X-8 5.2 5.2 58 58
상기 표 3을 보면, 본 발명의 화학식 1로 표시되는 화합물을 포함한 소자는 발광 효율이 우수하고, 장수명의 특성을 가지는 것을 알 수 있다. 특히, 상기 화학식 1으로 표시되는 화합물은 본 발명의 화학식 1의 R1 및 R2가 모두 알킬기인 화합물 X-7보다 효율이 높으며, 브릿지 알킬을 포함하지 않는 화합물 X-8보다 장수명 특성을 가지는 화합물이다.Looking at Table 3, it can be seen that the device including the compound represented by Chemical Formula 1 of the present invention has excellent luminous efficiency and long life. In particular, the compound represented by the formula (1) is a compound having a longer life property than the compound X-8, which is higher in efficiency than the compound X-7 in which R1 and R2 in the formula 1 of the present invention are both alkyl groups.
실험예 3: 도펀트 도핑 농도에 따른 발광 효율 변화 Experimental Example 3: Emission efficiency change according to dopant doping concentration
실시예 14, 비교예 10Example 14, Comparative Example 10
상기 실시예 3에서 발광층 물질로 하기 표 4에 기재된 도펀트 화합물을 사용하였고, 호스트와 도펀트를 99 : 1 내지 95 : 5의 중량비로 진공 증착한 것을 제외하고는 실시예 3과 동일한 방법으로 유기 발광 소자를 제조했다.In Example 3, a dopant compound shown in Table 4 was used as a light emitting layer material, and the organic light emitting device was manufactured in the same manner as in Example 3, except that the host and the dopant were vacuum deposited in a weight ratio of 99:1 to 95:5. Was prepared.
상기 실시예 14 및 비교예 10에 의해 제작된 유기 발광 소자를 10 mA/cm2의 전류밀도에서 발광 효율(EQE)을 측정하였다. 화합물 A-2의 도핑 농도에 따른 발광 효율(실시예 14)은 도 4에 도시하였으며, 화합물 X-7의 도핑 농도에 따른 발광 효율(비교예 10)은 도 5에 도시하였다.The organic light-emitting device manufactured by Example 14 and Comparative Example 10 was measured for the light emission efficiency (EQE) at a current density of 10 mA/cm 2 . The luminous efficiency according to the doping concentration of Compound A-2 (Example 14) is illustrated in FIG. 4, and the luminous efficiency according to the doping concentration of Compound X-7 (Comparative Example 10) is illustrated in FIG. 5.
도펀트(발광층)Dopant (light emitting layer) EQE, 10mA/cm2 EQE, 10mA/cm 2
도핑농도Doping concentration
1%One% 2%2% 3%3% 4%4% 5%5%
실시예 14Example 14 화합물 A-2Compound A-2 5.035.03 5.615.61 5.765.76 5.795.79 5.815.81
비교예 10Comparative Example 10 화합물 X-7Compound X-7 5.145.14 5.275.27 5.215.21 5.165.16 5.105.10
상기 화학식 1을 만족하는 화합물 A-2는 화합물 X-7 보다 분자의 부피가 큰 효과로 인해, 도핑농도가 증가 함에 따른 농도 소광 효과가 줄어드는 것을 확인 할 수 있다.Compound A-2 satisfying Chemical Formula 1 can be confirmed that the concentration quenching effect decreases as the doping concentration increases due to the effect of the bulkiness of the molecule than that of Compound X-7.

Claims (12)

  1. 하기 화학식 1로 표시되는 화합물:Compound represented by the formula (1):
    [화학식 1][Formula 1]
    Figure PCTKR2020000947-appb-I000057
    Figure PCTKR2020000947-appb-I000057
    상기 화학식 1에 있어서,In Chemical Formula 1,
    A1 내지 A3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 방향족 탄화수소고리; 또는 치환 또는 비치환된 방향족 헤테로고리이며,A1 to A3 are the same as or different from each other, and each independently an substituted or unsubstituted aromatic hydrocarbon ring; Or a substituted or unsubstituted aromatic heterocycle,
    X는 B 또는 N이고,X is B or N,
    Y는 N(R11)이면서, Z는 O; S; 또는 N(R12)이거나,Y is N(R11), Z is O; S; Or N(R12),
    Y는 O; S; 또는 N(R11)이면서, Z는 N(R12)이고,Y is O; S; Or N(R11), Z is N(R12),
    R1은 치환 또는 비치환된 아릴기이고,R1 is a substituted or unsubstituted aryl group,
    R2는 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이며,R2 is a substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group,
    R11은 -(L11)n11-Ar1이고,R11 is -(L11)n11-Ar1,
    R12은 -(L12)n12-Ar2이고,R12 is -(L12)n12-Ar2,
    L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 치환 또는 비치환된 아릴렌기; 또는 치환 또는 비치환된 2가의 헤테로고리기이고,L11 and L12 are the same as or different from each other, and each independently a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted divalent heterocyclic group,
    Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소; 할로겐기; 니트릴기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 할로알킬기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이고,Ar1 and Ar2 are the same as or different from each other, and each independently deuterium; Halogen group; Nitrile group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted haloalkyl group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
    n11 및 n12는 서로 동일하거나 상이하고, 각각 독립적으로 1 또는 2이고, n11 and n12 are the same as or different from each other, and each independently 1 or 2,
    n11이 2인 경우 L11은 서로 동일하거나 상이하고,When n11 is 2, L11 is the same as or different from each other,
    n12가 2인 경우 L12는 서로 동일하거나 상이하다.When n12 is 2, L12 is the same as or different from each other.
  2. 청구항 1에 있어서, 상기 화학식 1은 하기 화학식 2로 표시되는 화합물:The method according to claim 1, wherein Formula 1 is a compound represented by Formula 2:
    [화학식 2][Formula 2]
    Figure PCTKR2020000947-appb-I000058
    Figure PCTKR2020000947-appb-I000058
    상기 화학식 2에 있어서,In Chemical Formula 2,
    R1, R2 및 X 내지 Z의 정의는 화학식 1에서 정의한 바와 같고,R1, R2 and X to Z are the same as defined in Formula 1,
    Q1 내지 Q3는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 아민기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이고,Q1 to Q3 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted amine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
    q1 내지 q3는 각각 0 내지 3의 정수이고, q1 내지 q3가 각각 2 이상인 경우, 괄호 내의 치환기는 서로 동일하거나 상이하다.q1 to q3 are each an integer of 0 to 3, and when q1 to q3 are each 2 or more, the substituents in parentheses are the same or different from each other.
  3. 청구항 1에 있어서, 상기 화학식 1은 하기 화학식 301 내지 303 중 어느 하나로 표시되는 것인 화합물:The method according to claim 1, wherein Formula 1 is a compound represented by any one of the following formulas 301 to 303:
    [화학식 301][Chemical Formula 301]
    Figure PCTKR2020000947-appb-I000059
    Figure PCTKR2020000947-appb-I000059
    [화학식 302][Chemical Formula 302]
    Figure PCTKR2020000947-appb-I000060
    Figure PCTKR2020000947-appb-I000060
    [화학식 303][Formula 303]
    Figure PCTKR2020000947-appb-I000061
    Figure PCTKR2020000947-appb-I000061
    상기 화학식 301 내지 303에 있어서,In the above formulas 301 to 303,
    R1, R2, L11, L12, Ar1, Ar2, n11 및 n12의 정의는 화학식 1에서 정의한 바와 같고,The definitions of R1, R2, L11, L12, Ar1, Ar2, n11 and n12 are as defined in Formula 1,
    Y1은 O; 또는 S이고,Y1 is O; Or S,
    Z1은 O; 또는 S이고,Z1 is O; Or S,
    Q1 내지 Q3은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 아민기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이고.Q1 to Q3 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted amine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
    q1 내지 q3는 각각 0 내지 3의 정수이고, q1 내지 q3가 각각 2 이상인 경우, 괄호 내의 치환기는 서로 동일하거나 상이하다.q1 to q3 are each an integer of 0 to 3, and when q1 to q3 are each 2 or more, the substituents in parentheses are the same or different from each other.
  4. 청구항 1에 있어서, The method according to claim 1,
    R1 및 R2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소 또는 C1-C5의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 C6-C20의 아릴기인 것인 화합물.R1 and R2 are the same as or different from each other, and each independently is a C6-C20 aryl group substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium or C1-C5 alkyl groups or two or more groups selected from the group. Compound.
  5. 청구항 1에 있어서, The method according to claim 1,
    A1 내지 A3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 벤젠고리이고,A1 to A3 are the same as or different from each other, and each independently a substituted or unsubstituted benzene ring,
    X는 B이고,X is B,
    L11 및 L12는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 또는 C1-C5의 알킬기로 치환 또는 비치환된 C6-C20의 아릴렌기이고,L11 and L12 are the same as or different from each other, and each independently a direct bond; Or a C6-C20 arylene group unsubstituted or substituted with a C1-C5 alkyl group,
    Ar1 및 Ar2는 서로 동일하거나 상이하고, 각각 독립적으로 중수소 및 C1-C5의 알킬기 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 C6-C20의 아릴기; 또는 C2-C20의 헤테로고리기인 것인 화합물.Ar1 and Ar2 are the same or different from each other, and each independently a deuterium and a C1-C5 aryl group which is unsubstituted or substituted with one or more substituents selected from the group consisting of alkyl groups of C1-C5 or two or more groups selected from the group; Or a compound that is a heterocyclic group of C2-C20.
  6. 청구항 1에 있어서, 상기 화학식 1로 표시되는 화합물은 하기 화합물 중에서 선택되는 어느 하나인 것인 화합물:The compound according to claim 1, wherein the compound represented by Formula 1 is any one selected from the following compounds:
    Figure PCTKR2020000947-appb-I000062
    Figure PCTKR2020000947-appb-I000062
    Figure PCTKR2020000947-appb-I000063
    Figure PCTKR2020000947-appb-I000063
    Figure PCTKR2020000947-appb-I000064
    Figure PCTKR2020000947-appb-I000064
    Figure PCTKR2020000947-appb-I000065
    Figure PCTKR2020000947-appb-I000065
    Figure PCTKR2020000947-appb-I000066
    Figure PCTKR2020000947-appb-I000066
    Figure PCTKR2020000947-appb-I000067
    Figure PCTKR2020000947-appb-I000067
    Figure PCTKR2020000947-appb-I000068
    Figure PCTKR2020000947-appb-I000068
    Figure PCTKR2020000947-appb-I000069
    Figure PCTKR2020000947-appb-I000069
    Figure PCTKR2020000947-appb-I000070
    Figure PCTKR2020000947-appb-I000070
    Figure PCTKR2020000947-appb-I000071
    Figure PCTKR2020000947-appb-I000071
    Figure PCTKR2020000947-appb-I000072
    Figure PCTKR2020000947-appb-I000072
    Figure PCTKR2020000947-appb-I000073
    Figure PCTKR2020000947-appb-I000073
    Figure PCTKR2020000947-appb-I000074
    Figure PCTKR2020000947-appb-I000074
    Figure PCTKR2020000947-appb-I000075
    Figure PCTKR2020000947-appb-I000075
    Figure PCTKR2020000947-appb-I000076
    Figure PCTKR2020000947-appb-I000076
    Figure PCTKR2020000947-appb-I000077
    Figure PCTKR2020000947-appb-I000077
    Figure PCTKR2020000947-appb-I000078
    .
    Figure PCTKR2020000947-appb-I000078
    .
  7. 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1 층 이상은 청구항 1 내지 6 중 어느 한 항에 따른 화합물을 포함하는 것인 유기 발광 소자.A first electrode; A second electrode provided to face the first electrode; And one or more organic material layers provided between the first electrode and the second electrode, wherein one or more of the organic material layers comprises the compound according to any one of claims 1 to 6 Light emitting element.
  8. 청구항 7에 있어서, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 상기 화합물을 포함하는 것인 유기 발광 소자. The organic light emitting device of claim 7, wherein the organic material layer includes a light emitting layer, and the light emitting layer includes the compound.
  9. 청구항 7에 있어서, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 도펀트 물질을 포함하며, 상기 도펀트 물질은 상기 화합물을 포함하는 것인 유기 발광 소자. The organic light emitting device of claim 7, wherein the organic material layer includes a light emitting layer, the light emitting layer includes a dopant material, and the dopant material includes the compound.
  10. 청구항 7에 있어서, 상기 유기물층은 정공 주입층 또는 정공 수송층을 포함하고, 상기 정공 주입층 또는 정공 수송층은 상기 화합물을 포함하는 것인 유기 발광 소자. The organic light emitting device of claim 7, wherein the organic material layer includes a hole injection layer or a hole transport layer, and the hole injection layer or the hole transport layer contains the compound.
  11. 청구항 7에 있어서, 상기 유기물층은 전자 주입층 또는 전자 수송층을 포함하고, 상기 전자 주입층 또는 전자 수송층은 상기 화합물을 포함하는 것인 유기 발광 소자. The organic light emitting device of claim 7, wherein the organic material layer includes an electron injection layer or an electron transport layer, and the electron injection layer or electron transport layer contains the compound.
  12. 청구항 7에 있어서, 상기 유기물층은 발광층, 정공 주입층, 정공 수송층, 전자 주입층, 전자 수송층, 전자 차단층 및 정공 차단층으로 이루어진 군에서 선택되는 1층 또는 2층 이상을 더 포함하는 것인 유기 발광 소자. The method according to claim 7, The organic layer is a light emitting layer, a hole injection layer, a hole transport layer, an electron injection layer, an electron transport layer, an electron blocking layer and a hole blocking layer selected from the group consisting of more than one layer or more organic Light emitting element.
PCT/KR2020/000947 2019-01-18 2020-01-20 Compound and organic light emitting diode comprising same WO2020149716A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202080005797.8A CN112888695B (en) 2019-01-18 2020-01-20 Compound and organic light-emitting diode comprising same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2019-0006918 2019-01-18
KR20190006918 2019-01-18

Publications (1)

Publication Number Publication Date
WO2020149716A1 true WO2020149716A1 (en) 2020-07-23

Family

ID=71613128

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2020/000947 WO2020149716A1 (en) 2019-01-18 2020-01-20 Compound and organic light emitting diode comprising same

Country Status (3)

Country Link
KR (1) KR102353148B1 (en)
CN (1) CN112888695B (en)
WO (1) WO2020149716A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4151697A1 (en) * 2021-09-17 2023-03-22 Idemitsu Kosan Co., Ltd. Compound and an organic electroluminescence device comprising the compound

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022146123A1 (en) * 2021-01-04 2022-07-07 주식회사 엘지화학 Novel compound and organic light-emitting device comprising same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060051622A (en) * 2004-09-24 2006-05-19 주식회사 엘지화학 Organic light emitting device
KR20120087935A (en) * 2009-10-08 2012-08-07 메르크 파텐트 게엠베하 Materials for organic electroluminescent devices
CN106467553A (en) * 2016-07-29 2017-03-01 江苏三月光电科技有限公司 A kind of boracic organic electroluminescent compounds and its application in OLED
WO2018159662A1 (en) * 2017-02-28 2018-09-07 国立大学法人九州大学 Compound, light emitting material and organic light emitting element
KR20180122298A (en) * 2017-05-02 2018-11-12 주식회사 엘지화학 Novel compound and organic light emitting device comprising the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI636056B (en) * 2014-02-18 2018-09-21 學校法人關西學院 Polycyclic aromatic compound and method for production the same, material for organic device and application thereof
JP6729589B2 (en) 2015-07-24 2020-07-22 コニカミノルタ株式会社 Organic electroluminescence element, display device and lighting device
CN106467554A (en) 2016-07-29 2017-03-01 江苏三月光电科技有限公司 A kind of boracic organic electroluminescent compounds and its application
US10686141B2 (en) 2016-09-07 2020-06-16 Kwansei Gakuin Educational Foundation Polycyclic aromatic compound
CN111094302B (en) * 2017-11-06 2022-10-11 株式会社Lg化学 Polycyclic compound and organic light emitting device including the same
US20200411771A1 (en) * 2018-06-11 2020-12-31 Lg Chem, Ltd. Organic light-emitting device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060051622A (en) * 2004-09-24 2006-05-19 주식회사 엘지화학 Organic light emitting device
KR20120087935A (en) * 2009-10-08 2012-08-07 메르크 파텐트 게엠베하 Materials for organic electroluminescent devices
CN106467553A (en) * 2016-07-29 2017-03-01 江苏三月光电科技有限公司 A kind of boracic organic electroluminescent compounds and its application in OLED
WO2018159662A1 (en) * 2017-02-28 2018-09-07 国立大学法人九州大学 Compound, light emitting material and organic light emitting element
KR20180122298A (en) * 2017-05-02 2018-11-12 주식회사 엘지화학 Novel compound and organic light emitting device comprising the same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4151697A1 (en) * 2021-09-17 2023-03-22 Idemitsu Kosan Co., Ltd. Compound and an organic electroluminescence device comprising the compound
WO2023042574A1 (en) * 2021-09-17 2023-03-23 Idemitsu Kosan Co., Ltd. Compound and an organic electroluminescence device comprising the compound

Also Published As

Publication number Publication date
CN112888695A (en) 2021-06-01
KR20200090137A (en) 2020-07-28
KR102353148B1 (en) 2022-01-19
CN112888695B (en) 2023-12-22

Similar Documents

Publication Publication Date Title
WO2019088799A1 (en) Polycyclic compound and organic light-emitting device comprising same
WO2018186670A1 (en) Compound and organic light emitting element comprising same
WO2020022770A1 (en) Polycyclic compound and organic light-emitting device comprising same
WO2021172664A1 (en) Organic light-emitting device
WO2020167001A1 (en) Boron-containing compound, and organic light-emitting element comprising same
WO2021010656A1 (en) Organic light emitting element
WO2020184834A1 (en) Heterocyclic compound and organic light emitting device comprising same
WO2020122671A1 (en) Compound and organic light-emitting device comprising same
WO2020149716A1 (en) Compound and organic light emitting diode comprising same
WO2019172647A1 (en) Heterocyclic compound and organic light emitting device comprising same
WO2021172905A1 (en) Organic light-emitting device
WO2020149610A1 (en) Heterocyclic compound and organic light-emitting device comprising same
WO2022039518A1 (en) Novel compound and organic light-emitting device comprising same
WO2021101112A1 (en) Compound and organic light-emitting device comprising same
WO2019066337A1 (en) Compound, coating composition comprising same, organic light-emitting diode using same, and method for preparing same
WO2021029709A1 (en) Organic light-emitting device
WO2020153654A1 (en) Compound and organic light-emitting element comprising same
WO2020185026A1 (en) Compound and organic light emitting diode comprising same
WO2020130623A1 (en) Polycyclic compound and organic light-emitting device comprising same
WO2022080993A1 (en) Organic light-emitting device comprising organic compound
WO2024005486A1 (en) Compound and organic light-emitting element comprising same
WO2023234749A1 (en) Compound and organic light-emitting device comprising same
WO2024029927A1 (en) Compound and organic light-emitting device comprising same
WO2023033326A1 (en) Compound and organic light-emitting element comprising same
WO2022050656A1 (en) Organic light-emitting device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20741914

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20741914

Country of ref document: EP

Kind code of ref document: A1